







 
 
  





<HTML>

<!-- Mirrored from physrev.physiology.org/cgi/content/full/81/2/741 by HTTrack Website Copier/3.x [XR&CO'2010], Fri, 16 Jul 2010 00:29:24 GMT -->
<HEAD>
<TITLE>
	
	Alzheimer's Disease: Genes, Proteins, and Therapy -- Selkoe 81 (2): 741 -- Physiological Reviews</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>




	<!-- has inhead tag -->
	
		 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
		
	
		<style type="text/css"><!--
table.content_box_outer_table {
	padding-left:10px;
	padding-bottom:5px;
	padding-top:0px;
	padding-right:0px;
	}

table.content_box_outer_table_in_sidebar_frame {
	padding-left:10px;
	padding-bottom:0px;
	padding-top:10px;
	padding-right:10px;
	}

table.content_box_inner_table {
	background-color:#f0f0f0;
	font-family:Verdana,Arial,Helvetica,sans-serif;
	font-size:65%;
	padding-top:0px;
	padding-left:0px;
	padding-right:0px;
	padding-bottom:5px;
	}

table.content_box_pdfinframes {
	padding-top:0px;
	padding-left:0px;
	padding-right:0px;
	padding-bottom:4px;
	}

td.content_box_title_highlight {
	font-family:"Trebuchet MS",Verdana,Arial,Helvetica,sans-serif;
	font-style:italic;
	color:#ffffff;
	background-color:#003399;
	font-size:120%;
	font-weight:bold;
	text-align:center;
	padding:1px;
	vertical-align:middle;
	}

td.content_box_title {
	font-family:"Trebuchet MS",Verdana,Arial,Helvetica,sans-serif;
	font-style:italic;
	color:#ffffff;
	background-color:#828282;
	font-size:120%;
	font-weight:bold;
	padding:1px;
	text-align:center;
	vertical-align:middle;
	}

td.content_box_space_between_sections {
	padding-top:2px;
	}

td.content_box_arrow {
	text-align:right;
	padding-left:5px;
	padding-right:0px;
	padding-top:0px;
	padding-bottom:3px;
	}

td.content_box_item {
	text-align:left;
	vertical-align:top;
	padding-left:3px;
	padding-right:5px;
	padding-top:0px;
	padding-bottom:3px;
	}

td.content_box_pdfinframes_citation_cell {
	background-color:#ffffff;
	border:1px #000000 solid;
	padding:3px;
	font-family:Verdana,Arial,Helvetica,sans-serif;
	font-size:65%;
	text-align:left;
	}


font.openaccess {
	font-weight:bold;
	padding-left:3px;
	padding-right:3px;
	background-color:#ffffff;
	}
font.openaccess_open {
	color:#000000;
	}
font.openaccess_access {
	color:#cc0000;
	}
font.openaccess_oa {
	}
.content_box_openaccess_title {
	text-align:center;
	white-space:nowrap;
	background-color:#BABABA;
	}




div.referrer-based-search-line {
	font-family: arial,sans-serif;
	font-size: 0.75em;
	background-color: #009918;
	padding: 3px 25px;
	margin: 0px 4px 5px 0px;
}

div.referrer-based-search-line .search-terms{
	font-weight: bold;
}

div.referrer-based-search-line .collection-name{
	font-style: italic;
}

@media screen,print,handheld
{
    .notonscreen { display: none; }
}
--></style>

	        
<style type="text/css"><!--
	@media screen,print,handheld
{
    .notonscreen { display: none; }
}
--></style>
<!-- ac in the head available -->

 

		
		
	    <script language="javascript">
		<!-- 
	function popwin(url,wid,hei,fromtop,fromleft) {
		var winPref = "channelmode=no,toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=auto,resizable=no,width=" + wid + ",height=" + hei + ",top=" + fromtop + ",left=" + fromleft;
		window.open(url, "popwin", winPref);
	}
	// -->
	</script>
        <script type="text/javascript" src="http://physrev.physiology.org/javascript/ajax/xmlhttprequest.js"></script>
<script type="text/javascript" src="http://physrev.physiology.org/javascript/ajax/utility.js"></script>
<script type="text/javascript" src="http://physrev.physiology.org/javascript/entrez/callback.js"></script>

	
		
	

<meta name="robots" content="nofollow">



<meta name="citation_journal_title" content="Physiological Reviews">
<meta name="citation_publisher" content="Am Physiological Soc">
<meta name="citation_issn" content="0031-9333">

<meta name="citation_authors" content="Selkoe, Dennis J.">
<meta name="citation_title" content="Alzheimer's Disease: Genes, Proteins, and Therapy">
<meta name="citation_date" content="04/01/2001">
<meta name="citation_volume" content="81">
<meta name="citation_issue" content="2">
<meta name="citation_firstpage" content="741">
<meta name="citation_id" content="81/2/741">
<meta name="citation_mjid" content="physrev;81/2/741">
<meta name="citation_abstract_html_url" content="http://physrev.physiology.org/cgi/content/abstract/81/2/741">
<meta name="citation_fulltext_html_url" content="http://physrev.physiology.org/cgi/content/full/81/2/741">
<meta name="citation_pdf_url" content="http://physrev.physiology.org/cgi/reprint/81/2/741.pdf">
<meta name="citation_pmid" content="11274343">

<meta name="dc.Contributor" content="Selkoe, Dennis J.">
<meta name="dc.Title" content="Alzheimer's Disease: Genes, Proteins, and Therapy">

<meta name="dc.Date" content="04/01/2001">

<META NAME="ROBOTS" CONTENT="NOARCHIVE"> 

</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>
	



<A NAME="top"><!-- null --></A>


	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/"><IMG BORDER=0 WIDTH=220 HEIGHT=44 ALT="Physiol Rev" SRC="http://physrev.physiology.org/icons/banner/title.gif"></A>
			<a href="http://physrev.physiology.org/cgi/adclick/?ad=15862&amp;adclick=true&amp;url=http%3A%2F%2Fwww.the-aps.org%2Fpublications%2Fhinari.htm"><img src="http://physrev.physiology.org/adsystem/graphics/1279238463230/physiology/oare.jpg?ad=15862&amp;adview=true" alt="Watch the video to see how APS reaches out to developing nations." border="1" width="220" height="40"></a>
			
	<TABLE CELLPADDING=2 CELLSPACING=2 WIDTH=450>
	<TR>
		<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/help/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">HELP</FONT></A></FONT></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/cgi/feedback"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/subscriptions"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/contents-by-date.0.shtml"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/search.dtl"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/content/vol81/issue2/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>
	</TR>
	</TABLE>
	</TD>
		<TD><IMG alt=" " WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="http://physrev.physiology.org/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE=""><INPUT TYPE="hidden" NAME="sortspec" VALUE="relevance"><TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#003399"><IMG alt=" " WIDTH="2" HEIGHT="2" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#003399" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#003399" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="http://physrev.physiology.org/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#003399"><IMG alt=" " WIDTH="2" HEIGHT="2" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG alt=" " WIDTH="2" HEIGHT="2" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000"><LABEL FOR="qsintdefsauthor1">Author:</LABEL><BR></FONT>
					<INPUT TYPE="text" NAME="author1" ID="qsintdefsauthor1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000"><LABEL FOR="qsintdefsfulltext">Keyword(s):</LABEL><BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" ID="qsintdefsfulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000"><LABEL FOR="qsintdefspubdate_year">Year:</LABEL>&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" ID="qsintdefspubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000"><LABEL FOR="qsintdefsvolume">Vol:</LABEL>&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" ID="qsintdefsvolume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000"><LABEL FOR="qsintdefsfirstpage">Page:</LABEL>&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" ID="qsintdefsfirstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG alt=" " WIDTH="2" HEIGHT="2" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG alt=" " WIDTH="2" HEIGHT="2" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR><FONT SIZE="-2" FACE="verdana,arial,helvetica"></FONT><!-- debug:  --><HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>











 
	














	






	
		
<b>

	
		
		<FONT size="-1" COLOR=003399><I>Physiol. Rev.</I> 81: 741-766, 2001;
	         <BR>0031-9333/01 $15.00<BR></FONT>
        	
	

</b>

	 
 






 



 
	 
		  
			
	
		<table class="content_box_outer_table"
		 
			
				
					align="right"
				
			
		>
		
		
			<tr>
			<td>
		
	

<!-- beginning of inner table -->
	<table class="content_box_inner_table">
<!-- citation -->
	
		




	

	

	
		
			
<tr><td class="content_box_title_highlight" colspan="2">This Article</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				
				<strong><a href="http://physrev.physiology.org/cgi/content/abstract/81/2/741">
				Abstract</a></strong>
				 					<img alt="Freely available" width="32" height="7" border="0" src="http://physrev.physiology.org/icons/shared/toc/free.gif" />
				
	
				</td></tr>
			
		
		
	

	
	
	

	
	
	


	
	
	

	
	
	

	
	
	
	
	
	
	
	
	

	
		
		
	
	
		
	

	

	
		
			
		
	

	

	
	 

	
	 

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
		<strong>
		
		
		
			<a href="http://physrev.physiology.org/cgi/reprint/81/2/741">
		<strong>Full Text</strong> (PDF)</a>

 
		
		</strong>
		</td></tr>
	
	

	
	
	
	
	

	
	
	
	
	

	
	
	

	
	





	

	
		
	

	
		
	

	
		

	
		
		

			


	

			

			
		
	

			
	  
	

			

			

			
	
	




	
		
	

	
	









	
		
	





	
	
	

	
		
	

	 

	
	
		  
    

	

	

	

	








		
	
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;saveAlert=no&amp;cited_by_criteria_resid=physrev;81/2/741&amp;return_type=article&amp;return_url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741">
				Alert me when this article is cited</a></strong>
			</td></tr>
	

		
		

		
		

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;saveAlert=no&amp;correction_criteria_value=81/2/741&amp;return_type=article&amp;return_url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741">
				Alert me if a correction is posted</a></strong>
			</td></tr>
		























			
		
			
			
			
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
					<strong><a rel="nofollow" href="http://physrev.physiology.org/cgi/citemap?id=physrev;81/2/741">
					Citation Map</a></strong>
				</td></tr>
		
	

			
			
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Services</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/mailafriend?url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741&amp;title=Alzheimer%27s+Disease%3A+Genes%2C+Proteins%2C+and+Therapy">
				Email this article to a friend</a></strong>
			</td></tr>
			
			


	

	

	

		
		



			
			
			
		
	

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
		<strong>
		<a href="http://physrev.physiology.org/cgi/search?qbe=physrev;81/2/741&amp;journalcode=physrev&amp;minscore=5000">
		Similar articles in this journal</a>
		</strong>
		</td></tr>


		


		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong>
				<a href="http://physrev.physiology.org/cgi/external_ref?access_num=physrev%3B81%2F2%2F741&amp;link_type=ISI_RelatedRecords">
				Similar articles in Web of Science</a></strong>
				</strong>
			</td></tr>
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/external_ref?access_num=11274343&amp;link_type=MED_NBRS">
				Similar articles in PubMed</a></strong>
			</td></tr>
		
	


		



			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/etoc">
				Alert me to new issues of the journal</a></strong>
			</td></tr>
		

		
		
	

		
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
			<strong><a href="http://physrev.physiology.org/cgi/citmgr?gca=physrev;81/2/741">
			Download to citation manager</a></strong>
			</td></tr>
		
		
	


	
		
	

	



  			
		
		
		
	


	

	




	





		

		

	
	
	
		


	

	

	


	


<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Citing Articles</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="#otherarticles">
				Citing Articles via HighWire</a></strong>
			</td></tr>
	



	


	
		
		
		


			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong>
				
					
					<a href="http://physrev.physiology.org/cgi/external_ref?access_num=physrev%3B81%2F2%2F741&amp;link_type=ISI_Citing">
					Citing Articles via Web of Science (1912)</a>
				
				</strong>
			</td></tr>
		
	 
	

		
		
			
		

					
						
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=http://physrev.physiology.org/cgi/content/abstract/81/2/741&amp;link_type=GOOGLESCHOLAR">Citing Articles via Google Scholar</a></strong>
						</td></tr>		
						
				
			
		
		

	

	
	















	
		
			
				
				
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Google Scholar</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://scholar.google.com/scholar?q=%22author%3AD. J.+author%3ASelkoe%22">
							Articles by Selkoe, D. J.</a></strong></td></tr>
				
				
			
		
		
	
	
	
	

		
			
				
					
						
						
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=http://physrev.physiology.org/cgi/content/abstract/81/2/741&amp;link_type=GOOGLESCHOLARRELATED">Search for Related Content</a></strong>
						</td></tr>		
						
				
			
		
	










	





	
		
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">PubMed</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/external_ref?access_num=11274343&amp;link_type=PUBMED">
				PubMed Citation</a></strong>
			</td></tr>
		
	

	
		
		
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=Selkoe+DJ&amp;link_type=AUTHORSEARCH">
							Articles by Selkoe, D. J.</a></strong>
						</td></tr>
				
			
		

		
	

	















	
	


	












	


































	
		

	

		
			
		
	 
		











	

	






































	</td></tr></table>
</td></tr></table> 


		
	



 







 





	
	
	
	
	
	
    
	
	 
	
	
	
		<vardef id="TEXT">

<!-- /COPYRIGHT -->
<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


<P>
<FONT SIZE=-1>Physiological Reviews, Vol. 81, No. 2, April 2001, pp. 741-766<BR>
Copyright &copy;2001 by the American Physiological Society<BR></FONT>





<H2>
Alzheimer's Disease: Genes, Proteins, and Therapy

</H2>



<STRONG>
<NOWRAP>
Dennis J. 
Selkoe
</NOWRAP>
</STRONG>
<P>
Department of Neurology and Program in Neuroscience, Harvard
Medical School, and Center for Neurologic Diseases, Brigham and
Women's Hospital, Boston, Massachusetts
<P>





    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    








<P><P>
<BLOCKQUOTE><FONT SIZE=-1><B>

<A HREF="#SEC1">I.  INTRODUCTION: AN HISTORICAL PERSPECTIVE</A><BR>
    <A HREF="#SEC2">II.  DECIPHERING THE NEUROPATHOLOGICAL PHENOTYPE OF ALZHEIMER'S
DISEASE</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC2_1">A.&nbsp; Neuritic Plaques</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC2_2">B.&nbsp; The Nature of Diffuse ("Preamyloid") Plaques</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC2_3">C.&nbsp; Neurofibrillary Tangles Are Composed of
Hyperphosphorylated Tau Proteins</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC2_4">D.&nbsp; Dystrophic Cortical Neurites Within and Outside Neuritic
Plaques</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC2_5">E.&nbsp; Amyloid Microangiopathy</A><BR>
	<A HREF="#SEC3">III.  ORIGIN OF AMYLOID <IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0>-PROTEIN: CELL BIOLOGY OF
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0>-AMYLOID PRECURSOR PROTEIN</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC3_1">A.&nbsp; Expression and Heterogeneity of APP</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC3_2">B.&nbsp; Trafficking and Proteolytic Processing of APP</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC3_3">C.&nbsp; Inferred Functions of APP and Its Derivatives</A><BR>
	<A HREF="#SEC4">IV.  GENETICS OF FAMILIAL ALZHEIMER'S DISEASE</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC4_1">A.&nbsp; Familial Forms of AD Closely Resemble the Common
"Sporadic" Form</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC4_2">B.&nbsp; Missense Mutations in APP: A Very Rare Cause of Familial AD</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC4_3">C.&nbsp; Missense Mutations in the Presenilins: The Most Common
Cause of Autosomal Dominant AD to Date</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC4_4">D.&nbsp; The Apolipoprotein E4 Allele is a Major Genetic Risk Factor
for Late-Onset AD</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC4_5">E.&nbsp; Other Genetic Alterations Predisposing to AD Are Likely</A><BR>
	<A HREF="#SEC5">V.  GENOTYPE-TO-PHENOTYPE CONVERSIONS IN FAMILIAL ALZHEIMER'S
DISEASE</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC5_2">A.&nbsp; APP Mutations Increase the Production  of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0><SUB>42</SUB> Peptides</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC5_3">B.&nbsp; Presenilin Mutations Increase the Production of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0><SUB>42</SUB> Peptides</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC5_4">C.&nbsp; Inheritance of ApoE4 Alleles Increases  Steady-State
Levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0> Peptides  in the Brain</A><BR>
	<A HREF="#SEC6">VI.  FUNCTION OF PRESENILINS: A CENTRAL ROLE IN INTRAMEMBRANOUS
PROTEOLYSIS</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC6_1">A.&nbsp; Cell Biology of the Presenilins</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC6_2">B.&nbsp; Presenilin and the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/gamma.gif" ALIGN=BOTTOM ALT="gamma " BORDER=0>-Secretase Cleavage of APP</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC6_3">C.&nbsp; Presenilin as a Key Mediator of Notch Signaling</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC6_4">D.&nbsp; Presenilin May Be Required for Proteolysis  of Other
Integral Membrane Proteins</A><BR>
	<A HREF="#SEC7">VII.  THE COMPLEX INFLAMMATORY AND NEUROTOXIC CASCADE OF 
ALZHEIMER'S DISEASE</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC7_2">A.&nbsp; Clues to the Temporal Evolution of AD Emerge From Studies
of Down's Syndrome and APP Transgenic Mice</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC7_3">B.&nbsp; A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0><SUB>42</SUB> Accumulation, Diffuse Plaques, and the
Accrual of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/link/beta.gif" ALIGN=BOTTOM ALT="beta " BORDER=0><SUB>40</SUB></A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC7_4">C.&nbsp; The Inflammatory Process in AD</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC7_5">D.&nbsp; Free Radical Accumulation, Peroxidative Injury, and Altered
Calcium Homeostasis May Mediate Neuritic/Neuronal Injury</A><BR>
	<A HREF="#SEC8">VIII.  TREATING AND PREVENTING ALZHEIMER'S DISEASE</A><BR>
    &nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC8_1">A.&nbsp; Remaining Questions Abound</A><BR>
	&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="#SEC8_2">B.&nbsp; Potential Therapeutic Strategies</A><BR>
	<A HREF="#SEC9">IX.  CONCLUSION</A><BR>
    
</B></FONT></BLOCKQUOTE>
</P></P>




<a name = "Abstract"><!-- comment for mosaic --></a>



<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>





<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

<P><STRONG>
Selkoe, Dennis J.</STRONG>
Alzheimer's Disease: Genes, Proteins, and Therapy. <I>Physiol. Rev.</I> 81: 741-766, 2001.<IMG SRC=http://physrev.physiology.org/math/12pt/normal/mdash.gif>Rapid progress in
deciphering the biological mechanism of Alzheimer's disease (AD) has
arisen from the application of molecular<SUP> </SUP>and cell biology to this
complex disorder of the limbic and association<SUP> </SUP>cortices. In turn, new
insights into fundamental aspects of protein<SUP> </SUP>biology have resulted from
research on the disease. This beneficial<SUP> </SUP>interplay between basic and
applied cell biology is well illustrated<SUP> </SUP>by advances in understanding
the genotype-to-phenotype relationships<SUP> </SUP>of familial Alzheimer's
disease. All four genes definitively linked<SUP> </SUP>to inherited forms of the
disease to date have been shown to increase<SUP> </SUP>the production and/or
deposition of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein in the brain.<SUP> </SUP>In particular, evidence
that the presenilin proteins, mutations<SUP> </SUP>in which cause the most
aggressive form of inherited AD, lead<SUP> </SUP>to altered intramembranous
cleavage of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor<SUP> </SUP>protein by the protease called
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase has spurred progress<SUP> </SUP>toward novel therapeutics. The
finding that presenilin itself<SUP> </SUP>may be the long-sought
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase, coupled with the recent identification<SUP> </SUP>of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase,
has provided discrete biochemical targets for<SUP> </SUP>drug screening and
development. Alternate and novel strategies<SUP> </SUP>for inhibiting the early
mechanism of the disease are also emerging.<SUP> </SUP>The progress reviewed here,
coupled with better ability to diagnose<SUP> </SUP>the disease early, bode well
for the successful development of<SUP> </SUP>therapeutic and preventative drugs
for this major public health<SUP> </SUP>problem.
</P>



<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>



    
    <A NAME="SEC1">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;I.  INTRODUCTION: AN HISTORICAL PERSPECTIVE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>



<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<P>Few subjects in biomedicine have aroused the interest of the
scientific and lay communities alike as has Alzheimer's disease<SUP> </SUP>(AD).
The dramatic rise in life expectancy during the 20th century,<SUP> </SUP>from
roughly 49&nbsp;years to more than 76&nbsp;years in the United States,<SUP> </SUP>has
resulted in a burgeoning number of individuals achieving the<SUP> </SUP>age at
which neurodegenerative disorders become common. Among<SUP> </SUP>these, AD has
emerged as the most prevalent form of late-life<SUP> </SUP>mental failure in
humans. It was not always so. When Alois Alzheimer,<SUP> </SUP>a Bavarian
psychiatrist, first defined the clinicopathological<SUP> </SUP>syndrome that bears
his name at a meeting in Munich in 1906,&nbsp;neither<SUP> </SUP>he nor his audience
recognized that the disorder he described<SUP> </SUP>in a woman in her early 50s
might ultimately turn out to be indistinguishable<SUP> </SUP>from common senile
dementia. Indeed, it was not until the work<SUP> </SUP>of Blessed, Tomlinson, and
Roth in the late 1960s that AD became<SUP> </SUP>generally accepted as the most
common basis for senile dementia.<SUP> </SUP>We now recognize that a
histopathological syndrome indistinguishable<SUP> </SUP>from that which Alzheimer
originally described has an incidence<SUP> </SUP>which rises almost
logarithmically with age. As a result, AD,<SUP> </SUP>originally believed to be a
rare dementia occurring in the "presenile"<SUP> </SUP>period (that is, onset
of symptoms under 65&nbsp;years of age), is<SUP> </SUP>largely indistinguishable from
senile dementia of the Alzheimer<SUP> </SUP>type, and the cases accrue at a linear
rate rather than in a bimodal<SUP> </SUP>age<SUP> </SUP>distribution.</P>
	
    
	
	<P>Alzheimer's original patient, a woman referred to as Auguste D.&nbsp;in his
report, exemplified several cardinal features of the<SUP> </SUP>disorder that we
still observe in most patients nowadays: progressive<SUP> </SUP>memory impairment;
disordered cognitive function; altered behavior<SUP> </SUP>including paranoia,
delusions, and loss of social appropriateness;<SUP> </SUP>and a progressive
decline in language function. During the early<SUP> </SUP>and middle phases of
this slow, inexorable process, the patient's<SUP> </SUP>alertness is well
preserved, and motoric and sensory functions<SUP> </SUP>are essentially intact.
However, as subjects continue to lose<SUP> </SUP>ground cognitively, slowing of
motor functions such as gait and<SUP> </SUP>coordination often lead to a picture
resembling extrapyramidal<SUP> </SUP>motor disorders such as<SUP> </SUP>parkinsonism.</P>
	
    
	
	<P>For many decades after Alzheimer's original description, little
progress in defining the pathogenesis of AD occurred. Although<SUP> </SUP>neuropathological studies led to growing recognition of the commonness<SUP> </SUP>of the syndrome, the study of AD and other idiopathic neurodegenerative<SUP> </SUP>disorders was marked by mechanistic ignorance and therapeutic<SUP> </SUP>nihilism.
This situation began changing in the 1960s, when the<SUP> </SUP>advent of electron
microscopy allowed Michael Kidd in England<SUP> </SUP>and Robert Terry in the
United States to describe the striking<SUP> </SUP>ultrastructural changes
underlying the two classical lesions which<SUP> </SUP>Alzheimer had linked: senile
(neuritic) plaques and neurofibrillary<SUP> </SUP>tangles. In the mid 1970s, the
first clear neurochemical clue<SUP> </SUP>as to what might underlie the dementing
symptoms came from the<SUP> </SUP>observation that neurons synthesizing and
releasing acetylcholine<SUP> </SUP>underwent variable but usually severe
degeneration. This was observed<SUP> </SUP>as a decrease in the amounts and
activities of the synthetic and<SUP> </SUP>degradative enzymes, choline
acetyltransferase and acetylcholinesterase,<SUP> </SUP>in the limbic and cerebral
cortices and an associated loss of<SUP> </SUP>cholinergic cell bodies in the
subcortical nuclei that project<SUP> </SUP>to these regions, namely, the septal
nuclei and the basal forebrain<SUP> </SUP>cholinergic system. As a result,
substantial pharmacological research<SUP> </SUP>focused on attempting to enhance
acetylcholine levels in the synaptic<SUP> </SUP>cleft, primarily by inhibiting the
degradative enzyme. These efforts<SUP> </SUP>ultimately led to the only two drugs
specifically approved to<SUP> </SUP>date for treating Alzheimer's disease in the
United States: tetrahydroaminoacridine<SUP> </SUP>and<SUP> </SUP>donezepil.</P>
	
    
	
	<P>In the late 1970s and early 1980s, variable deficits of other
neurotransmitter systems were identified in AD brain tissue.<SUP> </SUP>It became
increasingly clear that AD, unlike Parkinson's disease,<SUP> </SUP>did not
involve degeneration of a single transmitter class of<SUP> </SUP>neurons but was
highly heterogeneous. This realization appeared<SUP> </SUP>to explain the lack of
robust clinical benefit in most patients<SUP> </SUP>treated with cholinergic
drugs. Attention increasingly focused<SUP> </SUP>on attempting to identify the
underlying mechanisms for the synpatic<SUP> </SUP>dysfunction and perikaryal
degeneration that affected multiple<SUP> </SUP>classes of neurons in the limbic
system and association cortices.<SUP> </SUP>In this context, investigators
increasingly trained their sights<SUP> </SUP>on the two classical
neuropathological lesions to which Alzheimer<SUP> </SUP>had called<SUP> </SUP>attention.</P>
	
    
	
	<P>As neurochemists began attempting to identify the composition and
molecular origin of the amyloid plaques and neurofibrillary<SUP> </SUP>tangles,
they were reminded by their neuropathological colleagues<SUP> </SUP>that these
lesions observed in the postmortem brain could be considered<SUP> </SUP>tombstones
of the process that occurred late in disease and were<SUP> </SUP>thus unlikely to
provide major insights into etiology and early<SUP> </SUP>pathogenesis. Thus one
observed not only an ongoing debate about<SUP> </SUP>which of the two lesions
might precede the other but a general<SUP> </SUP>sense that both lesions were
likely to be preceded by some or<SUP> </SUP>many biochemical steps that might not
become apparent simply by<SUP> </SUP>identifying the principal proteins composing
these lesions. However,<SUP> </SUP>increasingly rapid scientific progress since
the mid 1980s has<SUP> </SUP>proven these concerns ill-founded.</P>
	
    
	
	<P>Advances in biochemical pathology, that is, the use of compositional
analyses and immunocytochemistry to define the subunit<SUP> </SUP>composition of
the plaques and tangles, were followed by signal<SUP> </SUP>advances in the
molecular genetics of AD that have validated the<SUP> </SUP>critical role of the
subunit proteins in the fundamental mechanisms<SUP> </SUP>of AD as well as certain
other degenerative dementias. The elucidation<SUP> </SUP>of the
genotype-to-phenotype relationships for each genetic alteration<SUP> </SUP>linked
to familial forms of AD (a process which is still very<SUP> </SUP>active) has led
to a growing consensus about how at least the<SUP> </SUP>familial forms of the
disorder may begin. The result of this continuing<SUP> </SUP>work is that a rough
temporal outline of the disease cascade has<SUP> </SUP>begun to emerge. This
process and the closely related effort to<SUP> </SUP>identify points for
therapeutic intervention have been markedly<SUP> </SUP>assisted by the development
of imperfect but nonetheless highly<SUP> </SUP>useful cellular and animal models
of the presumed early features<SUP> </SUP>of the disease<SUP> </SUP>mechanism.</P>
	
    
	
	<P>In this article, I review the extensive neuropathological, biochemical,
genetic, cell biological, and transgenic modeling<SUP> </SUP>studies that have
contributed to our growing understanding of<SUP> </SUP>the etiopathogenesis of AD.
Given the enormous amount of scientific<SUP> </SUP>activity directed toward this
problem and to related basic biological<SUP> </SUP>questions, the review will
perforce be selective, and the reader<SUP> </SUP>will be referred to primary
literature and review articles that<SUP> </SUP>cover particular features of this
complex topic. At the end, we<SUP> </SUP>consider the imminent initiation of
therapeutic trials directed<SUP> </SUP>at certain key features of the disease
cascade. If these "rational"<SUP> </SUP>treatment approaches engender some
success, AD may emerge as a<SUP> </SUP>triumph of reductionist biology applied to
a disorder of the most<SUP> </SUP>complex of physiological systems, the human
cerebral<SUP> </SUP>cortex.</P>
	
    

    
    <A NAME="SEC2">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;II.  DECIPHERING THE NEUROPATHOLOGICAL PHENOTYPE OF ALZHEIMER'S
DISEASE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>




<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<A NAME="SEC2_1">
<P><B>A.&nbsp; Neuritic Plaques</B>

	
	    
	    <P>Neuritic plaques, one of the two diagnostic brain lesions observed
in Alzheimer's original patient, are microscopic foci of<SUP> </SUP>extracellular
amyloid deposition and associated axonal and dendritic<SUP> </SUP>injury,
generally found in large numbers in the limbic and association<SUP> </SUP>cortices
(<A HREF="#B24">24</A>). Such plaques contain extracellular deposits of<SUP> </SUP>amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein (A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">) that occur principally in a filamentous<SUP> </SUP>form, i.e., as star-shaped masses of amyloid fibrils. Dystrophic<SUP> </SUP>neurites occur both within this amyloid deposit and immediately<SUP> </SUP>surrounding it. These neurites are often dilated and tortuous<SUP> </SUP>and are
marked by ultrastructural abnormalities that include enlarged<SUP> </SUP>lysosomes, numerous mitochondria, and paired helical filaments,<SUP> </SUP>the
latter generally indistinguishable from those that comprise<SUP> </SUP>the
neurofibrillary tangles (see below). Such plaques are also<SUP> </SUP>intimately
associated with microglia expressing surface antigens<SUP> </SUP>associated with
activation, such as CD45 and HLA-DR, and they<SUP> </SUP>are surrounded by
reactive astrocytes displaying abundant glial<SUP> </SUP>filaments. The microglia
are usually within and adjacent to the<SUP> </SUP>central amyloid core of the
neuritic plaque, whereas the astrocytes<SUP> </SUP>often ring the outside of the
plaque, with some of their processes<SUP> </SUP>extending centripetally toward the
amyloid core. The time that<SUP> </SUP>it takes to develop such a neuritic plaque
is unknown, but these<SUP> </SUP>lesions probably evolve very gradually over a
substantial period<SUP> </SUP>of time, perhaps many months or years. The
surrounding neurites<SUP> </SUP>that contribute to any one plaque can emanate from
local neurons<SUP> </SUP>of diverse neurotransmitter classes. Much of the
fibrillar A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUP> </SUP>found in the neuritic plaques is the species ending at
amino acid<SUP> </SUP>42&nbsp;(A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>), the slightly longer, more
hydrophobic form that is<SUP> </SUP>particularly prone to aggregation
(<A HREF="#B70">70</A>). However, the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> species<SUP> </SUP>ending at amino acid 40&nbsp;(A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>), which is normally more abundantly<SUP> </SUP>produced by
cells than A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> (see below), is usually colocalized<SUP> </SUP>with
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> in the plaque. The cross-sectional diameter of
neuritic<SUP> </SUP>plaques in microscopic brain sections varies widely from 10&nbsp;to<SUP> </SUP>&gt;120 &#181;m, and the density and degree of compaction of the amyloid<SUP> </SUP>fibrils which comprise the extracellular core also shows great<SUP> </SUP>variation among<SUP> </SUP>plaques.</P>
	    
	
	
    
	
	<A NAME="SEC2_2">
<P><B>B.&nbsp; The Nature of Diffuse ("Preamyloid") Plaques</B>

	
	    
	    <P>When the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptide that Glenner originally identified in
meningovascular amyloid deposits from Alzheimer brains
(<A HREF="#B35">35</A>) was<SUP> </SUP>recognized as the subunit of the plaque amyloid
(<A HREF="#B38">38</A>, <A HREF="#B96">96</A>, <A HREF="#B144">144</A>),<SUP> </SUP>many laboratories
developed sensitive antibodies to endogenous<SUP> </SUP>or synthetic A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">.
Immunohistochemical staining with such antibodies<SUP> </SUP>revealed a far more
extensive number of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits than had been<SUP> </SUP>appreciated by the use
of classical silver impregnation methods,<SUP> </SUP>such as the Bielschowsky and
Bodian stains. In retrospect, it<SUP> </SUP>became apparent that the most
sensitive silver staining methods<SUP> </SUP>(e.g., the modified Bielschowsky
stain and the Gallya's silver<SUP> </SUP>stain) could also recognize many A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
deposits that lacked the compacted,<SUP> </SUP>fibrillar appearance of the
classical neuritic plaques. Many of<SUP> </SUP>the plaques found in limbic and
association cortices, and virtually<SUP> </SUP>all of those in brain regions not
clearly implicated in the typical<SUP> </SUP>symptomatology of AD (e.g., thalamus,
caudate, putamen, cerebellum),<SUP> </SUP>showed relatively light, amorphous A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
immunoreactivity that occurred<SUP> </SUP>in a finely granular pattern, without a
clearly fibrillar, compacted<SUP> </SUP>center. Moreover, staining with silver
stains highly capable of<SUP> </SUP>recognizing dystrophic neurites (e.g., the
Bodian method) as well<SUP> </SUP>as immunohistochemistry for various
neuronal/neuritic cytoskeletal<SUP> </SUP>proteins indicated that there was very
little or no detectable<SUP> </SUP>neuritic dystrophy in most of these
amorphous-appearing, nonfibrillar<SUP> </SUP>plaques.</P>
	    
	
	    
	    <P>The recognition of these amorphous plaques in the late 1980s
(<A HREF="#B71">71</A>, <A HREF="#B166">166</A>, <A HREF="#B199">199</A>) and their
detection in regions that also contained<SUP> </SUP>many neuritic plaques (i.e.,
limbic and association cortices)<SUP> </SUP>led to the concept that they might
represent precursor lesions<SUP> </SUP>of neuritic plaques. These lesions were
thus referred to as "diffuse"<SUP> </SUP>plaques or "preamyloid deposits."
When it later was determined<SUP> </SUP>that the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides deposited in
Alzheimer brain principally<SUP> </SUP>ended at either A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> or
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>, it became apparent that peptides<SUP> </SUP>ending at
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> were the subunits of the material comprising the<SUP> </SUP>diffuse plaques, with little or no A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> immunoreactivity,
in contrast<SUP> </SUP>to the mixed (A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">42 plus A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">40) deposits that generally
were found<SUP> </SUP>in the fibril-rich neuritic plaques (<A HREF="#B68">68</A>,
<A HREF="#B69">69</A>, <A HREF="#B85">85</A>, <A HREF="#B128a">128a</A>).<SUP> </SUP>The hypothesis
that diffuse plaques represent immature lesions<SUP> </SUP>that are precursors to
the plaques with surrounding cytopathology<SUP> </SUP>arose from two lines of
evidence. First, diffuse plaques were<SUP> </SUP>the sole form found in those
brain regions that largely or entirely<SUP> </SUP>lacked neuritic dystrophy, glial
changes, and neurofibrillary<SUP> </SUP>tangles and were not clearly implicated in
the typical clinical<SUP> </SUP>symptoms of AD, e.g., cerebellum, striatum, and
thalamus. Second,<SUP> </SUP>healthy aged humans free of AD or other dementing
processes often<SUP> </SUP>showed solely diffuse plaques in limbic and association
cortices,<SUP> </SUP>i.e., in the same regions as Alzheimer patients showed
mixtures<SUP> </SUP>of diffuse and neuritic plaques. The notion that diffuse
plaques<SUP> </SUP>could be earlier lesions was later supported by studies of
transgenic<SUP> </SUP>mice expressing mutant human APP. These mice usually showed
diffuse<SUP> </SUP>deposits before developing fibrillar, thioflavin
S-positive, and<SUP> </SUP>Congo red-positive neuritic/glial plaques.
Indeed, this hypothesis<SUP> </SUP>was particularly well supported by
immunohistochemical studies<SUP> </SUP>of patients with Down's syndrome
(<A HREF="#B85">85</A>). Such individuals often<SUP> </SUP>display diffuse deposits as
early as their teenage years but do<SUP> </SUP>not show neuritic/glial plaques
until some two decades later,<SUP> </SUP>a time at which they first display
abundant neurofibrillary tangles<SUP> </SUP>in limbic and association<SUP> </SUP>cortices.</P>
	    
	
	
    
	
	<A NAME="SEC2_3">
<P><B>C.&nbsp; Neurofibrillary Tangles Are Composed of
Hyperphosphorylated Tau Proteins</B>

	
	    
	    <P>Many neurons in the brain regions typically affected in AD
(entorrhinal cortex, hippocampus, parahippocampal gyrus, amygdala,<SUP> </SUP>frontal, temporal, parietal and occipital association cortices,<SUP> </SUP>and
certain subcortical nuclei projecting to these regions) contain<SUP> </SUP>large,
nonmembrane-bound bundles of abnormal fibers that occupy<SUP> </SUP>much of
the perinuclear cytoplasm. Electron microscopy reveals<SUP> </SUP>that most of
these fibers consist of pairs of ~10-nm filaments<SUP> </SUP>wound into helices
(paired helical filaments or PHF), with a helical<SUP> </SUP>period of ~160 nm.
Some tangle-bearing neurons also contain skeins<SUP> </SUP>of straight, 10-&nbsp;to
15-nm filaments interspersed with the PHF.<SUP> </SUP>Beginning in 1985,&nbsp;immunocytochemical and biochemical analyses<SUP> </SUP>of neurofibrillary tangles
suggested that they were composed of<SUP> </SUP>the microtubule-associated
protein tau (<A HREF="#B12">12</A>, <A HREF="#B43">43</A>, <A HREF="#B79">79</A>,
<A HREF="#B107">107</A>,<SUP> </SUP><A HREF="#B191">191</A>). This was later confirmed by
isolation of a subset of PHF<SUP> </SUP>that could be partially solubilized in
strong solvents such as<SUP> </SUP>SDS (<A HREF="#B84">84</A>) or digested with harsh
proteases (<A HREF="#B75">75</A>, <A HREF="#B185">185</A>), releasing<SUP> </SUP>tau proteins
which migrated electrophoretically at a higher molecular<SUP> </SUP>weight than
did normal tau prepared from tangle-free human or<SUP> </SUP>animal brains.
This slower migration was shown to result from<SUP> </SUP>increased
phosphorylation of tau; in vitro dephosphorylation with<SUP> </SUP>alkaline
phosphatase returned this PHF-derived tau to essentially<SUP> </SUP>normal
migration. Although some PHF can be solubilized by boiling<SUP> </SUP>in SDS
(<A HREF="#B84">84</A>), much of the tau in tangles is present in highly<SUP> </SUP>insoluble filaments (PHF) that are resistant to detergents such<SUP> </SUP>as SDS
and chaotrophic solvents such as guanidine hydrochloride<SUP> </SUP>(<A HREF="#B145">145</A>). Extensive analysis of the nature of
hyperphosphorylated<SUP> </SUP>tau using antibodies specific for various
phosphotau epitopes<SUP> </SUP>has helped clarify which residues are
phosphorylated in PHF tau<SUP> </SUP>(<A HREF="#B37">37</A>, <A HREF="#B80">80</A>,
<A HREF="#B84">84</A>, <A HREF="#B97">97</A>) A variety of kinases have been shown<SUP> </SUP>to be capable of phosphorylating tau in vitro at various sites<SUP> </SUP>(e.g.,
Refs. <A HREF="#B37">37</A>, <A HREF="#B65">65</A>). Nevertheless, it has not
become clear<SUP> </SUP>whether one or more kinases are principally responsible
for initiating<SUP> </SUP>the hyperphosphorylation of tau in vivo that leads to
its apparent<SUP> </SUP>dissociation from microtubules and aggregation into
insoluble<SUP> </SUP>paired helical filaments. In this regard, a recent study
provides<SUP> </SUP>evidence that a dysregulation of cyclin-dependent kinase 5&nbsp;(cdk5),<SUP> </SUP>as a result of proteolytic cleavage of its regulatory subunit<SUP> </SUP>p35 to yield a fragment (p25) which allows constitutive activity<SUP> </SUP>of the
kinase, could play a major role in the hyperphosphorylation<SUP> </SUP>of tau that
appears to underlie tangle formation in AD (<A HREF="#B111">111</A>).<SUP> </SUP>It has
been reported that calpain is responsible for cleavage<SUP> </SUP>of p35 and that
treating cells with A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> aggregates can trigger<SUP> </SUP>p35 activation and the
subsequent cdk5-mediated phosphorylation<SUP> </SUP>of tau and perhaps other
cytoplasmic substrates (<A HREF="#B83a">83a</A>).</P>
	    
	
	    
	    <P>The two classical lesions of AD, neuritic plaques and neurofibrillary
tangles, can occur independently of each other. Tangles<SUP> </SUP>composed of tau
aggregates that are biochemically similar to or,<SUP> </SUP>in some cases,
indistinguishable from those in AD have been described<SUP> </SUP>in more than a
dozen less common neurodegenerative diseases, in<SUP> </SUP>almost all of which
one finds no A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits and neuritic plaques.<SUP> </SUP>Conversely, A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
deposits can be seen in the brains of cognitively<SUP> </SUP>normal-aged
humans in the virtual absence of tangles. There are<SUP> </SUP>also infrequent
cases of AD itself which are "tangle poor," i.e.,<SUP> </SUP>only a few
neurofibrillary tangles are found in the neocortex<SUP> </SUP>despite abundant
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> plaques (<A HREF="#B168">168</A>). It appears that in quite a<SUP> </SUP>few such
cases, an alternate form of neuronal cytoplasmic inclusion,<SUP> </SUP>the Lewy
body (composed principally of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-synuclein protein), is<SUP> </SUP>found in
cortical pyramidal neurons. In other words, the Lewy<SUP> </SUP>body variant of AD
(not to be confused with diffuse Lewy body<SUP> </SUP>disease, which largely lacks
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> plaques) may represent a tangle-poor<SUP> </SUP>form of AD that still has
the usual amount of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> plaque formation<SUP> </SUP>(<A HREF="#B51">51</A>). The fact
that neurofibrillary tangles composed of altered,<SUP> </SUP>aggregated tau
proteins occur in disorders (e.g., subacute sclerosing<SUP> </SUP>panencephallitis, Kuf's disease, progressive supranuclear palsy,<SUP> </SUP>etc.)
in the absence of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposition suggests that tangles can<SUP> </SUP>arise
secondarily during the course of a variety of etiologically<SUP> </SUP>distinct
neuronal insults. As we shall discuss, there is growing<SUP> </SUP>evidence that
the formation of tangles in AD represents one of<SUP> </SUP>several cytological
responses by neurons to the gradual accumulation<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> and
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-associated<SUP> </SUP>molecules.</P>
	    
	
	
    
	
	<A NAME="SEC2_4">
<P><B>D.&nbsp; Dystrophic Cortical Neurites Within and Outside Neuritic
Plaques</B>

	
	    
	    <P>Many of the dilated and tortuous neurites found within and
immediately surrounding amyloid plaques contain PHF that are
structurally,<SUP> </SUP>biochemically, and immunocytochemically indistinguishable
from<SUP> </SUP>those that comprise the neurofibrillary tangles. In addition,<SUP> </SUP>plaques often contain numerous dystrophic neurites that are not<SUP> </SUP>immunoreactive for PHF tau. Tau-positive dystrophic neurites are<SUP> </SUP>also present in a more widespread distribution in the cortical<SUP> </SUP>neuropil
outside of the neuritic plaques. The prevalence and density<SUP> </SUP>of
dystrophic cortical neurites that contain altered forms of<SUP> </SUP>tau varies
substantially among Alzheimer cases. There is evidence<SUP> </SUP>that cases that
are particularly rich in neurofibrillary tangles<SUP> </SUP>are also those that
show widespread tau-immunoreactive dystrophic<SUP> </SUP>cortical neurites
(<A HREF="#B120">120</A>). Some of the intraplaque and extraplaque<SUP> </SUP>dystrophic
neurites are immunoreactive for phosphorylated forms<SUP> </SUP>of the
neurofilament subunit proteins, and the latter can thus<SUP> </SUP>coexist with
phosphotau reactivity. This finding suggests that<SUP> </SUP>there may be several
substrates for the altered kinase and phosphatase<SUP> </SUP>(<A HREF="#B176">176</A>)
activities that occur in tangle-bearing neurons and dystrophic<SUP> </SUP>neurites.</P>
	    
	
	
    
	
	<A NAME="SEC2_5">
<P><B>E.&nbsp; Amyloid Microangiopathy</B>

	
	    
	    <P>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> was originally isolated from amyloid-laden meningeal
arterioles and venules that are often found just outside of the brains<SUP> </SUP>of patients with AD or Down's syndrome (<A HREF="#B34">34</A>,
<A HREF="#B35">35</A>). Similarly,<SUP> </SUP>small arterioles, venules, and capillaries
within cerebral cortex<SUP> </SUP>also frequently bear amyloid deposits. This
microvascular angiopathy<SUP> </SUP>is characterized at the ultrastructural level
by amyloid fibrils<SUP> </SUP>found in the abluminal basement membrane of the
vessels, sometimes<SUP> </SUP>with apparent extension or "spillover" of the
fibrils into the<SUP> </SUP>surrounding perivascular neuropil (a lesion referred
to as dyshorric<SUP> </SUP>angiopathy) (<A HREF="#B178">178</A>). The A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides that
occur as filaments in<SUP> </SUP>the microvessel basement membranes appear, on the
basis of immunoreactivity,<SUP> </SUP>to be principally A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>
species, although evidence has been presented<SUP> </SUP>that the initially
deposited species in vessels destined to develop<SUP> </SUP>amyloid angiopathy may
be A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> (<A HREF="#B165">165</A>). It is intriguing that
meningeal<SUP> </SUP>arterioles that penetrate and traverse the cerebral cortex
can<SUP> </SUP>have amyloid deposits in their walls that abruptly stop as the<SUP> </SUP>vessel enters the subcortical white matter. Only rare microvessels<SUP> </SUP>within the white matter show A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits. The extent of amyloid<SUP> </SUP>angiopathy varies widely among AD brains that have relatively<SUP> </SUP>similar
burdens of parenchymal (i.e., plaque associated) A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">. As<SUP> </SUP>a result, the
contribution of this microvascular amyloidosis to<SUP> </SUP>the cortical
dysfunction that occurs in AD and the mechanism by<SUP> </SUP>which amyloid alters
microvascular function remain matters of<SUP> </SUP>active study (see for example
Refs. <A HREF="#B110">110</A>, <A HREF="#B172">172</A>). Amyloid-bearing<SUP> </SUP>vessels composed of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits
essentially indistinguishable<SUP> </SUP>from those of AD can occur in the virtual
absence of parenchymal<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits in the brains of elderly subjects
without AD (<A HREF="#B178">178</A>).<SUP> </SUP>Such amyloid-bearing vessels in this
condition [referred to as<SUP> </SUP>congophilic amyloid angiopathy (CAA)], as
well as those in AD<SUP> </SUP>can occasionally rupture, apparently due to hyaline
necrosis surrounding<SUP> </SUP>the amyloid deposit in the vessel wall, leading to
one or multiple<SUP> </SUP>cerebral hemorrhages (<A HREF="#B178">178</A>). Nevertheless,
the large majority<SUP> </SUP>of AD subjects do not experience cerebral
hemorrhages, despite<SUP> </SUP>the presence of some or many microvascular amyloid<SUP> </SUP>deposits.</P>
	    
	
	
    

    
    <A NAME="SEC3">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;III.  ORIGIN OF AMYLOID <IMG SRC="http://physrev.physiology.org/math/12pt/Large/beta.gif" ALIGN=BOTTOM ALT="beta ">-PROTEIN: CELL BIOLOGY OF
<IMG SRC="http://physrev.physiology.org/math/12pt/Large/beta.gif" ALIGN=BOTTOM ALT="beta ">-AMYLOID PRECURSOR PROTEIN</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>





<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<A NAME="SEC3_1">
<P><B>A.&nbsp; Expression and Heterogeneity of APP</B>

	
	    
	    <P>The purification and partial sequencing of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> protein from
meningovascular amyloid deposits in AD and Down's syndrome<SUP> </SUP>(<A HREF="#B34">34</A>, <A HREF="#B35">35</A>) and the subsequent observation that
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> was also the<SUP> </SUP>subunit of the plaque amyloid (<A HREF="#B38">38</A>,
<A HREF="#B96">96</A>, <A HREF="#B144">144</A>) led to the cloning<SUP> </SUP>of the gene
encoding the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-APP (<A HREF="#B72">72</A>). A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> is derived from its<SUP> </SUP>large
precursor protein by sequential proteolytic cleavages (see<SUP> </SUP>sect.
<font size=-1>III</font><I>B</I>). APP comprises a heterogeneous group of
ubiquitously<SUP> </SUP>expressed polypeptides migrating between 110&nbsp;and 140&nbsp;kDa
on electrophoretic<SUP> </SUP>gels (<A HREF="#B146">146</A>). This heterogeneity arises
both from alternative splicing<SUP> </SUP>(yielding 3&nbsp;major isoforms of 695,&nbsp;751,&nbsp;and 770&nbsp;residues) as well<SUP> </SUP>as by a variety of posttranslational
modifications, including<SUP> </SUP>the addition of <I>N</I>- and
<I>O</I>-linked sugars, sulfation, and phosphorylation<SUP> </SUP>(<A HREF="#B62">62</A>, <A HREF="#B108">108</A>, <A HREF="#B181">181</A>,
<A HREF="#B183">183</A>). The APP splice forms containing 751<SUP>&nbsp;</SUP>or 770&nbsp;amino
acids are widely expressed in nonneuronal cells throughout<SUP> </SUP>the body and
also occur in neurons. However, neurons express even<SUP> </SUP>higher levels of
the 695-residue isoform, which occurs at very<SUP> </SUP>low abundance in
nonneuronal cells (<A HREF="#B45">45</A>). The difference between<SUP> </SUP>the
751/770- and 695-residue forms is the presence in the former<SUP> </SUP>of an exon
that codes for a 56-amino acid motif that is homologous<SUP> </SUP>to the
Kunitz-type of serine protease inhibitors (KPI), indicating<SUP> </SUP>one
potential function of these longer APP isoforms. Indeed, the<SUP> </SUP>KPI-containing forms of APP found in human platelets serve as<SUP> </SUP>inhibitors of factor XIa, which is a serine protease in the coagulation<SUP> </SUP>cascade (<A HREF="#B158">158</A>). APP is highly conserved in evolution and
expressed<SUP> </SUP>in all mammals in which it has been sought. A partial homolog<SUP> </SUP>of APP is found in <I>Drosophila</I> (referred to as APPL)
(<A HREF="#B130">130</A>). Indeed,<SUP> </SUP>APP is a member of a larger gene family,
the amyloid precursor-like<SUP> </SUP>proteins (APLPs) (<A HREF="#B157">157</A>,
<A HREF="#B182">182</A>), which have substantial homology,<SUP> </SUP>both within the
large ectodomain and particularly within the cytoplasmic<SUP> </SUP>tail, but are
largely divergent in the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUP> </SUP>region.</P>
	    
	
	
    
	
	<A NAME="SEC3_2">
<P><B>B.&nbsp; Trafficking and Proteolytic Processing of APP</B>

	
	    
	    <P>APP is a single transmembrane polypeptide that is
cotranslationally translocated into the endoplasmic reticulum via its
signal<SUP> </SUP>peptide and then posttranslationally modified ("matured")
through<SUP> </SUP>the secretory pathway. Its acquisition of <I>N</I>- and
<I>O</I>-linked sugars<SUP> </SUP>occurs rapidly after biosynthesis, and its
half-life is relatively<SUP> </SUP>brief (~45-60 min in most cell types
tested) (<A HREF="#B183">183</A>). Both during<SUP> </SUP>and after the trafficking of
APP through the secretory pathway,<SUP> </SUP>it can undergo a variety of
proteolytic cleavages to release secreted<SUP> </SUP>derivatives into vesicle
lumens and the extracellular space (Fig.<SUP> </SUP><a href="#F1">1</a>). The first proteolytic cleavage
identified, that made by an<SUP> </SUP>activity designated <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase, occurs
12&nbsp;amino acids NH<SUB>2</SUB>-terminal<SUP> </SUP>to the single transmembrane
domain of APP (<A HREF="#B28">28</A>, <A HREF="#B156">156</A>). This processing<SUP> </SUP>results in the release of the large soluble ectodomain fragment<SUP> </SUP>(<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APP<SUB>s</SUB>) into the lumen/extracellular space and retention
of an<SUP> </SUP>83-residue COOH-terminal fragment (CTF) in the membrane.
Alternatively,<SUP> </SUP>some APP molecules not subjected to <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase
cleavage can be<SUP> </SUP>cleaved by an activity designated <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase, which
principally<SUP> </SUP>cuts 16&nbsp;residues NH<SUB>2</SUB>-terminal to the
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-cleavage site, generating<SUP> </SUP>a slightly smaller ectodomain derivative
(<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-APP<SUB>s</SUB>) (<A HREF="#B147">147</A>) and retaining<SUP> </SUP>a 99-residue
CTF (C99) in the membrane that begins at residue<SUP> </SUP>1&nbsp;of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> region
(reviewed in Ref. <A HREF="#B143">143</A>).



<A NAME="F1"><!-- FIG 1 --></A>

<P><BR CLEAR=ALL><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=112 SRC="http://physrev.physiology.org/content/vol81/issue2/images/small/9j0210134001.gif"></A><BR>

<STRONG>View larger version</STRONG> (20K):
<BR><NOBR><A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F1">[in this window]</A>
<BR><A HREF="http://physrev.physiology.org/cgi/content-nw/full/81/2/741/F1"
    onClick="startTarget('F1', 590, 446); this.href='/cgi/content-nw/full/81/2/741/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
    </NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. </STRONG>

Schematic diagrams of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein (APP) and
its principal metabolic derivatives. Top diagram depicts the
largest of the known APP alternate splice forms, comprising 770&nbsp;amino
acids. Regions of interest are indicated at their correct relative
positions. A 17-residue signal peptide occurs at the NH<SUB>2</SUB>
terminus (box with vertical lines). Two alternatively spliced exons of
56&nbsp;and 19&nbsp;amino acids are inserted at residue 289; the first contains a
serine protease inhibitor domain of the Kunitz type (KPI). A single
membrane-spanning domain (TM) at amino acids 700-723 is indicated
by the vertical dotted lines. The amyloid &szlig;-protein (A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">) fragment
includes 28&nbsp;residues just outside the membrane plus the first 12-14
residues of the transmembrane domain. In the middle diagram, the arrow
indicates the site (after residue 687; same site as the white dot in
the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> region of APP in the upper diagram) of a constitutive
proteolytic cleavage made by protease(s) designated <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase that
enables secretion of the large, soluble ectodomain of APP
(APP<SUB>s</SUB>-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">) into the medium and retention of the 83-residue
COOH-terminal fragment in the membrane. The C83 fragment can
undergo cleavage by a protease(s) called <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase at residue 711&nbsp;or residue 713&nbsp;to release the p3 peptides. The bottom diagram depicts
the alternative proteolytic cleavage after residue 671&nbsp;by a protease(s)
called <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase that results in the secretion of the slightly
truncated APP<SUB>s</SUB>-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> molecule and the retention of a
99-residue COOH-terminal fragment. The C99 fragment can also
undergo cleavage by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase to release the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
peptides.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->



</P>
	    
	
	    
	    <P>Until 1992,&nbsp;it was assumed that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generation was a pathological
event, because the cleavage of the C99 fragment resulting<SUP> </SUP>from the
so-called <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase activity appeared to occur in the<SUP> </SUP>middle of
the transmembrane domain. It was assumed that this would<SUP> </SUP>require the
release of C99 from the membrane, for example, as<SUP> </SUP>a result of some
preexisting membrane injury that allowed access<SUP> </SUP>to a soluble protease.
However, the use of sensitive A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> antibodies<SUP> </SUP>to probe the conditioned
media of APP-expressing cells revealed<SUP> </SUP>secreted A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> that was
constitutively released from cells under<SUP> </SUP>entirely normal cellular
conditions (<A HREF="#B13">13</A>, <A HREF="#B50">50</A>, <A HREF="#B148">148</A>,
<A HREF="#B151">151</A>).<SUP> </SUP>This result suggested that the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase
cleavage could be followed<SUP> </SUP>by a constitutive cleavage at the COOH
terminus of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> region,<SUP> </SUP>made by an activity dubbed <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase.
At the same time, a peptide<SUP> </SUP>fragment designated p3 was discovered to be
produced by the sequential<SUP> </SUP>actions of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">- and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretases
(<A HREF="#B44">44</A>, <A HREF="#B50">50</A>). These unexpected<SUP> </SUP>findings indicated
that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production was a normal metabolic event,<SUP> </SUP>and indeed, the
peptide was detected in both cerebrospinal fluid<SUP> </SUP>and plasma in healthy
subjects throughout life (<A HREF="#B148">148</A>, <A HREF="#B151">151</A>).
Precisely<SUP> </SUP>where during its complex intracellular trafficking APP can
undergo<SUP> </SUP>the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-, <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-, and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavages is not settled.
Clearly,<SUP> </SUP>a substantial portion of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APP<SUB>s</SUB> is generated by
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase acting<SUP> </SUP>on plasma membrane inserted APP
(<A HREF="#B155">155</A>). On the other hand, <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APP<SUB>s</SUB><SUP> </SUP>can also be
generated during the secretory intracellular trafficking<SUP> </SUP>of APP
(<A HREF="#B23">23</A>, <A HREF="#B133">133</A>). With regard to the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase
cleavage,<SUP> </SUP>this can occur in part late in the secretory trafficking of
APP<SUP> </SUP>(<A HREF="#B49">49</A>). The recent identification and cloning of
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase by<SUP> </SUP>several laboratories (<A HREF="#B63">63</A>,
<A HREF="#B153">153</A>, <A HREF="#B177">177</A>, <A HREF="#B201">201</A>) will now enable<SUP> </SUP>a
precise localization of this novel membrane-anchored aspartyl<SUP> </SUP>protease. The sites of cleavage of the C99 and C83 fragments by<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase and the nature of that enzyme are also under active<SUP> </SUP>study. It appears that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> can be
made in considerable<SUP> </SUP>part during the internalization and endosomal
processing of APP<SUP> </SUP>(<A HREF="#B77">77</A>, <A HREF="#B112">112</A>). There are
conflicting data about whether much of<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> is generated
early in the secretory trafficking of APP (i.e.,<SUP> </SUP>in endoplasmic
reticulum, intermediate compartment, and early<SUP> </SUP>Golgi) or principally
after APP reaches the cell surface. Some<SUP> </SUP>evidence suggests that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
peptides generated very early in the<SUP> </SUP>secretory pathway (i.e., in
endoplasmic reticulum) may not be<SUP> </SUP>destined for secretion and are
retained and catabolized inside<SUP> </SUP>cells (<A HREF="#B16">16</A>). However, it is
likely that the majority of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generated<SUP> </SUP>within cells is destined for
secretion. Steady-state levels of<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> in human cerebrospinal fluid
are in the range of 3-8 nM (<A HREF="#B101">101</A>),<SUP> </SUP>whereas the level in
plasma is generally under 500&nbsp;pM (<A HREF="#B137">137</A>).<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>
and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> species can both be detected in these
extracellular<SUP> </SUP>fluids.</P>
	    
	
	    
	    <P>Pulse-chase experiments have demonstrated that most C83 and C99
fragments (the immediate substrates of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase) are generated<SUP> </SUP>from APP molecules that have undergone full <I>N</I>- plus
<I>O</I>-linked glycosylation<SUP> </SUP>(i.e., within or after the Golgi)
(<A HREF="#B49">49</A>, <A HREF="#B183">183</A>). These results<SUP> </SUP>support the concept
that the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-, <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-, and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavages<SUP> </SUP>of APP occur primarily
at or near the cell surface, perhaps in<SUP> </SUP>substantial part in recycling
endosomes (<A HREF="#B112">112</A>).</P>
	    
	
	    
	    <P>In polarized epithelial cells such as Madin-Darby canine kidney
(MDCK) cells, APP is principally targeted to the basolateral<SUP> </SUP>membrane,
where it can undergo <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase cleavage to release<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APP<SUB>s</SUB> basolaterally, although a small fraction is
targeted and<SUP> </SUP>processed apically (<A HREF="#B47">47</A>, <A HREF="#B48">48</A>). In
neurons, which are one of<SUP> </SUP>the cells that express the highest levels of
APP in the body (particularly<SUP> </SUP>APP<SUB>695</SUB>), APP can be
anterogradely transported in the fast component<SUP> </SUP>of axonal transport
(<A HREF="#B76">76</A>). APP is present in vesicles in axonal<SUP> </SUP>terminals,
although not specifically in synaptic vesicles. Cell<SUP> </SUP>biological studies
demonstrate that APP in the axonal terminals<SUP> </SUP>can be retrogradely
transported up the axon to the cell body,<SUP> </SUP>and some molecules are then
fully translocated to the somatodendritic<SUP> </SUP>surface (<A HREF="#B200">200</A>).
During its retrograde axonal trafficking, some<SUP> </SUP>APP molecules can
apparently recycle to the axolemmal surface<SUP> </SUP>(<A HREF="#B200">200</A>).
Although it has been assumed that APP axonal terminals<SUP> </SUP>might be a
principal site for the generation of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">, this has not<SUP> </SUP>been
definitively determined, and APP that recycles in endosomes<SUP> </SUP>at various
neuronal subsites may be capable of undergoing the<SUP> </SUP>sequential <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">- and
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavages to release the peptide.<SUP> </SUP>Indeed, although APP is
particularly abundantly expressed in neurons<SUP> </SUP>and they have been
directly shown to secrete substantial amounts<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides
(<A HREF="#B50">50</A>), other brain cells also express APP and<SUP> </SUP>release
variable amounts of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">, including astrocytes, microglia,<SUP> </SUP>and
endothelial and smooth muscle cells, and these could all contribute<SUP> </SUP>to
the secreted pool of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> that eventually leads to extracellular<SUP> </SUP>deposition. Moreover, the fact that virtually all peripheral cells<SUP> </SUP>also
express APP and generate A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> and that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> is present in plasma<SUP> </SUP>raises
the possibility that circulating A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> could cross the blood-brain<SUP> </SUP>barrier and contribute to cerebral A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation. Direct evidence<SUP> </SUP>that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> can cross the blood-brain barrier in small amounts using<SUP> </SUP>a mechanism consistent with receptor-mediated endocytosis has<SUP> </SUP>been
reported (<A HREF="#B116">116</A>, <A HREF="#B117">117</A>, <A HREF="#B209">209</A>).</P>
	    
	
	
    
	
	<A NAME="SEC3_3">
<P><B>C.&nbsp; Inferred Functions of APP and Its Derivatives</B>

	
	    
	    <P>A number of possible functions have been ascribed to APP
holoproteins and/or their major secreted derivative
(<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APP<SUB>s</SUB>) based<SUP> </SUP>on cell culture studies. Soluble <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-APPs
appear to be capable of<SUP> </SUP>acting as an autocrine factor
(<A HREF="#B132">132</A>) and a neuroprotective and<SUP> </SUP>perhaps neuritotrophic
factor (<A HREF="#B98">98</A>). The fact that the alternatively<SUP> </SUP>spliced forms
containing 751&nbsp;and 770&nbsp;residues contain a 56-residue<SUP> </SUP>insert in the
middle of the ectodomain encoding a KPI motif (<A HREF="#B167">167</A>)<SUP> </SUP>has
led to in vitro studies that confirm an ability of these isoforms<SUP> </SUP>to
inhibit serine proteases such as trypsin and chymotrypsin
(<A HREF="#B154">154</A>).<SUP> </SUP>As mentioned previously, the KPI-containing
isoforms also function<SUP> </SUP>as an inhibitor of factor XIa (a serine
protease) in the clotting<SUP> </SUP>cascade (<A HREF="#B158">158</A>). The secreted APP
isoforms can confer cell-cell<SUP> </SUP>and cell-substrate adhesive
properties in culture (e.g., Ref.<SUP> </SUP><A HREF="#B140">140</A>). The APP holoprotein has also
been suggested to function<SUP> </SUP>in cell-cell interactions when inserted
at the plasma membrane,<SUP> </SUP>based on in vitro studies (<A HREF="#B122">122</A>).
All of these imputed functions<SUP> </SUP>have not yet been clearly confirmed in
vivo. Deletion of the APP<SUP> </SUP>gene in mice results in neither early
mortality nor appreciable<SUP> </SUP>morbidity; cerebral gliosis and changes in
locomotor behavior<SUP> </SUP>occur later in adult life (<A HREF="#B207">207</A>), and
neurons cultured at birth<SUP> </SUP>have diminished viability and retarded
neurite outgrowth (<A HREF="#B113">113</A>).<SUP> </SUP>This lack of a vital consequence
of APP deletion in vivo may result<SUP> </SUP>from the fact that mammals express
proteins closely homologous<SUP> </SUP>to APP, the APLPs (<A HREF="#B157">157</A>,
<A HREF="#B182">182</A>). Delineation of the precise functions<SUP> </SUP>of APP and its
homologs in vivo awaits further study. No evidence<SUP> </SUP>has emerged that a
fundamental cellular function of APP is lost<SUP> </SUP>in AD patients. Instead,
APP mutations seem to act by a toxic<SUP> </SUP>gain-of-function mechanism,
namely, by increasing production of<SUP> </SUP>the potentially cytotoxic A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
fragment (see<SUP> </SUP>below).</P>
	    
	
	
    

    
    <A NAME="SEC4">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;IV.  GENETICS OF FAMILIAL ALZHEIMER'S DISEASE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>






<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<A NAME="SEC4_1">
<P><B>A.&nbsp; Familial Forms of AD Closely Resemble the Common
"Sporadic" Form</B>

	
	    
	    <P>It has been known for at least several decades that clinically
typical AD can cluster in families and can specifically be<SUP> </SUP>inherited in
an autosomal dominant fashion. Estimates of the prevalence<SUP> </SUP>of inherited
forms of AD have varied widely from as little as<SUP> </SUP>5-10% to as high as
50% or more. Some investigators believe that<SUP> </SUP>in the fullness of time,
a large majority of AD cases will be<SUP> </SUP>shown to have underlying genetic
determinants, many of which may<SUP> </SUP>appear as polymorphic alleles that
predispose to the disease but<SUP> </SUP>do not invariably cause it. Determining
how frequently genetic<SUP> </SUP>factors underlie the disease is difficult in a
late-onset disorder<SUP> </SUP>such as AD, particularly one that was not
specifically diagnosed<SUP> </SUP>and recorded before the last two decades.
Moreover, the recognition<SUP> </SUP>that polymorphic alleles of apolipoprotein E
can predispose strongly<SUP> </SUP>to the development of AD in the 60s and 70s
suggests that other<SUP> </SUP>polymorphic genes could predispose to the disorder
but would be<SUP> </SUP>difficult to detect in genetic epidemiological studies,
because<SUP> </SUP>they do not always produce the disease and will thus not show<SUP> </SUP>high<SUP> </SUP>penetrance.</P>
	    
	
	    
	    <P>Despite the uncertainty about the degree to which AD is accounted
for by genetic factors, it has become clear from phenotypic<SUP> </SUP>analyses of
familial versus apparently non-familial ("sporadic")<SUP> </SUP>cases that
these two forms are phenotypically highly similar or<SUP> </SUP>often
indistinguishable, save for the earlier age of onset of<SUP> </SUP>the known
autosomal dominant forms. When the age of the patient<SUP> </SUP>is not known to
the neuropathologist, the histological phenotype<SUP> </SUP>of the early-onset
cases is very difficult to distinguish from<SUP> </SUP>those of common late-onset
patients. Similarly, the clinical manifestations<SUP> </SUP>of familial
(autosomal dominant) AD are generally quite similar<SUP> </SUP>or almost
indistinguishable from those of the sporadic cases,<SUP> </SUP>although some
families may show distinctive clinical signs (e.g.,<SUP> </SUP>myoclonus,
seizures, early and prominent extrapyramidal signs,<SUP> </SUP>etc.). This general
phenotypic similarity strongly suggests that<SUP> </SUP>information about the
mechanism of the autosomal dominant forms<SUP> </SUP>caused by mutations in the
APP and presenilin genes is likely<SUP> </SUP>to be directly relevant to the
pathogenesis of the common, apparently<SUP> </SUP>nonfamilial<SUP> </SUP>forms.</P>
	    
	
	
    
	
	<A NAME="SEC4_2">
<P><B>B.&nbsp; Missense Mutations in APP: A Very Rare Cause of Familial AD</B>

	
	    
	    <P>The first specific genetic cause of AD to be identified was the
occurrence of missense mutations in APP (<A HREF="#B36">36</A>) (Table
<a href="#T1">1</a>).<SUP> </SUP>Despite extensive genetic surveying,
such mutations have only<SUP> </SUP>been confirmed in some two dozen or so
families worldwide. Nevertheless,<SUP> </SUP>the location of the mutations (Fig.
<a href="#F2">2</a>) and the subsequent delineation<SUP> </SUP>of
their genotype-to-phenotype relationships have provided critical<SUP> </SUP>insights into the mechanism of AD. The mutations are strategically<SUP> </SUP>located either immediately before the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase cleavage site,<SUP> </SUP>shortly after the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-secretase site, or shortly COOH-terminal to<SUP> </SUP>the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavage site. The fact that, despite substantial<SUP> </SUP>investigation, no other mutations in the large APP protein that<SUP> </SUP>cause
AD have been discovered strongly suggests that these missense<SUP> </SUP>mutations
lead to AD by altering proteolytic processing at the<SUP> </SUP>three secretase
sites in subtly different ways. This hypothesis<SUP> </SUP>has been confirmed by
analysis of each of the mutations, initially<SUP> </SUP>in transfected cells or
primary cells from patients and then in<SUP> </SUP>transgenic mouse models
(reviewed in Ref. <A HREF="#B142">142</A>). Families harboring<SUP> </SUP>APP missense mutations that
cause AD generally have the onset<SUP> </SUP>of the disorder before age 65,&nbsp;often
in their 50s.

<P><BR CLEAR=ALL><CENTER>
<TABLE BORDER WIDTH="95%" CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1><TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF><NOBR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</NOBR><BR><NOBR><STRONG>View this table:</STRONG></NOBR>
<BR><NOBR><A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/T1">[in this window]</A></NOBR><BR>
<NOBR><A HREF="http://physrev.physiology.org/cgi/content-nw/full/81/2/741/T1"
	onClick="startTarget('T1', 500, 400); this.href='/cgi/content-nw/full/81/2/741/T1'"
	onMouseOver="window.status='View table in a separate window';
		return true"
TARGET='T1'>[in a new window]</A><BR>&nbsp;</NOBR>
</TD>
<TD ALIGN=LEFT VALIGN=TOP>
<A NAME="T1"><!-- TABLE 1 --></A>
<B>Table 1.</B> 
<I>

    Confirmed genetic factors predisposing to
Alzheimer's disease:  relationships to the
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid phenotype

</P>
</I>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>





<A NAME="F2"><!-- FIG 2 --></A>

<P><BR CLEAR=ALL><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=105 SRC="http://physrev.physiology.org/content/vol81/issue2/images/small/9j0210134002.gif"></A><BR>

<STRONG>View larger version</STRONG> (98K):
<BR><NOBR><A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F2">[in this window]</A>
<BR><A HREF="http://physrev.physiology.org/cgi/content-nw/full/81/2/741/F2"
    onClick="startTarget('F2', 590, 431); this.href='/cgi/content-nw/full/81/2/741/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
    </NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. </STRONG>

<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-APP mutations genetically linked to familial Alzheimer's
disease or related disorders. The sequence within APP that contains the
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> and transmembrane region is expanded and shown by the
single-letter amino acid code. The underlined residues represent
the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-42 peptide. The vertical broken lines indicate the location
of the transmembrane domain. The bold letters below the line indicate
the currently known missense mutations identified in certain patients
with familial Alzheimer's disease and/or hereditary cerebral
hemorrhage with amyloidosis. Three-digit numbers refer to the
residue number according to the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-APP770
isoform.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->



</P>
	    
	
	    
	    <P>There is another way that alterations in the APP gene can predispose to
the development of AD. The overexpression of structurally<SUP> </SUP>normal APP
owing to elevated gene dosage in trisomy 21&nbsp;(Down's<SUP> </SUP>syndrome) almost
invariably leads to the premature occurrence<SUP> </SUP>of classical AD
neuropathology (neuritic plaques and neurofibrillary<SUP> </SUP>tangles) during
middle adult years. A life-long increase in APP<SUP> </SUP>expression due to
duplication of all of chromosome 21&nbsp;or, in the<SUP> </SUP>case of translocation
Down's syndrome, that portion of 21q containing<SUP> </SUP>the APP gene results
in overproduction of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> peptides<SUP> </SUP>dating from birth (<A HREF="#B173">173</A>). This is assumed to be responsible
for<SUP> </SUP>the strikingly early appearance of many A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> diffuse
plaques,<SUP> </SUP>which can occur as soon as age 12&nbsp;yr (<A HREF="#B85">85</A>).
Down's subjects often<SUP> </SUP>display diffuse plaques composed solely of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> in their teens<SUP> </SUP>and 20s, with accrual of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> peptides onto these plaques and<SUP> </SUP>the appearance of
associated microgliosis, astrocytosis, and surrounding<SUP> </SUP>neuritic
dystrophy usually beginning in their late 20s or 30s<SUP> </SUP>(<A HREF="#B85">85</A>,
<A HREF="#B94">94</A>). This observation underscores the importance of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB><SUP> </SUP>accumulation as a seminal event in the development
of AD-type<SUP> </SUP>brain pathology. The appearance of neurofibrillary
tangles is<SUP> </SUP>also delayed until the late 20s, 30s, or beyond in most
Down's<SUP> </SUP>patients. The gradual accrual of AD-type brain lesions in
these<SUP> </SUP>individuals, who are retarded from birth for other reasons,
appears<SUP> </SUP>to be associated in many cases with progressive loss of
cognitive<SUP> </SUP>and behavioral functions after the age of 35&nbsp;or<SUP> </SUP>so.</P>
	    
	
	    
	    <P>Because the entire chromosome 21&nbsp;is duplicated in the vast majority of
cases of Down's syndrome, it is difficult to attribute<SUP> </SUP>the Alzheimer
syndrome that they develop directly to APP gene<SUP> </SUP>dosage. However, this
issue has been essentially resolved by the<SUP> </SUP>recent evaluation of a
patient with translocation Down's syndrome<SUP> </SUP>in which the obligate
Down's region in the distal portion of chromosome<SUP> </SUP>21&nbsp;was duplicated,
but the break point was telomeric to the APP<SUP> </SUP>gene. The subject bearing
this particular translocation had typical<SUP> </SUP>phenotypic features of
Down's syndrome but did not develop clear-cut<SUP> </SUP>evidence of
behavioral deterioration during middle age. At autopsy,<SUP> </SUP>no significant
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposition or other Alzheimer-type neuropathology<SUP> </SUP>was observed
(<A HREF="#B119">119</A>). This absence of amyloid deposition and attendant<SUP> </SUP>cytopathological changes is highly unusual in Down's subjects,<SUP> </SUP>and
this case suggests that when this occurs, it is because the<SUP> </SUP>APP gene is
not duplicated. The careful clinicopathological analysis<SUP> </SUP>of this
unusual case provides further strong support for the primacy<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
deposition in producing classical AD<SUP> </SUP>neuropathology.</P>
	    
	
	
    
	
	<A NAME="SEC4_3">
<P><B>C.&nbsp; Missense Mutations in the Presenilins: The Most Common
Cause of Autosomal Dominant AD to Date</B>

	
	    
	    <P>The realization that autosomal dominant AD is genetically
heterogeneous led to intensive searches for loci in the genome besides<SUP> </SUP>APP that could explain the many families that did not link to<SUP> </SUP>chromosome 21.&nbsp;Establishment of a linkage of some of these families<SUP> </SUP>to
chromosome 14&nbsp;(<A HREF="#B135">135</A>) led ultimately to further linkage
analysis<SUP> </SUP>and positional cloning that identified a novel gene on
chromosome<SUP> </SUP>14q which came to be known as presenilin 1&nbsp;(PS1)
(<A HREF="#B150">150</A>). Missense<SUP> </SUP>mutations were found that appeared to be
causative of AD in certain<SUP> </SUP>families with clinical onset in their 40s
and 50s, sometimes as<SUP> </SUP>early as the 30s. Shortly thereafter, an
homologous gene was discovered<SUP> </SUP>on chromosome 1,&nbsp;mutations in which
explain the early-onset kindreds<SUP> </SUP>referred to as the Volga German
families, as well as AD in an<SUP> </SUP>Italian family (<A HREF="#B90">90</A>). This
gene was ultimately designated presenilin<SUP> </SUP>2&nbsp;(PS2). Further intensive
genetic surveys have identified as<SUP> </SUP>many as 75&nbsp;missense mutations in
presenilin 1&nbsp;and three in presenilin<SUP> </SUP>2&nbsp;as molecular causes of
early-onset AD in several hundred families<SUP> </SUP>worldwide (reviewed in
Ref. <A HREF="#B52">52</A>). Presenilin 1&nbsp;missense mutations<SUP> </SUP>cause the earliest and most
aggressive form of AD, commonly leading<SUP> </SUP>to onset of symptoms before the
age of 50&nbsp;and demise of the patient<SUP> </SUP>in his/her 60s. We discuss below
how instructive these mutations<SUP> </SUP>have been for understanding both the
role of presenilin in AD<SUP> </SUP>and gaining insight into the normal functions
of these interesting<SUP> </SUP>polytopic membrane<SUP> </SUP>proteins.</P>
	    
	
	
    
	
	<A NAME="SEC4_4">
<P><B>D.&nbsp; The Apolipoprotein E4 Allele is a Major Genetic Risk Factor
for Late-Onset AD</B>

	
	    
	    <P>Whereas the autosomal dominant mutations in APP or the presenilins
are quite infrequent causes of AD, the discovery that the<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 allele
of apolipoprotein E (ApoE) predisposes to AD provided<SUP> </SUP>a major genetic
risk factor for the disorder in the typical late-onset<SUP> </SUP>period
(<A HREF="#B163">163</A>). Studies initiated by searching for proteins in<SUP> </SUP>human cerebrospinal fluid that could bind immobilized A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides<SUP> </SUP>on
a filter led to the identification of ApoE as such a protein<SUP> </SUP>and the
recognition that its gene localized to chromosome 19q,<SUP> </SUP>in a region
previously found to show genetic linkage to AD in<SUP> </SUP>some late-onset
families (<A HREF="#B163">163</A>). Further genetic analyses indicated<SUP> </SUP>that
the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 allele of ApoE is overrepresented in subjects with<SUP> </SUP>AD compared
with the general population and that inheritance of<SUP> </SUP>one or two <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4
alleles heightens the likelihood of developing AD<SUP> </SUP>and makes its mean
age of onset earlier than in subjects harboring<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">2 and or <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">3
alleles (<A HREF="#B18">18</A>, <A HREF="#B134">134</A>). Thus the ApoE4 protein
helps<SUP> </SUP>precipitate the disorder primarily in subjects in their 60s and<SUP> </SUP>70s. There is also evidence that inheritance of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">2 allele<SUP> </SUP>may
confer protection against the development of AD (<A HREF="#B17">17</A>).
Although<SUP> </SUP>inheritance of a single <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 allele may increase the
likelihood<SUP> </SUP>of developing AD in the 60s and 70s, some two- to fivefold
and<SUP> </SUP>two <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 alleles may increase the risk well above fivefold, it
should<SUP> </SUP>be emphasized that ApoE4 is a risk factor for, not an invariant<SUP> </SUP>cause of, AD. Some humans homozygous for the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 isoform still<SUP> </SUP>show no
Alzheimer symptoms in their ninth decade of life and beyond.<SUP> </SUP>Conversely, a great many humans develop AD without harboring <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4<SUP> </SUP>alleles. The recognition that inheritance of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 predisposes humans<SUP> </SUP>to
AD provided one of the first genetic risk factors for a common<SUP> </SUP>late-onset<SUP> </SUP>disease.</P>
	    
	
	
    
	
	<A NAME="SEC4_5">
<P><B>E.&nbsp; Other Genetic Alterations Predisposing to AD Are Likely</B>

	
	    
	    <P>Whereas there is universal agreement that alterations in the four
aforementioned genes can cause familial forms of AD, various<SUP> </SUP>methods of
genetic analysis indicate that additional genes predisposing<SUP> </SUP>to AD
exist. In this regard, an AD-linked locus on chromosome<SUP> </SUP>12&nbsp;in
certain pedigrees appears to represent alterations in or<SUP> </SUP>near the gene
encoding <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>2</SUB>-macroglobulin (<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>2</SUB>M)
(<A HREF="#B10">10</A>). A polymorphism<SUP> </SUP>in an intronic region of the
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>2</SUB>M gene segregates with the AD phenotype<SUP> </SUP>in some
late-onset subjects (<A HREF="#B10">10</A>). Additional studies
confirming<SUP> </SUP>this association have appeared (<A HREF="#B2">2</A>,
<A HREF="#B25">25</A>, <A HREF="#B102">102</A>, <A HREF="#B129">129</A>), and work<SUP> </SUP>to
determine whether the enhanced genetic risk is attributable<SUP> </SUP>directly to
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>2</SUB>M or to a nearby gene is<SUP> </SUP>underway.</P>
	    
	
	    
	    <P>The fact that numerous families exist whose AD phenotype does not link
to any of the five genes implicated to date indicates<SUP> </SUP>that additional
genetic risk factors and perhaps even dominantly<SUP> </SUP>transmitted causative
genes will be found. Indeed, recent studies<SUP> </SUP>have revealed an apparent
major locus for late-onset familial<SUP> </SUP>AD on chromosome 10q (<A HREF="#B8a">8a</A>). It
is likely that over the next one<SUP> </SUP>to two decades, a much larger portion
of AD will be shown to have<SUP> </SUP>genetic determinants than is currently
believed. Indeed, clinical<SUP> </SUP>surveys already indicate that, upon careful
questioning, a family<SUP> </SUP>history of first degree relatives with a
dementing syndrome resembling<SUP> </SUP>AD is obtained in as many as one-half
to two-thirds of patients<SUP> </SUP>presenting with clinically probable<SUP> </SUP>AD.</P>
	    
	
	
    

    
    <A NAME="SEC5">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;V.  GENOTYPE-TO-PHENOTYPE CONVERSIONS IN FAMILIAL ALZHEIMER'S
DISEASE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>







<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<P>The rapid accrual of information about the proteolytic processing
of APP and the aggregational properties of its A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> derivatives<SUP> </SUP>coincided with the identification of gene defects that cause or<SUP> </SUP>predispose to AD. The systematic correlation of these two distinct<SUP> </SUP>bodies of knowledge during the last few years has led to an emerging<SUP> </SUP>understanding of the fundamental pathogenetic mechanism of AD.<SUP> </SUP>Experiments to decipher the genotype-to-phenotype relationships<SUP> </SUP>have
been conducted in cell culture, in transgenic mice and, most<SUP> </SUP>importantly, in patients who actually harbor the relevant genetic<SUP> </SUP>mutations. For all four genes unequivocally confirmed to date<SUP> </SUP>(APP,
ApoE4, PS1, and PS2), inherited alterations in the gene<SUP> </SUP>products have
been credibly linked to increases in the production<SUP> </SUP>and/or the cerebral
deposition of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides (<A HREF="#B142">142</A>). Such<SUP> </SUP>studies have
provided the strongest support for the hypothesis<SUP> </SUP>that cerebral
accumulation of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> is an early, invariant, and necessary<SUP> </SUP>event in the
genesis of<SUP> </SUP>AD.</P>
	
    
	
	<A NAME="SEC5_2">
<P><B>A.&nbsp; APP Mutations Increase the Production  of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> Peptides</B>

	
	    
	    <P>The nine known missense mutations in APP currently linked to
familial AD (Fig. <a href="#F2">2</a>) have been found to increase A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production<SUP> </SUP>by
subtly different mechanisms. A double mutation in the two amino<SUP> </SUP>acids
immediately preceding the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase cleavage site (often<SUP> </SUP>referred
to as the "Swedish" APP mutation based on the ethnic<SUP> </SUP>origin of the
family in which it occurs) induces increased cleavage<SUP> </SUP>by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase
to generate more A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>. The five
mutations<SUP> </SUP>occurring just COOH-terminal to the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase
cleavage sites<SUP> </SUP>appear in slightly different ways to selectively enhance
the production<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> species ending at residue 42.&nbsp;The two remaining
mutations<SUP> </SUP>that are located internally in A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> could be expected to
enhance<SUP> </SUP>the aggregational properties of all A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> species, although this<SUP> </SUP>has only been shown for the E693Q mutation that causes hereditary<SUP> </SUP>cerebral hemorrahge with amyloidosis of the Dutch type
(<A HREF="#B89">89</A>).<SUP> </SUP>The other, immediately adjacent internal mutation
(A692G) leads<SUP> </SUP>to a mixed phenotype of <I>1</I>) AD-type plaque
and tangle formation<SUP> </SUP>associated with dementia and <I>2</I>) severe
microvascular <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloidosis<SUP> </SUP>with occasional cerebral hemorrhages
(<A HREF="#B56">56</A>). This mutation has<SUP> </SUP>been shown in transfected cells to
lead to changes in the heterogeneous<SUP> </SUP>NH<SUB>2</SUB>-terminal
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase cleavages that have the overall effect<SUP> </SUP>of favoring
production of the full-length peptide beginning at<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
Asp1(<A HREF="#B46">46</A>). The recent cloning of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase, a novel
membrane-anchored<SUP> </SUP>aspartyl protease with its active site in its
ectodomain and the<SUP> </SUP>identification of a close homolog thereof (BACE-2)
(<A HREF="#B63">63</A>, <A HREF="#B153">153</A>,<SUP> </SUP><A HREF="#B177">177</A>,
<A HREF="#B201">201</A>), has led to studies in transfected cells suggesting<SUP> </SUP>that the A692G APP mutation specifically enhances the proportion<SUP> </SUP>of APP
that is cleaved by BACE-2 and shifts cleavage by the latter<SUP> </SUP>toward the
Asp1 NH<SUB>2</SUB> terminus (M.&nbsp;Farzan, personal communication).<SUP> </SUP>These interesting early data suggest that the identification of<SUP> </SUP>the
actual <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">-, <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-, and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretases will provide much clearer<SUP> </SUP>mechanistic insights into exactly how missense mutations in APP<SUP> </SUP>lead to
heightened production of various A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> species, in each case<SUP> </SUP>inducing an
amyloidogenic phenotype that produces<SUP> </SUP>AD.</P>
	    
	
	
    
	
	<A NAME="SEC5_3">
<P><B>B.&nbsp; Presenilin Mutations Increase the Production of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> Peptides</B>

	
	    
	    <P>Perhaps the most intriguing genotype-to-phenotype relationships in
AD involve the presenilin mutations. When presenilin 1<SUP>&nbsp;</SUP>and 2&nbsp;were first
cloned, the mechanism by which mutations in them<SUP> </SUP>produced the AD
phenotype was an open matter and was not necessarily<SUP> </SUP>expected to
involve enhanced A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production. However, direct assays<SUP> </SUP>of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> in the plasma and the
cultured skin fibroblast<SUP> </SUP>media of humans harboring these mutations soon
revealed a selective<SUP> </SUP>approximately twofold elevation of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> levels (<A HREF="#B137">137</A>). Extensive<SUP> </SUP>modeling of
these mutations in cultured cells and transgenic mice<SUP> </SUP>has confirmed
this finding (e.g., Refs. <A HREF="#B11">11</A>, <A HREF="#B15">15</A>, <A HREF="#B26">26</A>, <A HREF="#B174">174</A>,<SUP> </SUP><A HREF="#B195">195</A>). A particularly
important observation has been the finding<SUP> </SUP>that crossing mice
transgenic for human APP with mice expressing<SUP> </SUP>a PS1 missense mutation
leads to a substantially accelerated AD-like<SUP> </SUP>phenotype in the
offspring, with A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> plaques (first diffuse and<SUP> </SUP>then
mature) occurring as early as 3-4 mo of age (<A HREF="#B57">57</A>). But
even<SUP> </SUP>before confirmation of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>-elevating effect of
presenilin<SUP> </SUP>mutations was obtained in transfected cells and transgenic
mice,<SUP> </SUP>quantitative image analysis of the brain amyloid deposits of
patients<SUP> </SUP>who had these mutations using A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>- and
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>-specific antibodies<SUP> </SUP>demonstrated directly that
inheritance of presenilin mutations<SUP> </SUP>leads to a 1.5-&nbsp;to 3-fold increase
in the relative abundance of<SUP> </SUP>plaques containing A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
peptides, compared with the levels observed<SUP> </SUP>in sporadic cases of AD
(<A HREF="#B86">86</A>, <A HREF="#B95">95</A>). The molecular mechanism<SUP> </SUP>by which
missense mutations in the presenilins selectively increase<SUP> </SUP>the
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavage of C99 (and also C83) to yield more peptides<SUP> </SUP>ending at A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> compared with A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> will be
discussed after reviewing<SUP> </SUP>current knowledge about the complex biology
of the presenilins<SUP> </SUP>(see sect. <font size=-1>VI</font>).</P>
	    
	
	
    
	
	<A NAME="SEC5_4">
<P><B>C.&nbsp; Inheritance of ApoE4 Alleles Increases  Steady-State
Levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> Peptides  in the Brain</B>

	
	    
	    <P>Even before ApoE4 was recognized as a genetic risk factor for
late-onset disease, immunohistochemistry had demonstrated the<SUP> </SUP>presence of ApoE protein in a high percentage of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits in<SUP> </SUP>AD
brain tissue (<A HREF="#B103">103</A>). Once the genetic connection between AD<SUP> </SUP>and ApoE4 inheritance was made, further immunohistochemical studies<SUP> </SUP>of
brains of patients lacking or expressing the ApoE4 protein<SUP> </SUP>showed that
inheritance of ApoE4 was associated with a significantly<SUP> </SUP>higher A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
plaque burden than was observed in patients lacking<SUP> </SUP>ApoE4
(<A HREF="#B31">31</A>, <A HREF="#B126">126</A>, <A HREF="#B138">138</A>). Although some
brains of ApoE4 allele<SUP> </SUP>carriers showed higher neurofibrillary tangle
densities, overall<SUP> </SUP>this change did not usually reach the statistically
significant<SUP> </SUP>levels of elevation observed for A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits.
Importantly, studies<SUP> </SUP>in nonogenarians who died without showing
clear-cut clinical symptoms<SUP> </SUP>of AD demonstrated that ApoE4 genotype
was again linked to enhanced<SUP> </SUP>amounts of diffuse A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
plaques in the brain, suggesting that<SUP> </SUP>the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-elevating effects
associated with ApoE4 inheritance could<SUP> </SUP>be observed
presymptomatically or in hosts who would not necessarily<SUP> </SUP>develop AD
(<A HREF="#B118">118</A>).</P>
	    
	
	    
	    <P>The mechanism by which ApoE4 protein leads to increased A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposition
has been difficult to pinpoint. No evidence has emerged<SUP> </SUP>that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
production is significantly elevated in cells that coexpress<SUP> </SUP>APP with
the ApoE4 protein versus with the ApoE2 or ApoE3 proteins<SUP> </SUP>(<A HREF="#B9">9</A>). Rather, ApoE4 seems to enhance the steady-state
levels<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides, A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> in particular
(<A HREF="#B31">31</A>), presumably by decreasing<SUP> </SUP>its clearance from the
brain tissue in some way. In vitro studies<SUP> </SUP>quantifying the degree of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> fibrillogenesis using synthetic peptides<SUP> </SUP>suggest that the presence
of the ApoE4 protein results in increased<SUP> </SUP>numbers of fibrils, compared
with levels obtained in the presence<SUP> </SUP>of ApoE3 (<A HREF="#B29">29</A>,
<A HREF="#B93">93</A>), although the way in which ApoE proteins<SUP> </SUP>cause these
effects, e.g., by ApoE4 serving as a less effective<SUP> </SUP>inhibitor of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
fibrillogenesis or rather as a more potent stimulator,<SUP> </SUP>is not settled.
An alternative mechanism for the AD-promoting<SUP> </SUP>effect of ApoE4
inheritance emerges from evidence in transgenic<SUP> </SUP>mice expressing either
the E4 or E3 human protein. Mice expressing<SUP> </SUP>E4 appear to have decreased
neuritic outgrowth of cultured neurons<SUP> </SUP>and decreased maintenance of
established neurites (<A HREF="#B105">105</A>). These<SUP> </SUP>studies suggest that
ApoE4 protein is less supportive of normal<SUP> </SUP>neuronal form and function
than are ApoE3 or E2 proteins. However,<SUP> </SUP>such a neuronal vulnerability
in ApoE4 gene carriers may not be<SUP> </SUP>the actual mechanism of the ApoE4
effect on the AD phenotype,<SUP> </SUP>given the fact that deposition of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> into
cerebral and meningeal<SUP> </SUP>vessels to produce the syndrome of congophilic
amyloid angiopathy<SUP> </SUP>is also enhanced by the gene dosage of ApoE4, even
in the absence<SUP> </SUP>of Alzheimer-type neuropathology (<A HREF="#B40">40</A>).
In other words, the fact<SUP> </SUP>that ApoE4 alleles have clearly been found to
enhance A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposition<SUP> </SUP>not only in parenchymal plaque deposits but
also in microvessels<SUP> </SUP>outside of the brain parenchyma (and in the
absence of AD) potentially<SUP> </SUP>separates the ApoE4 effect in promoting the
AD cerebral phenotype<SUP> </SUP>(i.e., neuritic plaques) from any deleterious
effects ApoE4 may<SUP> </SUP>have on neuronal/neuritic function in general. Thus
the most parsimonious<SUP> </SUP>explanation for ApoE4 effects vis &aacute; vis AD
is that this isoform<SUP> </SUP>somehow enhances the deposition or decreases the
clearance of<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptides, particularly A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>, in both
the cerebral cortex and<SUP> </SUP>its<SUP> </SUP>microvasculature.</P>
	    
	
	    
	    <P>Such an amyloid-enhancing mechanism is supported by studies
in which mice transgenic for mutant human APP are crossed with<SUP> </SUP>mice in
which the endogenous mouse ApoE gene is deleted. The resultant<SUP> </SUP>offspring show substantially decreased A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> plaque burden compared<SUP> </SUP>with
that seen in the parental APP transgenic line, suggesting<SUP> </SUP>that the
absence of ApoE significantly decreases the tendency<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> to accrue
as diffuse and mature plaques (<A HREF="#B5">5</A>). Moreover,<SUP> </SUP>mice lacking
endogenous ApoE that express human ApoE3 or E4 plus<SUP> </SUP>mutant human APP
develop less A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits than similar mice expressing<SUP> </SUP>no ApoE at all
(<A HREF="#B58">58</A>).</P>
	    
	
	    
	    <P>An important caveat about in vitro studies attempting to elucidate the
mechanisms by which the ApoE proteins induce such effects<SUP> </SUP>is that they
need always to be conducted in the presence of lipid,<SUP> </SUP>i.e., where ApoE
is assembled into lipoprotein particles. There<SUP> </SUP>is currently no evidence
that any significant portion of ApoE<SUP> </SUP>proteins occurs as free
polypeptides in brain or other tissues.<SUP> </SUP>As a result, early studies
examining the effects of pure ApoE<SUP> </SUP>on A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> in vitro are difficult to
interpret. Carefully designed<SUP> </SUP>in vitro and in vivo experiments should
ultimately clarify whether<SUP> </SUP>ApoE4 increases A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> steady-state levels
in brain by less efficiently<SUP> </SUP>preventing its aggregation, by inhibiting
its degradation or its<SUP> </SUP>reuptake into cells, or by other effects on its<SUP> </SUP>clearance.</P>
	    
	
	
    

    
    <A NAME="SEC6">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;VI.  FUNCTION OF PRESENILINS: A CENTRAL ROLE IN INTRAMEMBRANOUS
PROTEOLYSIS</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>








<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<A NAME="SEC6_1">
<P><B>A.&nbsp; Cell Biology of the Presenilins</B>

	
	    
	    <P>Shortly after the PS1 and PS2 genes were cloned and missense
mutations within them shown to cause autosomal dominant AD, two<SUP> </SUP>important observations about their biology were made. First, the<SUP> </SUP>presenilin holoproteins (~44 kDa) were found to undergo constitutive<SUP> </SUP>endoproteolysis in many cell types and in the brain and thus exist<SUP> </SUP>in
major part as stable heterodimers composed of the
NH<SUB>2</SUB>-terminal<SUP> </SUP>fragment (NTF) and COOH-terminal fragment
(CTF) (<A HREF="#B11">11</A>, <A HREF="#B115">115</A>, <A HREF="#B123">123</A>,<SUP> </SUP><A HREF="#B169">169</A>). The very low levels of holoprotein in cells and
tissue,<SUP> </SUP>together with the evidence from pulse-chase experiments
that the<SUP> </SUP>holoprotein is rapidly converted into fragments
(<A HREF="#B115">115</A>), probably<SUP> </SUP>by endoproteolysis occurring within
endoplasmic reticulum vesicles<SUP> </SUP>and subsequent stabilization of the
fragments in the Golgi (<A HREF="#B206">206</A>),<SUP> </SUP>suggests that the fragments
are the principal biologically functional<SUP> </SUP>form of presenilins. The
constitutive proteolytic cleavage site<SUP> </SUP>(<A HREF="#B115">115</A>,
<A HREF="#B162">162</A>) occurs within a hydrophobic portion of the
cytoplasmic<SUP> </SUP>loop between the sixth and seventh of the eight putative
transmembrane<SUP> </SUP>domains (<A HREF="#B91">91</A>). The steady-state levels of
presenilin NTFs and<SUP> </SUP>CTFs seem to be tightly regulated, as
overexpression of PS1 in<SUP> </SUP>transfected cells or transgenic mice generally
does not increase<SUP> </SUP>the overall level of PS fragments (<A HREF="#B11">11</A>,
<A HREF="#B170">170</A>). Excess PS holoproteins<SUP> </SUP>are rapidly degraded, mainly
by the proteasome (<A HREF="#B73">73</A>, <A HREF="#B161">161</A>). Once<SUP> </SUP>formed, PS
fragments can associate into higher molecular mass<SUP> </SUP>(~100-200 kDa)
complexes that may represent the principal form<SUP> </SUP>in which presenilin
functions in cells (<A HREF="#B14">14</A>, <A HREF="#B205">205</A>).</P>
	    
	
	    
	    <P>The second major observation was the identification of the homolog in
<I>Caenorhabditis elegans</I> of the mammalian presenilins,<SUP> </SUP>a gene
designated <I>sel-12</I> (<A HREF="#B88">88</A>). <I>Sel-12</I> was
identified in genetic<SUP> </SUP>screens as a facilitator of the worm homolog of
Notch, <I>lin-12</I>.<SUP> </SUP>The existence of mutations in
<I>sel-12</I> that decrease or eliminate<SUP> </SUP>its function has enabled
the use of the nematode as a model system<SUP> </SUP>for studying the function of
the human presenilins (<A HREF="#B6">6</A>, <A HREF="#B87">87</A>).<SUP> </SUP>For example, a
loss-of-function mutation in <I>sel-12</I> can produce<SUP> </SUP>a lethal
defect in egg-laying in the worm that is due to a defect<SUP> </SUP>in lin-12
(i.e., Notch) signaling during differentiation of the<SUP> </SUP>vulva
(<A HREF="#B88">88</A>). Other proteins that interact genetically with sel-12<SUP> </SUP>have been identified in <I>C.&nbsp;elegans</I> (<A HREF="#B192">192</A>). In
addition, the use<SUP> </SUP>of the yeast two-hybrid system has led to
identification of several<SUP> </SUP>novel or known mammalian proteins that appear
to interact with<SUP> </SUP>presenilin. Prominent among these are members of the
Armadillo<SUP> </SUP>family called the catenins, including an apparent
neuron-specific<SUP> </SUP>member of this family, designated
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/delta.gif" ALIGN=BOTTOM ALT="delta ">-catenin (<A HREF="#B205">205</A>, <A HREF="#B208">208</A>). Both<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/delta.gif" ALIGN=BOTTOM ALT="delta ">- and
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-catenins coimmunoprecipitate with presenilin 1.&nbsp;The catenin<SUP> </SUP>binding
site appears to be in the distal portion of the large<SUP> </SUP>cytoplasmic loop
between transmembrane (TM) domains 6&nbsp;and 7.&nbsp;It<SUP> </SUP>has been shown that this
region is dispensable for the function<SUP> </SUP>of presenilin in the
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase mechanism (i.e., in A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generation),<SUP> </SUP>and therefore, the
interaction with the catenins may not turn<SUP> </SUP>out to have pathogenic
relevance in AD. Presenilins have recently<SUP> </SUP>been shown to participate in
multi-protein complexes near and<SUP> </SUP>at the cell surface that include
the cadherins, important molecules<SUP> </SUP>mediating cell-cell adhesion
(<A HREF="#B33">33</A>). Furthermore, the fact that<SUP> </SUP>mutations of conserved
residues in PS1 as well as PS2 can elevate<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
production and are linked to familial AD suggests that sequences<SUP> </SUP>that
diverge between the two homologs (such as the region of the<SUP> </SUP>PS1 loop
which binds the catenins) are less likely to be required<SUP> </SUP>for the
critical stabilization of the presenilin heterodimers<SUP> </SUP>and for their
AD-promoting activity than are highly conserved<SUP> </SUP>sequences, such as
their COOH termini (<A HREF="#B175">175</A>). Indeed, the latter<SUP> </SUP>site is a
good candidate for the binding of the currently unknown<SUP> </SUP>cellular
factors that regulate presenilin endoproteolysis and<SUP> </SUP>stabilize the
heterodimers (<A HREF="#B198">198</A>).</P>
	    
	
	    
	    <P>The loss of function of presenilin produced by gene deletion in mice
leads to a profound phenotype that includes markedly<SUP> </SUP>abnormal
somitogenesis and axial skeletal development with shortened<SUP> </SUP>body
length, as well as cerebral hemorrhages (<A HREF="#B149">149</A>,
<A HREF="#B190">190</A>). In<SUP> </SUP>addition, these mice, which die just before or at
birth, show<SUP> </SUP>abnormal embryonic neurodevelopment in the forebrain marked
by<SUP> </SUP>premature loss of neuronal precursors (<A HREF="#B149">149</A>). Deletion
of just<SUP> </SUP>one PS1 gene in the mouse has not been associated with any
major<SUP> </SUP>phenotypic abnormalities to date. An important functional insight<SUP> </SUP>has been gained by complementation studies in presenilin homozygous<SUP> </SUP>knockout mice. Crossing presenilin heterozygous knockout mice<SUP> </SUP>with mice
transgenic for AD-causing mutant PS leads to some offspring<SUP> </SUP>that
have no endogenous (mouse) presenilin but express the human<SUP> </SUP>mutant
form. Such mice survive and do not have the devastating<SUP> </SUP>phenotype found
in presenilin homozygous mice, although they may<SUP> </SUP>have subtle
alterations (<A HREF="#B20">20</A>, <A HREF="#B121">121</A>). Therefore, missense
mutations<SUP> </SUP>in the human presenilins that cause early-onset AD appear
to act<SUP> </SUP>as gain rather than loss of function<SUP> </SUP>mutations.</P>
	    
	
	
    
	
	<A NAME="SEC6_2">
<P><B>B.&nbsp; Presenilin and the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-Secretase Cleavage of APP</B>

	
	    
	    <P>Presenilin knock-out mice have also proven to be critical for
deciphering the role of presenilins in APP metabolism. Such<SUP> </SUP>mice show
normal levels of APP holoproteins as well as normal<SUP> </SUP>secretory
derivatives from the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha ">- and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase cleavages but<SUP> </SUP>grossly
abnormal <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase function (<A HREF="#B22">22</A>). Neurons cultured<SUP> </SUP>from these mice (<A HREF="#B22">22</A>) and the brain tissue itself
(<A HREF="#B196">196</A>) accumulate<SUP> </SUP>high levels of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase APP
substrates C83 and C99. There<SUP> </SUP>is a corresponding substantial (~70%)
decrease in the production<SUP> </SUP>of both A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> (<A HREF="#B22">22</A>). This evidence that presenilin
plays<SUP> </SUP>a required role in the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase mechanism has received
substantial<SUP> </SUP>support from several types of experiments. Even before the
realization<SUP> </SUP>that presenilin is necessary for proper <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase
cleavage of<SUP> </SUP>APP, it was shown that presenilin could bind to and
immunoprecipitate<SUP> </SUP>with full-length APP molecules in several cell
types (<A HREF="#B184">184</A>, <A HREF="#B197">197</A>).<SUP> </SUP>This interaction was shown
not to require the cytoplasmic tail<SUP> </SUP>of APP (<A HREF="#B197">197</A>). Because
the presenilins have very small ectodomain<SUP> </SUP>loops, it was unlikely that
presenilin and APP would interact<SUP> </SUP>via their respective ectodomains.
This left the transmembrane<SUP> </SUP>domains as the likely site of interaction.
However, this evidence<SUP> </SUP>for coimmunoprecipitation of presenilin and APP
was sharply challenged<SUP> </SUP>by investigators who could show no such
interaction (<A HREF="#B171">171</A>). From<SUP> </SUP>this controversy arose two broad
hypotheses for the mechanism<SUP> </SUP>of the presenilins in
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase-mediated APP processing. The<SUP> </SUP>first, based on the ability
to coprecipitate the proteins, suggested<SUP> </SUP>that presenilin participates
directly in the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase mechanism,<SUP> </SUP>i.e., is part of the catalytic
complex, presumably as a cofactor<SUP> </SUP>(<A HREF="#B197">197</A>). The alternate
hypothesis argued that presenilin and APP<SUP> </SUP>do not physically interact;
rather, presenilin regulates the membrane<SUP> </SUP>trafficking of certain
proteins, presumably including the components<SUP> </SUP>of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase
reaction (the protease and APP) in a way that<SUP> </SUP>allows them to come
together (<A HREF="#B104">104</A>, <A HREF="#B171">171</A>). In the author's
laboratory,<SUP> </SUP>confirmation of the presenilin-APP interactions in
multiple experiments<SUP> </SUP>and evidence that the two fractionate to the same
enriched vesicular<SUP> </SUP>fractions on gradients (<A HREF="#B196">196</A>,
<A HREF="#B206">206</A>) and that the subcellular distribution<SUP> </SUP>of C83 and C99
(the immediate substrates of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase reaction)<SUP> </SUP>was not
altered in mice bearing or lacking PS1 suggested that<SUP> </SUP>presenilin was
inseparable from the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavage event,<SUP> </SUP>i.e., that it is a
physical participant rather than having an<SUP> </SUP>indirect role via membrane<SUP> </SUP>trafficking.</P>
	    
	
	    
	    <P>In a separate line of work, Wolfe and colleagues (<A HREF="#B186">186</A>,
<A HREF="#B187">187</A>) designed peptidomimetic transition state analogs to
attempt<SUP> </SUP>to inhibit <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase and showed that certain
difluoroalcohol<SUP> </SUP>and difluoroketone inhibitors mimicking the
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40-45</SUB> region<SUP> </SUP>could indeed decrease A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> secretion and
raise cellular levels of<SUP> </SUP>C83 and C99. The chemical nature of these
inhibitors strongly<SUP> </SUP>suggested that the unknown <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase had the
properties of an<SUP> </SUP>aspartyl protease (<A HREF="#B187">187</A>). This concept
also fit with evidence<SUP> </SUP>from cell biological experiments that the
generation of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> appeared<SUP> </SUP>to require a mildly acidic pH (e.g., Ref.
<A HREF="#B44">44</A>). Moreover, cathepsin<SUP> </SUP>D, a well-characterized soluble aspartyl
protease, was considered<SUP> </SUP>as a potential candidate for <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase,
until it was shown that<SUP> </SUP>deletion of the cathepsin D gene in mice did
not obviate A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production<SUP> </SUP>(<A HREF="#B131">131</A>).</P>
	    
	
	    
	    <P>Accumulating data suggested that presenilin was physically inseparable
from the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase reaction (<A HREF="#B197">197</A>), including the<SUP> </SUP>finding of presenilin heterodimers within isolated vesicles that<SUP> </SUP>can
undergo A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generation (<A HREF="#B196">196</A>), and there was evidence that<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase had the properties of an aspartyl protease
(<A HREF="#B187">187</A>).<SUP> </SUP>These considerations led Wolfe et al.
(<A HREF="#B188">188</A>) to identify and mutate<SUP> </SUP>two unusual intramembranous
aspartates found near the middle of<SUP> </SUP>the predicted TM6 and TM7 domains
of all presenilins. Mutation<SUP> </SUP>of either of these evolutionarily
conserved aspartates to alanine<SUP> </SUP>or glutamate and subsequent cellular
expression showed that the<SUP> </SUP>mutant holoprotein could no longer undergo
endoproteolysis, signifying<SUP> </SUP>an essential role for both intramembranous
aspartates in this<SUP> </SUP>reaction. Furthermore, mutation of either TM
aspartate markedly<SUP> </SUP>reduced A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
production and elevated the C83 and C99<SUP> </SUP>substrates, in a fashion
essentially indistinguishable from the<SUP> </SUP>earlier effects noted for PS1
gene deletion (<A HREF="#B22">22</A>). When these<SUP> </SUP>two phenomena (inhibition
of presenilin endoproteolysis and of<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavage) were
examined together by placing an aspartate-to-alanine<SUP> </SUP>mutation in the
natural variant of presenilin that lacks exon<SUP> </SUP>9&nbsp;(and therefore the site
for PS1 endoproteolytic cleavage), this<SUP> </SUP>mutant holoprotein still
abrogated <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase cleavage of APP<SUP> </SUP>(<A HREF="#B188">188</A>). The latter
result indicates that even in a presenilin<SUP> </SUP>isoform that cannot and does
not undergo endoproteolysis, the<SUP> </SUP>TM aspartates are still required for
proper <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase processing<SUP> </SUP>of C83 and C99. An additional
experimental approach was to express<SUP> </SUP>either wild-type or
aspartate-mutant PS1 in microsomes and demonstrate<SUP> </SUP>that the former
allowed de novo A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generation from recombinantly<SUP> </SUP>expressed C99,
whereas the latter did not, and that A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> generation<SUP> </SUP>in the presence of
the wild-type presenilin occurred at mildly<SUP> </SUP>acidic, not neutral, pH
(<A HREF="#B188">188</A>).</P>
	    
	
	    
	    <P>The interpretation of the results just summarized has been a matter of
some controversy. One interpretation is that presenilin<SUP> </SUP>is required as
a "diaspartyl" cofactor for <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase and that<SUP> </SUP>mutation of
either aspartate prevents that function. The alternate<SUP> </SUP>interpretation
is that presenilin actually represents <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase,<SUP> </SUP>a novel
intramembranous protease activated by autoproteolysis<SUP> </SUP>(<A HREF="#B188">188</A>). Recent evidence consistent with either hypothesis
has<SUP> </SUP>come from subcellular factionation experiments in which it was<SUP> </SUP>shown that C83 and C99, the substrates of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase, can be<SUP> </SUP>coprecipitated with presenilin heterodimers in Golgi- and
<I>trans</I>-Golgi<SUP> </SUP>network-like membrane vesicles, whereas the
APP holoprotein coprecipitates<SUP> </SUP>with presenilin holoprotein in an
earlier, endoplasmic reticulum-rich<SUP> </SUP>vesicular compartment
(<A HREF="#B193">193</A>, 194). These data confirm a direct<SUP> </SUP>interaction of the APP <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase substrates with presenilin.<SUP> </SUP>Furthermore, the vesicles containing such complexes have substantial<SUP> </SUP>steady-state levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> when presenilin is wild type but not<SUP> </SUP>when it contains the aspartate mutations, and new A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> can be generated<SUP> </SUP>in a cell-free reaction from the former but not the latter vesicles<SUP> </SUP>(<A HREF="#B193">193</A>). Interestingly, stable expression of the TM
aspartate to<SUP> </SUP>alanine mutations in both PS1 and PS2 in the same cell
decreases<SUP> </SUP>A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production to undetectable levels, suggesting an
absolute requirement<SUP> </SUP>for functional presenilins (and their TM
aspartates in particular)<SUP> </SUP>to generate any A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> (<A HREF="#B74">74</A>).</P>
	    
	
	    
	    <P>At this writing, absolute resolution of whether presenilin serves
either as <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase or as a necessary cofactor has not<SUP> </SUP>been
achieved. Two types of experiments could resolve this issue.<SUP> </SUP>First, one
could demonstrate the generation of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> in artificial<SUP> </SUP>phospholipid
vesicles (liposomes) expressing only presenilin and<SUP> </SUP>its substrates, C99
or C83. However, it appears highly likely<SUP> </SUP>that presenilin and APP exist
in multiprotein complexes, including<SUP> </SUP>the presence of the limiting
cellular factor(s) that allow endoproteolysis<SUP> </SUP>and stabilize the
fragments (<A HREF="#B169">169</A>), and these other members of<SUP> </SUP>the reaction
have not been identified. Therefore, the reconstitution<SUP> </SUP>experiments
face two major obstacles: the potential need for one<SUP> </SUP>or several unknown
cofactor proteins to allow the reaction to<SUP> </SUP>proceed, and the need to
allow presenilin to fold properly into<SUP> </SUP>artificial membranes in a way
that allows its proteolytic activity.<SUP> </SUP>Given the difficulty and length
of time that may be needed to<SUP> </SUP>achieve this goal, a second and more
attractive experimental approach<SUP> </SUP>has been undertaken. The facts that
widespread screening of compounds<SUP> </SUP>on A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secreting cells has yielded
inhibitors with high potency<SUP> </SUP>and with all of the properties of bona
fide <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase inhibitors<SUP> </SUP>and that other such inhibitors have been
rationally designed (<A HREF="#B187">187</A>)<SUP> </SUP>have allowed identification of
the cognate targets of these inhibitors.<SUP> </SUP>It has been shown that such
compounds bind specifically and selectively<SUP> </SUP>to presenilin heterodimers
(<A HREF="#B28a">28a</A>, <A HREF="#B91a">91a</A>). This result is tantamount<SUP> </SUP>to proving that presenilin and
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase are one and the same.<SUP> </SUP>Although it remains formally
possible that an unknown protease<SUP> </SUP>could be so intimately associated
with presenilin that the inhibitors<SUP> </SUP>bind to presenilin while also
binding to the active site, the<SUP> </SUP>use of compounds that are transition
state mimics and have a sequence<SUP> </SUP>closely resembling the substrate (the
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> region of APP) (<A HREF="#B28a">28a</A>)<SUP> </SUP>would make it highly likely that the protein
to which the compound<SUP> </SUP>bound (i.e., PS) was the actual aspartyl
protease. Such evidence<SUP> </SUP>goes a long way toward resolving the question
of whether presenilin<SUP> </SUP>is the long-sought <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase and is thus
a direct target for<SUP> </SUP>inhibition to chronically lower brain A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> levels.
In this regard,<SUP> </SUP>phase I clinical trials of a <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase inhibitor
emerging from<SUP> </SUP>broad-scale screening have recently been initiated
(<A HREF="#B29a">29a</A>).</P>
	    
	
	
    
	
	<A NAME="SEC6_3">
<P><B>C.&nbsp; Presenilin as a Key Mediator of Notch Signaling</B>

	
	    
	    <P>As the work summarized in the preceding section was unfolding,
further analyses of presenilin/sel-12 function in simpler organisms<SUP> </SUP>(e.g., <I>Drosophila </I>and<I> C.&nbsp;elegans</I>) led to the
important insight<SUP> </SUP>that presenilin was required for proper Notch
signaling (<A HREF="#B21">21</A>,<SUP> </SUP><A HREF="#B164">164</A>, <A HREF="#B204">204</A>). Signal
transduction mediated by the cell surface<SUP> </SUP>receptors Notch in
<I>Drosophila</I> and lin-12 and glp-1 in<I> C.&nbsp;elegans</I><SUP> </SUP>has
been shown to be essential for a large variety of cell fate<SUP> </SUP>decisions
during development (for reviews, see Refs. <A HREF="#B4">4</A>, <A HREF="#B41">41</A>).<SUP> </SUP>The vital importance
of cell-cell interactions controlled by the<SUP> </SUP>lin-12/Notch pathway
for proper development of vertebrates and<SUP> </SUP>invertebrates is clear from
many genetic analyses, but the biochemical<SUP> </SUP>mechanism by which these
receptors transmit cell surface signals<SUP> </SUP>to the nucleus to alter
expression of a variety of downstream<SUP> </SUP>genes in the Notch pathway has
been poorly understood. It has<SUP> </SUP>appeared increasingly probable that
signal transduction by ligand-activated<SUP> </SUP>Notch receptors might
involve proteolytic processing of the receptor<SUP> </SUP>to release the
intracellular domain to the nucleus (e.g., Ref.<SUP> </SUP><A HREF="#B78">78</A>). Mutation of an
amino acid at the putative cleavage site<SUP> </SUP>within or just cytoplasmic to
the single TM domain of Notch markedly<SUP> </SUP>decreased Notch signaling in
mammalian cells, thus linking intramembranous<SUP> </SUP>proteolysis of Notch with
its function in activating transcription<SUP> </SUP>of nuclear genes
(<A HREF="#B139">139</A>). Very low concentrations of the intracellular<SUP> </SUP>domain
of Notch (NICD) appear to reach the nucleus, making this<SUP> </SUP>fragment
difficult to detect immunocytochemically (<A HREF="#B139">139</A>). Either<SUP> </SUP>during or after nuclear entry of NICD, it can bind to and activate<SUP> </SUP>members of the CSL family of downstream Notch effectors such as<SUP> </SUP>CBF-1
and<SUP> </SUP>Su(H).</P>
	    
	
	    
	    <P>Compelling evidence that the presenilin proteins are essential
participants in this cleavage event has arisen from studies<SUP> </SUP>of flies
and mammalian cells (Fig. <a href="#F3">3</a>). Lethal loss
of function<SUP> </SUP>mutations in the <I>Drosophila</I> presenilin abolish
Notch signaling<SUP> </SUP>by preventing NICD from being released to the nucleus
(<A HREF="#B164">164</A>, <A HREF="#B204">204</A>).<SUP> </SUP>The presenililn null mutations
produce a somatic and neural phenotype<SUP> </SUP>in the fly that is highly
similar to that of flies lacking Notch.<SUP> </SUP>Moreover, mouse cells devoid of
PS1 undergo markedly decreased<SUP> </SUP>proteolytic release of NICD from a Notch
construct (<A HREF="#B21">21</A>, <A HREF="#B159">159</A>).<SUP> </SUP>Peptidomimetic compounds
designed to inhibit the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase processing<SUP> </SUP>of APP
(<A HREF="#B187">187</A>) show the same rank potency in inhibiting the
intramembranous<SUP> </SUP>cleavage of Notch (<A HREF="#B21">21</A>). It has recently
been shown that the<SUP> </SUP>aspartate-mutant forms of PS, which block
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase proteolysis<SUP> </SUP>of C83 and C99 of APP (<A HREF="#B188">188</A>),
also inhibit the release of NICD<SUP> </SUP>and its translocation to the nucleus
(<A HREF="#B8">8</A>, <A HREF="#B124">124</A>). Therefore,<SUP> </SUP>it appears that
presenilin can serve as an essential cofactor<SUP> </SUP>in the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase
cleavage of Notch or, more likely, as the protease<SUP> </SUP>itself (Fig. <a href="#F3">3</a>). It
should also be noted that complex formation<SUP> </SUP>between Notch and
presenilin has been observed (<A HREF="#B125">125</A>). It appears<SUP> </SUP>that Notch
and presenilin can interact at or close to the cell<SUP> </SUP>surface, because
biotinylation of each protein has been observed<SUP> </SUP>and biotinylated Notch
can be recovered by immunoprecipitating<SUP> </SUP>presenilin heterodimers
(<A HREF="#B124">124</A>). Several other studies have also<SUP> </SUP>suggested a
localization of at least some presenilin molecules<SUP> </SUP>at or close to the
plasma membrane (<A HREF="#B33">33</A>, <A HREF="#B82">82</A>, <A HREF="#B141">141</A>).
This emerging<SUP> </SUP>evidence of a surface localization of mammalian
presenilin fits<SUP> </SUP>with the fact that <I>Drosophila</I> presenilin has
been reported to<SUP> </SUP>be detected in or very near the plasma membrane
(<A HREF="#B203">203</A>). Before<SUP> </SUP>publication of the various results just
summarized, the majority<SUP> </SUP>of studies examining presenilin subcellular
localization suggested<SUP> </SUP>that it resided primarily or solely in
endoplasmic reticulum and<SUP> </SUP>early Golgi compartments (e.g., Refs. <A HREF="#B3">3</A>, <A HREF="#B81">81</A>).



<A NAME="F3"><!-- FIG 3 --></A>

<P><BR CLEAR=ALL><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=126 SRC="http://physrev.physiology.org/content/vol81/issue2/images/small/9j0210134003.gif"></A><BR>

<STRONG>View larger version</STRONG> (25K):
<BR><NOBR><A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F3">[in this window]</A>
<BR><A HREF="http://physrev.physiology.org/cgi/content-nw/full/81/2/741/F3"
    onClick="startTarget('F3', 590, 478); this.href='/cgi/content-nw/full/81/2/741/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
    </NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. </STRONG>

Hypothetical model of the role of presenilin (PS) in Notch and APP
processing based on current information. The diagram shows the
predicted 8&nbsp;TM domain topology of PS, which occurs principally as a
cleaved heterodimer. Some Notch and APP molecules form complexes with
PS. Two aspartates (D) in TM6 and TM7 of PS are required for the
cleavages of Notch and APP within their TM domains, and these may align
with the respective sites of cleavage in the two substrates. It is
unknown whether PS directly effects these cleavages or whether a still
unidentified aspartyl protease (<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase) present in the complexes
does so. PS-mediated proteolysis of both Notch and APP is preceded
by ectodomain shedding due to tumor necrosis factor-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "> converting
enzyme (TACE). Alternatively, APP can undergo ectodomain shedding by
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase. Several motifs are depicted in Notch: epidermal growth
factor-like repeats (yellow circles), LNG repeats (orange
diamonds), a single TM (white box), the RAM23 domain (blue square), a
nuclear localization sequence (red rectangle), and 6&nbsp;cdc10/ankyrin
repeats (green ovals). After the putative intramembranous cleavage
mediated by PS, the Notch intracellular domain is released to the
nucleus to activate transcription of target genes. APP contains the
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> region (light blue box), which is released into the lumen after
sequential cleavages of APP by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase and then <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase/PS.
The fate of the APP intracellular domain is
unknown.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->



</P>
	    
	
	
    
	
	<A NAME="SEC6_4">
<P><B>D.&nbsp; Presenilin May Be Required for Proteolysis  of Other
Integral Membrane Proteins</B>

	
	    
	    <P>The exciting parallels between Notch processing and APP processing
with regard to the presenilins have raised the question<SUP> </SUP>of whether
there may be other substrates that require presenilin<SUP> </SUP>for proteolysis
and other enzymes that are intramembranous aspartyl<SUP> </SUP>proteases. In this
regard, other members of the APP family, namely,<SUP> </SUP>APLP1 and APLP2, are
very likely to undergo presenilin-mediated<SUP> </SUP>intramembranous
proteolysis as part of their constitutive metabolism;<SUP> </SUP>CTFs of APLP2 are
sharply increased in mice lacking presenilin<SUP> </SUP>1&nbsp;(<A HREF="#B104">104</A>). One
substrate possibly linked to presenilin function<SUP> </SUP>is Ire1, a protein
that is a key sensor for the accumulation of<SUP> </SUP>unfolded proteins in the
endoplasmic reticulum and thus initiates<SUP> </SUP>the unfolded protein response
(UPR) pathway. Examination of Ire1<SUP> </SUP>processing in cells derived from PS1
knockout mice suggested that<SUP> </SUP>presenilin is required for proper cleavage
of Ire1, putatively<SUP> </SUP>within its single transmembrane domain
(<A HREF="#B106">106</A>). In separate experiments,<SUP> </SUP>AD-causing missense
mutations in PS1 were reported to alter UPR<SUP> </SUP>signaling
(<A HREF="#B103">103</A>). However, a role for PS1 in Ire1 processing and<SUP> </SUP>the
UPR has not yet been confirmed. It is likely that additional<SUP> </SUP>substrates will be identified, but we can already list at least<SUP> </SUP>five kinds of putative substrates that require presenilin for<SUP> </SUP>their cleavage: APP, Notch receptors, APLP1, APLP2, and perhaps<SUP> </SUP>presenilin itself. Various chimeric type 1&nbsp;membrane proteins having<SUP> </SUP>heterologous transmembrane domains can undergo
PS-mediated intramembranous<SUP> </SUP>cleavage in flies, confirming the
relative lack of sequence specificity<SUP> </SUP>of presenilin/<IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase
(<A HREF="#B163a">163a</A>). It therefore appears that presenilin<SUP> </SUP>is generally responsible
for the proteolytic turnover of the transmembrane<SUP> </SUP>domains of a
variety of single-pass proteins that undergo ectodomain<SUP> </SUP>release.</P>
	    
	
	    
	    <P>The recent progress in Notch and presenilin biology allows one to place
the emerging public health catastrophe of AD into<SUP> </SUP>a new perspective. It
may turn out that the principal conserved<SUP> </SUP>function of the presenilins
is to mediate the final proteolytic<SUP> </SUP>cleavage of the Notch receptors,
thereby conferring great developmental<SUP> </SUP>advantages during evolution.
However, the survival of large numbers<SUP> </SUP>of humans far beyond
reproductive age due to advances such as<SUP> </SUP>antibiotics may have
increasingly permitted a kinetically less<SUP> </SUP>favored substrate of this
reaction (APP) to be converted to a<SUP> </SUP>highly stable, long-lived and
self-aggregating product (A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>)<SUP> </SUP>that can accumulate
to produce progressive neurodegeneration.<SUP> </SUP>Quantitative biochemical
comparisons of Notch and APP as binding<SUP> </SUP>partners and substrates of
presenilin would help to support or<SUP> </SUP>deny this<SUP> </SUP>hypothesis.</P>
	    
	
	    
	    <P>I would even speculate that partial loss of function mutations in human
PS1 could decrease the efficiency of APP processing<SUP> </SUP>to
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> (just as AD-causing gain of function mutations
increase<SUP> </SUP>it), and that such mutations might be found in very old humans<SUP> </SUP>(centenarians) who show very little age-related A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation<SUP> </SUP>and thus have  escaped AD. It would be particularly interesting<SUP> </SUP>to search for such "AD escapees" among the very old who carry<SUP> </SUP>one
or two ApoE4 alleles and yet have failed to develop clinical<SUP> </SUP>or
neuropathological evidence of<SUP> </SUP>AD.</P>
	    
	
	
    

    
    <A NAME="SEC7">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;VII.  THE COMPLEX INFLAMMATORY AND NEUROTOXIC CASCADE OF 
ALZHEIMER'S DISEASE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>









<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<P>Although many of the details of APP and presenilin biology
reviewed above and the roles of these proteins in genetic forms<SUP> </SUP>of AD
have been well confirmed, the subsequent events triggered<SUP> </SUP>by excessive
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> accumulation in brain regions important for<SUP> </SUP>memory
and cognition remain the subject of intensive study and<SUP> </SUP>debate. A full
description of the extensive information on the<SUP> </SUP>possible downstream
events that follow A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation is beyond<SUP> </SUP>the scope of this
review, which is focused instead on the key<SUP> </SUP>gene products that appear
to initiate AD. However, I review here<SUP> </SUP>the current understanding of
certain principal steps in the AD<SUP> </SUP>cascade that seem ultimately to lead
to the loss of synapses and<SUP> </SUP>somata, the dendritic dystrophy, and the
neurotransmitter deficits<SUP> </SUP>that are the proximate basis for the dementia
(Fig. <a href="#F4">4</a>).



<A NAME="F4"><!-- FIG 4 --></A>

<P><BR CLEAR=ALL><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=140 HEIGHT=200 SRC="http://physrev.physiology.org/content/vol81/issue2/images/small/9j0210134004.gif"></A><BR>

<STRONG>View larger version</STRONG> (35K):
<BR><NOBR><A HREF="http://physrev.physiology.org/cgi/content/full/81/2/741/F4">[in this window]</A>
<BR><A HREF="http://physrev.physiology.org/cgi/content-nw/full/81/2/741/F4"
    onClick="startTarget('F4', 458, 640); this.href='/cgi/content-nw/full/81/2/741/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
    </NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. </STRONG>

A hypothetical sequence of the pathogenetic steps of familial forms
of Alzheimer's disease.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->



</P>
	
    
	
	<A NAME="SEC7_2">
<P><B>A.&nbsp; Clues to the Temporal Evolution of AD Emerge From Studies
of Down's Syndrome and APP Transgenic Mice</B>

	
	    
	    <P>Because brain tissue from patients with AD can only be studied at
the end of the patient's life, it has been difficult to<SUP> </SUP>establish
directly the sequence of pathogenic events in the disorder.<SUP> </SUP>However,
powerful clues to this sequence have come from deciphering<SUP> </SUP>the highly
similar, if not indistinguishable, neuropathological<SUP> </SUP>process that
occurs in Down's syndrome. Because Down's patients<SUP> </SUP>develop their
first diffuse plaques at the end of the first or<SUP> </SUP>the beginning of the
second decade of life and yet do not show<SUP> </SUP>full-blown AD
histopathology until the end of the third or fourth<SUP> </SUP>decade, young and
middle-aged subjects dying with Down's syndrome<SUP> </SUP>can be carefully
examined to attempt to establish a temporal sequence<SUP> </SUP>of changes (e.g.,
Ref. <A HREF="#B85">85</A>).</P>
	    
	
	    
	    <P>Another source of dynamic information about the disease cascade has
been the study of mice transgenic for mutant human APP,<SUP> </SUP>either with or
without coexpression of mutant presenilin. Although<SUP> </SUP>lesion formation
occurs in a temporally compressed fashion in<SUP> </SUP>these mice
(<A HREF="#B29b">29b</A>, <A HREF="#B61">61</A>), some features of the cellular and
protein<SUP> </SUP>changes that precede and/or accompany neuritic/neuronal
alteration<SUP> </SUP>can be deduced by careful analysis of such models. Based on
studies<SUP> </SUP>of Down's syndrome and transgenic models as well as the
age-related<SUP> </SUP>histopathological and biochemical changes observed in
the brains<SUP> </SUP>of elderly humans dying without dementia, one can begin to
construct<SUP> </SUP>a rough sequence of AD<SUP> </SUP>pathogenesis.</P>
	    
	
	
    
	
	<A NAME="SEC7_3">
<P><B>B.&nbsp; A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> Accumulation, Diffuse Plaques, and the
Accrual of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB></B>

	
	    
	    <P>The increased production of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> documented in
patients with APP and presenilin mutations (as well as in children with
Down's<SUP> </SUP>syndrome) leads to rising levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>, both in
interstitial<SUP> </SUP>fluid of the brain and probably intracellularly. With
regard to<SUP> </SUP>the latter possibility, it has recently been shown that the
neurons<SUP> </SUP>of young subjects with Down's syndrome as well as some neurons<SUP> </SUP>in aged normals and subjects with mild AD can show intraneuronal<SUP> </SUP>immunoreactivity for A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> (<A HREF="#B39">39</A>). Indeed,
stable dimers of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB><SUP> </SUP>have been detected in nonneural and
neural cells in culture, before<SUP> </SUP>their release into the medium
(<A HREF="#B180">180</A>). Because A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> is far more<SUP> </SUP>prone to
aggregation into protofibrils and fibrils than A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB>
(<A HREF="#B53">53</A>,<SUP> </SUP><A HREF="#B70">70</A>, <A HREF="#B179">179</A>),
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> generally forms the earliest morphologically<SUP> </SUP>detectable deposits (diffuse plaques), well before the accrual<SUP> </SUP>of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> on such lesions (<A HREF="#B68">68</A>, <A HREF="#B69">69</A>,
<A HREF="#B85">85</A>). A major unresolved<SUP> </SUP>question is whether activation of
glial cells and injury to neurites<SUP> </SUP>and their cell bodies is mediated by
or even requires A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> plaque<SUP> </SUP>formation or rather is initiated and
propagated by  small, relatively<SUP> </SUP>soluble and diffusible
oligomeric species of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">, perhaps resembling<SUP> </SUP>the protofibrils found
in synthetic peptide studies. There is<SUP> </SUP>evidence in transgenic mice
expressing mutant human APP that structural<SUP> </SUP>changes of synapses as well
as electorphysiological alterations<SUP> </SUP>can be detected in relatively young
mice before the formation<SUP> </SUP>of any A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> deposits (diffuse
plaques) (<A HREF="#B60">60</A>). Such in vivo studies<SUP> </SUP>are mirrored in some
respects by studies of toxicity in cultured<SUP> </SUP>neurons exposed to stable
oligomeric species of synthetic A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> (e.g.,<SUP> </SUP>Refs. <A HREF="#B55">55</A>, <A HREF="#B83">83</A>). One cannot
yet conclude that in AD, oligomeric<SUP> </SUP>species of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
(which have only been partially characterized<SUP> </SUP>in human brain) are able
to initiate cellular dysfunction before<SUP> </SUP>any plaque formation; rather,
it may turn out that some plaque<SUP> </SUP>formation is necessary to allow the
cellular pathology to begin,<SUP> </SUP>but perhaps only because the plaques
represent a substantial reservoir<SUP> </SUP>of aggregated A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
species that can continuously release diffusible<SUP> </SUP>oligomers,
protofibrils, and the like to potentially activate<SUP> </SUP>and injure
surrounding cells. Thought of in this way, plaque development<SUP> </SUP>may
represent an invariant accompaniment of the  disease and even<SUP> </SUP>be
necessary for its early clinical manifestations, but the plaques<SUP> </SUP>per se
may not be the principal source of cellular injury. It<SUP> </SUP>would be
interesting to be able to examine the progression of<SUP> </SUP>cytopathology in
transgenic mice that develop stable A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> oligomers<SUP> </SUP>but
never go on to form diffuse or fibrillar plaques, but this<SUP> </SUP>would be a
difficult model to<SUP> </SUP>achieve.</P>
	    
	
	    
	    <P>With its substantially greater resistance to fibrillogenesis,
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> may only codeposit on preexisting A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>
diffuse plaques<SUP> </SUP>after considerable time. In Down's syndrome,
immunohistochemical<SUP> </SUP>studies clearly suggest that this interval may be
years or perhaps<SUP> </SUP>even a decade or more (<A HREF="#B85">85</A>). In the case
of patients dying from<SUP> </SUP>the effects of presenilin missense mutations,
the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> plaque<SUP> </SUP>burden is very high, and there can
sometimes be rather few A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB><SUP> </SUP>immunopositive plaques,
raising the question of whether A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> deposition<SUP> </SUP>is by
itself sufficient to initiate and propagate disease. Generally,<SUP> </SUP>however, A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>40</SUB> becomes another major component of senile
plaques<SUP> </SUP>as they mature and become increasingly<SUP> </SUP>fibrillar.</P>
	    
	
	
    
	
	<A NAME="SEC7_4">
<P><B>C.&nbsp; The Inflammatory Process in AD</B>

	
	    
	    <P>Like other aspects of research on the mechanism of AD, studies of
brain inflammatory changes were at first unpopular and deemed<SUP> </SUP>to be
unlikely to lead to an understanding of early pathogenesis.<SUP> </SUP>Nonetheless, the early efforts of a few investigators have been<SUP> </SUP>followed by a large number of studies that document a profound<SUP> </SUP>inflammatory disturbance in limbic and association cortices in<SUP> </SUP>AD.
Activated microglia displaying a variety of cell surface markers<SUP> </SUP>that
distinguish them from the resting microglia resident in the<SUP> </SUP>brain are
often found within and immediately surrounding maturing<SUP> </SUP>amyloid plaques
that contain at least some A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> fibrils. There is<SUP> </SUP>evidence that
HLA-DR-immunoreactive microglia can appear in at<SUP> </SUP>least some
diffuse plaques, presumably before the development<SUP> </SUP>of fibrillar,
thioflavin-, and Congo red-positive mature plaques<SUP> </SUP>(e.g., Ref. <A HREF="#B67">67</A>).
Microglia are reasonable candidates for early<SUP> </SUP>cellular respondents in
the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-mediated pathogenic cascade, because<SUP> </SUP>they represent
monocyte/macrophage-derived cells in the nervous<SUP> </SUP>system that are
capable of responding rapidly to the accrual of<SUP> </SUP>extracellular
("foreign") material. It is likely that microglia<SUP> </SUP>and astrocytes
would perceive A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> oligomers and fibrils as a foreign<SUP> </SUP>material,
because these kinds of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> assemblies are apparently<SUP> </SUP>never observed
during brain development and in the immature nervous<SUP> </SUP>system. With the
assumption that microglia can become activated<SUP> </SUP>by A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> aggregates
and/or proteins linked to them, it is likely<SUP> </SUP>that they participate in
the triggering of the classical complement<SUP> </SUP>pathway. Indeed, an initial
component of that pathway, C1q, has<SUP> </SUP>been shown to bind to A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> in vitro
(<A HREF="#B127">127</A>) and trigger the complement<SUP> </SUP>cascade, including the
accrual of the membrane attack complex<SUP> </SUP>C5b-9
(<A HREF="#B66">66</A>). Microglia could also be the source of
interleukin-1<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUP> </SUP>and a variety of other proinflammatory cytokines that
have been<SUP> </SUP>detected immunohistochemicallly in AD brain sections (e.g.,
Refs.<SUP> </SUP><A HREF="#B42">42</A>, <A HREF="#B100">100</A>). Cytokine release could in turn explain, at least<SUP> </SUP>in
part, the prominent reactive astrocytosis that immediately<SUP> </SUP>surrounds
many maturing, fibril-rich plaques. Such astrocytes<SUP> </SUP>are another
likely source of a variety of inflammatory mediators,<SUP> </SUP>including
additional cytokines and acute phase proteins such as<SUP> </SUP><IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>1</SUB>-antichymotrypsin, which is known to be intimately
associated<SUP> </SUP>with fibrillar plaque cores (<A HREF="#B1">1</A>).</P>
	    
	
	    
	    <P>The complex ways in which A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation might lead to microgliosis,
astrocytosis, and the overproduction and release of<SUP> </SUP>various
inflammatory mediators has been reviewed in detail (<A HREF="#B100">100</A>,<SUP> </SUP><A HREF="#B128">128</A>). Mounting evidence for early inflammatory changes
seen in<SUP> </SUP>the brains of Down's syndrome and of APP transgenic mice
(although<SUP> </SUP>generally less robustly than in humans) suggests that the
inflammatory<SUP> </SUP>response may be an important mediator of subsequent
neuritic/neuronal<SUP> </SUP>injury.</P>
	    
	
	
    
	
	<A NAME="SEC7_5">
<P><B>D.&nbsp; Free Radical Accumulation, Peroxidative Injury, and Altered
Calcium Homeostasis May Mediate Neuritic/Neuronal Injury</B>

	
	    
	    <P>Considerable experimental evidence suggests that the effects of
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation, including those arising from an A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-initiated<SUP> </SUP>inflammatory response, may include excessive generation of free<SUP> </SUP>radicals and peroxidative injury to proteins, lipids, and other<SUP> </SUP>macromolecules (e.g., Refs. <A HREF="#B7">7</A>, <A HREF="#B54">54</A>). Among the many possible<SUP> </SUP>metabolic
consequences of progressive A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation and aggregation<SUP> </SUP>(whether
occurring inside and/or outside neurons), altered ionic<SUP> </SUP>homeostasis,
particularly excessive calcium entry into neurons,<SUP> </SUP>could well
contribute to selective neuronal dysfunction and death,<SUP> </SUP>based on
studies of the effects of aggregated A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> in culture (<A HREF="#B92">92</A>,<SUP> </SUP><A HREF="#B99">99</A>, <A HREF="#B114">114</A>). Two major questions about
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-mediated neuritic and<SUP> </SUP>neuronal injury are as follows:
<I>1</I>) does the initial injury occur<SUP> </SUP>at the level of synapses or
dendrites rather than in the cell<SUP> </SUP>body, and <I>2</I>) does cell
injury require binding of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> monomers or<SUP> </SUP>oligomers to specific
cell-surface receptors or rather does it<SUP> </SUP>occur via a general
perturbation of the plasma membrane implicating<SUP> </SUP>many cell surface
proteins? Attempts to identify specific cell-surface<SUP> </SUP>molecules that
could serve as bona fide A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> receptors have included<SUP> </SUP>implication of
the receptor for advanced glycation end products<SUP> </SUP>(RAGE)
(<A HREF="#B202">202</A>), the scavenger receptors (<A HREF="#B27">27</A>), and a
novel A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-binding<SUP> </SUP>protein called BBP1 (<A HREF="#B109">109</A>). However, it
can be argued that neurons<SUP> </SUP>and other cells clearly did not evolve
receptors for binding A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUP> </SUP>oligomers/fibrils (since such are very
unlikely to occur in normal<SUP> </SUP>biology during development), and yet it is
such oligomeric or<SUP> </SUP>polymeric species that  appear to confer cell
toxicity, not monomers.<SUP> </SUP>Therefore, it is reasonable to speculate that
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-mediated neuritic<SUP> </SUP>injury does not involve a specific
ligand-receptor interaction<SUP> </SUP>in the classical sense but rather a
perturbation of the plasma<SUP> </SUP>membrane by the hydrophobic aggregates that
might alter the functional<SUP> </SUP>properties of a variety of cell-surface
molecules. In any event,<SUP> </SUP>excess calcium accumulation seems one
reasonable downstream mediator<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-induced toxicity
(<A HREF="#B99">99</A>) and could explain, for example,<SUP> </SUP>the activation of
certain kinases that could subsequently contribute<SUP> </SUP>to the
hyperphosphorylation of tau polypeptides before their polymerization<SUP> </SUP>into paired helical<SUP> </SUP>filaments.</P>
	    
	
	    
	    <P>It is now clear from the discovery of human tau mutations that cause
severe neurofibrillary degeneration (<A HREF="#B64">64</A>, <A HREF="#B160">160</A>)
that<SUP> </SUP>the accumulation of hyperphosphorylated forms of tau and the
presumed<SUP> </SUP>dysfunction of such molecules in maintaining microtubule
stabilization<SUP> </SUP>represent a major threat to neuronal form and function.
As mentioned<SUP> </SUP>earlier, a particularly intriguing recent development in
attempting<SUP> </SUP>to understand the link between A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation, neuronal
injury,<SUP> </SUP>and tangle formation has come from the recognition that AD
neurons<SUP> </SUP>bearing neurofibrillary tangles accumulate a fragment of p35,<SUP> </SUP>the regulatory protein for the cyclin-dependent kinase 5&nbsp;(cdk5),<SUP> </SUP>a
kinase which is capable of phosphorylating tau and other proteins<SUP> </SUP>(<A HREF="#B111">111</A>). According to these data, calpain may be activated
in some<SUP> </SUP>neurons to cleave p35 and generate the p25 fragment that is
mislocated<SUP> </SUP>within the cell and allows constitutive activity of cdk5
(<A HREF="#B83a">83a</A>).<SUP> </SUP>The resultant phosphorylation of various cellular
substrates including<SUP> </SUP>tau could explain how abnormal tau accumulates and
ultimately<SUP> </SUP>polymerizes into PHF. Whether extracellular A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> oligomers
are capable<SUP> </SUP>of triggering the conversion of p35 to p25 inside neurons
to initiate<SUP> </SUP>this cascade remains to be seen. This or several other
suggested<SUP> </SUP>mechanisms could explain the almost invariant accumulation of<SUP> </SUP>hyperphosphorylated tau and subsequent tangle formation that is<SUP> </SUP>a key
cytopathological feature in affected brain regions in almost<SUP> </SUP>all AD<SUP> </SUP>subjects.</P>
	    
	
	    
	    <P>The ultimate effects of the complex inflammatory, ionic, and oxidative
changes that occur in affected cortical regions is<SUP> </SUP>neuritic dystrophy,
synaptic loss, shrinkage of neuronal perikarya,<SUP> </SUP>and selective neuronal
loss. Presumably, these processes occur<SUP> </SUP>gradually over many years in
the preclinical phase of AD and then<SUP> </SUP>continue during its clinical
progression. An obvious result of<SUP> </SUP>such a synaptotoxic process would be
the loss of cholinergic enzymes<SUP> </SUP>(choline acetyltransferase and
acetylcholinesterase) as well as<SUP> </SUP>injury to a variety of other
neurotransmitter and neuromodulator<SUP> </SUP>systems. Such losses would
seriously compromise synaptic transmission<SUP> </SUP>and could explain the
difficulty in storing new information and<SUP> </SUP>failure to retrieve recently
stored information that characterizes<SUP> </SUP>the early stages of<SUP> </SUP>AD.</P>
	    
	
	
    

    
    <A NAME="SEC8">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;VIII.  TREATING AND PREVENTING ALZHEIMER'S DISEASE</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>










<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#SEC9"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<A NAME="SEC8_1">
<P><B>A.&nbsp; Remaining Questions Abound</B>

	
	    
	    <P>Although the outlines of a pathogenic cascade (Fig. <a href="#F4">4</a>) that could
explain cognitive dysfunction in AD patients are emerging,<SUP> </SUP>many
important questions remain. One would like to know the relative<SUP> </SUP>contributions of extracellular and intraneuronal A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> accumulation<SUP> </SUP>in
potentially initiating neurotoxicity. Also, are A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> fibrils<SUP> </SUP>the
principal toxic moiety in the disease or, more likely, are<SUP> </SUP>smaller
assemblies (stable but diffusable oligomers) the
microglia-activating<SUP> </SUP>and neuron-injuring species? Is apoptosis
of neurons an important<SUP> </SUP>part of the pathogenic cascade that, if
inhibited, would slow<SUP> </SUP>or prevent brain dysfunction (<A HREF="#B19">19</A>).
Although both of the presenilins<SUP> </SUP>(particularly mutant presenilin 2)
have been associated with enhanced<SUP> </SUP>apoptosis in cell culture studies
(<A HREF="#B59">59</A>, <A HREF="#B189">189</A>), expression of<SUP> </SUP>FAD mutations in
presenilins by knock-in techniques in mice have<SUP> </SUP>not yet produced
clear evidence that such mutations enhance neuronal<SUP> </SUP>apoptosis in vivo
(<A HREF="#B152">152</A>). How a putative proapoptotic function<SUP> </SUP>of presenilin
relates to the possibility that presenilin is an<SUP> </SUP>aspartyl protease that
processes APP, Notch, and other intramembranous<SUP> </SUP>substrates needs to be
elucidated. The presence of innumerable<SUP> </SUP>tangle-bearing neurons in
the AD brain that still show relatively<SUP> </SUP>well-preserved organelle
structure by electron microscopy, coupled<SUP> </SUP>with evidence that mutations
in tau can lead to accelerated tangle<SUP> </SUP>formation and ultimately neuronal
death, may suggest that a gradual<SUP> </SUP>nonapoptotic neuronal dysfunction
(i.e., the tau alteration/microtubule<SUP> </SUP>destabilization process) can
precede neuronal death, which then<SUP> </SUP>might finally occur by<SUP> </SUP>apoptosis.</P>
	    
	
	    
	    <P>What about the selective vulnerability of neuronal populations to the
AD process? Local and regional differences in the pathogenic<SUP> </SUP>process
may arise on at least two broad levels. First, A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> can<SUP> </SUP>accumulate chronically in some brain regions (e.g., cerebellum,<SUP> </SUP>striatum, and thalamus) with very little evolution to fibril-rich<SUP> </SUP>amyloid plaques and little associated neuritic and glial cytopathology.<SUP> </SUP>This finding suggests the possible existence of pro- or
anti-aggregating<SUP> </SUP>factors that vary among brain regions and that
enable A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> to<SUP> </SUP>proceed into oligomeric forms or prevent
it from doing so. Second,<SUP> </SUP>even in regions where abundant A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
oligomerization/fibrillization<SUP> </SUP>can occur, some surrounding neurons and
their processes appear<SUP> </SUP>to undergo few or no neurotoxic changes. This
suggests some intrinsic<SUP> </SUP>ability on the part of certain neurons to
resist A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-mediated<SUP> </SUP>cytotoxicity.</P>
	    
	
	
    
	
	<A NAME="SEC8_2">
<P><B>B.&nbsp; Potential Therapeutic Strategies</B>

	
	    
	    <P>Despite these and other unresolved questions, sufficient progress
in delineating the disease cascade has now been achieved<SUP> </SUP>to envision
several discrete targets for treatment. Inhibitors<SUP> </SUP>of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production,
that is, small compounds that cross the blood-brain<SUP> </SUP>barrier and
decrease but do not eliminate either <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">- or <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase<SUP> </SUP>activity,
could be therapeutic in the early clinical phases of<SUP> </SUP>the disease,
particularly in patients with minimal cognitive impairment,<SUP> </SUP>and in
nondemented subjects. In the case of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase inhibitors,<SUP> </SUP>these
could be designed to decrease A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> production by some 30-40%<SUP> </SUP>or so,
hopefully without interfering in a quantitatively meaningful<SUP> </SUP>way with
Notch processing. The fact that very small amounts of<SUP> </SUP>the Notch
intracellular fragment are apparently sufficient to<SUP> </SUP>activate signaling
in cells (<A HREF="#B139">139</A>) may mean that some decrease<SUP> </SUP>in Notch
proteolysis can be tolerated, particularly in AD patients,<SUP> </SUP>in whom
developmental issues are not at<SUP> </SUP>stake.</P>
	    
	
	    
	    <P>An alternate and attractive approach would be to use small molecules to
bind A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> monomers and prevent their assembly into potentially<SUP> </SUP>cytotoxic oligomers. However, if an anti-aggregating compound<SUP> </SUP>solely blocked amyloid fibril formation, this could actually allow<SUP> </SUP>increased accumulation of metastable intermediates such as oligomers<SUP> </SUP>and might theoretically aggravate the disease. One advantage of<SUP> </SUP>an
anti-oligomerization strategy is that one would be targeting<SUP> </SUP>a
purely pathological event in the disease, rather than interfering<SUP> </SUP>with
normal metabolic reactions such as those of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">- and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase.</P>
	    
	
	    
	    <P>A third general approach would be to administer anti-inflammatory
drugs that could interfere with aspects of the microglial,<SUP> </SUP>astrocytic,
and cytokine responses that occur in the AD brain.<SUP> </SUP>The epidemiological
evidence that consumption of nonsteroidal<SUP> </SUP>anti-inflammatory drugs
for other purposes may be associated with<SUP> </SUP>a somewhat lower likelihood
of developing AD could potentially<SUP> </SUP>be explained on this basis. However,
it would presumably be best<SUP> </SUP>to design novel compounds that interfere
with one or more specific<SUP> </SUP>steps in the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-induced inflammatory
cascade in the brain, rather<SUP> </SUP>than relying on conventional
anti-inflammatory drugs that have<SUP> </SUP>considerable potential toxicity,
particularly in older<SUP> </SUP>patients.</P>
	    
	
	    
	    <P>Finally, one could use a variety of antioxidants, free radical
scavengers, calcium channel blockers, and modulators of certain<SUP> </SUP>signal
transduction pathways that might protect neurons from the<SUP> </SUP>downstream
effects of the accumulation of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> intracellularly and/or<SUP> </SUP>extracellularly. The problem with this approach may turn out to<SUP> </SUP>be that
there are multiple ways in which neurons respond to A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUP> </SUP>and the
A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-associated inflammatory process, and blocking one or<SUP> </SUP>two of these
might not significantly decrease overall neuronal<SUP> </SUP>dysfunction and loss.
One could also envision the use of neurorestorative<SUP> </SUP>factors, e.g.,
neurotrophins and small compounds mimicking their<SUP> </SUP>actions, that might
rescue synapses and cell bodies undergoing<SUP> </SUP>active injury. However, this
approach would operate in the presence<SUP> </SUP>of ongoing new injury from the
putative cytotoxic effects of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">.</P>
	    
	
	    
	    <P>An intriguing approach to lower the levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> and reduce A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
deposits in the brain comes from a recent study in APP transgenic<SUP> </SUP>mice.
Parenteral immunization with synthetic human A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptide<SUP> </SUP>led to a
strong humoral response and the apparent movement of<SUP> </SUP>some of the A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
antibodies across the blood-brain barrier into<SUP> </SUP>the brain parenchyma
(<A HREF="#B136">136</A>). Although the mechanism remains unclear,<SUP> </SUP>the
anti-A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> antibody response led to enhanced clearing of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> deposits<SUP> </SUP>in mice that already had begun to develop plaques, possibly by<SUP> </SUP>the
recruitment of local microglia. Moreover, immunization of<SUP> </SUP>young mice
before the development of Alzheimer-type histopathology<SUP> </SUP>was
associated with a marked inhibition of subsequent plaque formation<SUP> </SUP>and
the associated gliosis and neuritic dystrophy. Presumably,<SUP> </SUP>the very
high levels of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> antibodies induced peripherally in<SUP> </SUP>these mice led
to a small fraction crossing the blood-brain barrier<SUP> </SUP>and acting
centrally. No untoward antigen-antibody reaction ensued,<SUP> </SUP>i.e., the
inflammatory cytopathology in the mouse was prevented<SUP> </SUP>rather than
worsened. The recent initiation of human trials using<SUP> </SUP>this A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">
vaccination approach will be followed with great<SUP> </SUP>interest.</P>
	    
	
	    
	    <P>Because the success of any one of these strategies cannot be predicted
and because two or more approaches might ultimately<SUP> </SUP>be combined, all
such approaches and others not reviewed here<SUP> </SUP>need to be pursued.
Current, largely symptomatic treatments aimed<SUP> </SUP>at enhancing the levels
of depleted neurotransmitters, particularly<SUP> </SUP>acetylcholine, may continue
to be useful, even if more specific<SUP> </SUP>treatments aimed at early steps in
the disease are<SUP> </SUP>forthcoming.</P>
	    
	
	
    

    
    <A NAME="SEC9">
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;IX.  CONCLUSION</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>











<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>



<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">Next</A><BR>


<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/darrow.gif">References</A>

</FONT></TH>
</TR></TABLE>

    
	
	<P>A new diagnostic and treatment paradigm is emerging from the very
substantial progress in elucidating the functions and dysfunctions<SUP> </SUP>of
gene products implicated in AD. In the future, it is likely<SUP> </SUP>that
individuals reaching their 50s or beyond will be offered<SUP> </SUP>a specific
risk-assessment profile to determine their likelihood<SUP> </SUP>of developing
AD. Such an assessment, modeled on that now widely<SUP> </SUP>used to judge the
risk of serious atherosclerotic disease, would<SUP> </SUP>include inquiry about a
positive family history of AD or a related<SUP> </SUP>dementia, identification of
specific predisposing genetic factors,<SUP> </SUP>structural and functional brain
imaging to detect evidence of<SUP> </SUP>presymptomatic lesions, and measurement
of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB>, tau, and other<SUP> </SUP>markers of the neuropathology in
cerebrospinal fluid and perhaps<SUP> </SUP>(in the case of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">) even in blood. On
the basis of further epidemiological<SUP> </SUP>experience with such assessment
measures in large populations<SUP> </SUP>of healthy elderly AD subjects, it should
be possible to estimate,<SUP> </SUP>first crudely and later more accurately, the
likelihood that an<SUP> </SUP>individual will develop AD. If this can be
accomplished, then<SUP> </SUP>those at particularly high risk could be offered
preventative<SUP> </SUP>treatments with one or more of the agents contemplated in
the<SUP> </SUP>previous section. Although the achievement of an integrated
diagnostic<SUP> </SUP>and therapeutic approach to this complex and devastating
disorder<SUP> </SUP>may seem remote, the current rate of scientific progress and
the<SUP> </SUP>likelihood of novel clinical trials in the near future indicate<SUP> </SUP>that some level of practical success may come sooner than one<SUP> </SUP>might<SUP> </SUP>think.</P>
	
    

</TXT>



<!-- Stray figures and tables -->


<!-- Appendices -->

<!-- Acknowledgments -->


<!-- Footnotes -->




<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>






<!-- Reprint -->

<A NAME="reprint"><!-- comment for mosaic --></A>
<P>Address for reprint requests and other correspondence: D.&nbsp;J.&nbsp;Selkoe, Center for Neurologic Diseases, Brigham and Women's Hospital,
77&nbsp;Avenue Louis Pasteur, HIM 730,&nbsp;Boston, MA 02115.
</P>



<!-- Received & Accepted -->

<!-- Notes -->


<!-- Abbreviations -->

<!-- Bibliography -->

<A NAME="References"><!-- comment for mosaic --></A>



<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="http://physrev.physiology.org/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>
<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Top</A><BR>












<A HREF="#SEC9"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="http://physrev.physiology.org/icons/toc/uarrow.gif">Previous</A><BR>




</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Abraham CR,
Selkoe DJ, and Potter H.


Immunochemical identification of the serine protease inhibitor, <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>1</SUB>-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
<I>Cell</I>
52: 487-501, 1988<!-- HIGHWIRE ID="81:2:741:1" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1988M352400002&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=3257719&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Alvarez V,
Alvarez R,
Lahoz CH,
Martinez C,
Pena J,
Guisasola M,
Salas-Puig J,
Moris G,
Uria D,
Menes BB,
Ribacoba R,
Vidal JA,
Sanchez JM, and Coto E.


Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease.
<I>Biochem Biophys Res Commun</I>
264: 48-50, 1999<!-- HIGHWIRE ID="81:2:741:2" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000083153500010&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10527839&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Annaert WG,
Levesque L,
Craessaerts K,
Dierinck I,
Snellings G,
Westaway D,
Zhang L,
St George-Hyslop P,
Cordell B,
Fraser P, and De Strooper B.


Presenilin 1&nbsp;controls <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons.
<I>J Cell Biol</I>
147: 277-294, 1999<!-- HIGHWIRE ID="81:2:741:3" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=147/2/277" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Artavanis-Tsakonas S,
Rand MD, and Lake RJ.


Notch signaling: cell fate control and signal integration in development.
<I>Science</I>
284: 770-776, 1999<!-- HIGHWIRE ID="81:2:741:4" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=284/5415/770" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Bales KR,
Verina T,
Dodel RC,
Du Y,
Altstiel L,
Bender M,
Hyslop P,
Johnstone EM,
Little SP,
Cummins DJ,
Piccardo P,
Ghetti B, and Paul SM.


Lack of apolipprotein E dramatically reduces amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide deposition.
<I>Nature Genet</I>
17: 263-264, 1997<!-- HIGHWIRE ID="81:2:741:5" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997YD66700011&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9354781&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Baumeister R,
Leimer U,
Zweckbronner I,
Jakubek C,
Grunberg J, and Haass C.


Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate <I>Caenorhabditis elegans</I> notch signalling independently of proteolytic processing.
<I>Genes Function</I>
1: 149-159, 1997<!-- HIGHWIRE ID="81:2:741:6" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9680315&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Behl C,
Davis JB,
Lesley R, and Schubert D.


Hydrogen peroxide mediates amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein toxicity.
<I>Cell</I>
77: 817-827, 1994<!-- HIGHWIRE ID="81:2:741:7" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994NT33100007&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8004671&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Berezovska O,
Jack AC,
McLean P,
Aster JC,
Hicks C,
Xia W,
Wolfe MS,
Kimberly WT,
Weinmaster G,
Selkoe DJ, and Hyman BT.


Aspartate mutations in presenilin and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservtion of Notch signaling.
<I>J Neurochem</I>
75: 583-593, 2000<!-- HIGHWIRE ID="81:2:741:8" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000088231600016&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10899933&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B8a">8a.</a>
    <TD VALIGN=TOP>Bertram L, Blacker D, Mullin K,
Keeney D, Jones J, Basu S.&nbsp;Yhu S, McInnis MG, Go RCP, Vekrellis K,
Selkoe DJ, Saunders AJ, and Tanzi RE. Evidence for
genetic linkage of Alzheimer's disease to chromosome 10q.
<I>Science</I>. In press.
    <!-- HIGHWIRE ID="81:2:741:9" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Biere AL,
Ostaszewski B,
Zhao H,
Gillespie S,
Younkin SG, and Selkoe DJ.


Co-expression of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein (<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">APP) and apolipoprotein E in cell culture: analysis of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">APP processing.
<I>Neurobiol Dis</I>
2: 177-187, 1995<!-- HIGHWIRE ID="81:2:741:10" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9174001&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Blacker D,
Wilcox MA,
Laird NM,
Rodes L,
Horvath SM,
Go RC,
Perry R,
Watson B Jr,
Bassett SS,
McInnis MG,
Albert MS,
Hyman BT, and Tanzi RE.


Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
<I>Nature Genet</I>
19: 357-360, 1998<!-- HIGHWIRE ID="81:2:741:11" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000075107600018&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9697696&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Borchelt DR,
Thinakaran G,
Eckman CB,
Lee MK,
Davenport F,
Ratovitsky T,
Prada C-M,
Kim G,
Seekins S,
Yager D,
Slunt HH,
Want R,
Seeger M,
Levey AI,
Gandy SE,
Copeland NG,
Jenkins NA,
Price DL,
Younkin SG, and Sisodia SS.


Familial Alzheimer's disease-linked presenilin 1&nbsp;variants elevate A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-42/1-40 ratio in vitro and in vivo.
<I>Neuron</I>
17: 1005-1013, 1996<!-- HIGHWIRE ID="81:2:741:12" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VV15100021&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8938131&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Brion J,
Passareiro E,
Nunez J, and Flament-Durand J.


Mise en evidence immunologique de la protein tau au niveau des lesions de degenerescence neurofibrillaire de la maladie D'Alzheimer.
<I>Arch Biol</I>
95: 229-235, 1985<!-- HIGHWIRE ID="81:2:741:13" --><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Busciglio J,
Gabuzda DH,
Matsudaira P, and Yankner BA.


Generation of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid in the secretory pathway in neuronal and nonneuronal cells.
<I>Proc Natl Acad Sci USA</I>
90: 2092-2096, 1993<!-- HIGHWIRE ID="81:2:741:14" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=90/5/2092" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Capell A,
Grunberg J,
Pesold B,
Diehlmann A,
Citron M,
Nixon R,
Beyreuther K,
Selkoe DJ, and Haass C.


The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-&nbsp;to 150-kDa molecular mass complex.
<I>J Biol Chem</I>
273: 3205-3211, 1998<!-- HIGHWIRE ID="81:2:741:15" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/6/3205" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Citron M,
Westaway D,
Xia W,
Carlson G,
Diehl T,
Levesque G,
Johnson-Wood K,
Lee M,
Seubert P,
Davis A,
Kholodenka D,
Motter R,
Sherrington R,
Perry B,
Yao H,
Strome R,
Lieberburg I,
ROmmens J,
Kim S,
Schenk D,
Fraser P,
St. George-Hyslop P, and Selkoe DJ.


Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein in both transfected cells and transgenic mice.
<I>Nature Med</I>
3: 67-72, 1997<!-- HIGHWIRE ID="81:2:741:16" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WA73300039&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8986743&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Cook DG,
Forman MS,
Sung JC,
Leight S,
Kolson DL,
Iwatsubo T,
Lee VMY, and Doms RW.


Alzheimer's A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">(1---42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.
<I>Nature Med</I>
3: 1021-1023, 1997<!-- HIGHWIRE ID="81:2:741:17" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997XT84200036&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9288730&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Corder EH,
Saunders AM,
Risch NJ,
Strittmatter WJ,
Schmechel DE,
Gaskell PC Jr,
Rimmler JB,
Locke PA,
Conneally PM,
Schmader KE,
Small GW,
Roses AD,
Haines JL, and Pericak-Vance MA.


Protective effect of apolipoprotein E type 2&nbsp;allele for late onset Alzheimer's disease.
<I>Nature Genet</I>
7: 180-184, 1994<!-- HIGHWIRE ID="81:2:741:18" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994NQ03700019&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7920638&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Corder EH,
Saunders AM,
Strittmatter WJ,
Schmechel DE,
Gaskell PC Jr,
Small GW,
Roses AD,
Haines JL, and Pericak-Vance MA.


Gene dose of apolipoprotein E type 4&nbsp;allele and the risk of Alzheimer's disease in late onset families.
<I>Science</I>
261: 921-923, 1993<!-- HIGHWIRE ID="81:2:741:19" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=261/5123/921" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Cotman CW.


Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease.
<I>Neurobiol Aging</I>
19: S29-S32, 1998<!-- HIGHWIRE ID="81:2:741:20" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000072966500007&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9562464&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Davis JA,
Naruse S,
Chen H,
Eckman C,
Younkin S,
Price DL,
Borchelt DR,
Sisodia SS, and Wong PC.


An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos.
<I>Neuron</I>
20: 603-609, 1998<!-- HIGHWIRE ID="81:2:741:21" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000072755600023&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9539132&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

De Strooper B,
Annaert W,
Cupers P,
Saftig P,
Craessaerts K,
Mumm JS,
Schroeter EH,
Schrijvers V,
Wolfe MS,
Ray WJ,
Goate A, and Kopan R.


A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
<I>Nature</I>
398: 518-522, 1999<!-- HIGHWIRE ID="81:2:741:22" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10206645&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

De Strooper B,
Saftig P,
Craessaerts K,
Vanderstichele H,
Gundula G,
Annaert W,
Von Figura K, and Van Leuven F.


Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.
<I>Nature</I>
391: 387-390, 1998<!-- HIGHWIRE ID="81:2:741:23" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9450754&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

De Strooper B,
Umans L,
Van Leuven F, and Van Den Berghe H.


Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein: cleavage of APP occurs in a late compartment of the default secretion pathway.
<I>J Cell Biol</I>
121: 295-304, 1993<!-- HIGHWIRE ID="81:2:741:24" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=121/2/295" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Dickson DW.


The pathogenesis of senile plaques.
<I>J Neuropathol Exp Neurol</I>
56: 321-339, 1997<!-- HIGHWIRE ID="81:2:741:25" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WR82700001&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9100663&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Dodel RC,
Du Y,
Bales KR,
Gao F,
Eastwood B,
Glazier B,
Zimmer R,
Cordell B,
Hake A,
Evans R,
Gallagher-Tho0mpson D,
Thompson LW,
Tinklenberg JR,
Pfefferbaum A,
Sullivan EV,
Yesavage J,
Alstiel L,
Gasser T,
Farlow MR,
Murphy GM Jr, and Paul SM.


Alpha2 macroglobulin and the risk of Alzheimer's disease.
<I>Neurology</I>
54: 438-442, 2000<!-- HIGHWIRE ID="81:2:741:26" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=54/2/438" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Duff K,
Eckman C,
Zehr C,
Yu X,
Prada C-M,
Perez-Tur J,
Hutton M,
Buee L,
Harigaya Y,
Yager D,
Morgan D,
Gordon MN,
Holcomb L,
Refolo L,
Zenk B,
Hardy J, and Younkin S.


Increased amyloid-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">42(43) in brains of mice expressing mutant presenilin 1.
<I>Nature</I>
383: 710-713, 1996<!-- HIGHWIRE ID="81:2:741:27" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8878479&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

El Khoury J,
Hickman SE,
Thomas CA,
Cao L,
Silverstein SC, and Loike JD.


Scavenger receptor-mediated adhesion of microglia to <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid fibrils.
<I>Nature</I>
382: 716-719, 1996<!-- HIGHWIRE ID="81:2:741:28" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8751442&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Esch FS,
Keim PS,
Beattie EC,
Blacher RW,
Culwell AR,
Oltersdorf T,
McClure D, and Ward PJ.


Cleavage of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide during constitutive processing of its precursor.
<I>Science</I>
248: 1122-1124, 1990<!-- HIGHWIRE ID="81:2:741:29" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=248/4959/1122" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B28a">28a.</a>
    <TD VALIGN=TOP>

Esler WP,
Kimberly WT,
Ostaszewski BL,
Diehl TS,
Moore CL,
Tsai J-Y,
Rahmati T,
Xia W,
Selkoe DJ, and Wolfe MS.


Transition-state analog inhibitors of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase bind directly to Presenilin-1.
<I>Nat Cell Biol</I>
2: 428-434, 2000<!-- HIGHWIRE ID="81:2:741:30" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000088133700019&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10878808&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Evans KC,
Berger EP,
Cho C-G,
Weisgraber KH, and Lansbury PT Jr.


Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
<I>Proc Natl Acad Sci USA</I>
92: 763-767, 1995<!-- HIGHWIRE ID="81:2:741:31" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=92/3/763" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B29a">29a.</a>
    <TD VALIGN=TOP>Felsenstein KM.
The next generation of AD therapeutics: the future is now
(Abstract). <I>World Alzheimer Congress 2000: 7th Annual
Conference on AD and Related Disorders</I>, p. 613.
    <!-- HIGHWIRE ID="81:2:741:32" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B29b">29b.</a>
    <TD VALIGN=TOP>

Games D,
Adams D,
Alessandrini R,
Barbour R,
Berthelette P,
Blackwell C,
Carr T,
Clemens J,
Donaldson T,
Gillespie F,
Guido T,
Hagopian S,
Johnson-Wood K,
Khan K,
Lee M,
Leibowitz P,
Lieberburg I,
Little S,
Masliah E,
McConlogue L,
Montoya-Zavala M,
Mucke L,
Paganini L,
Penniman E,
Power M,
Schenk D,
Seubert P,
Snyder B,
Soriano F,
Tan H,
Vitale J,
Wadsworth S,
Wolozin B, and Zhao J.


Alzheimer-type neuropathology in transgenic mice overexpressing V717F <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>Nature</I>
373: 523-527, 1995<!-- HIGHWIRE ID="81:2:741:33" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7845465&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Garcia JV,
Fenton BW, and Rosner MR.


Isolation and characterization of an insulin-degrading enzyme from <I>Drosophila melanogaster.</I>
<I>Biochemistry</I>
27: 4237-4244, 1988<!-- HIGHWIRE ID="81:2:741:34" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=3139025&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Gearing M,
Mori H, and Mirra SS.


A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide length and apolipoprotein E genotype in Alzheimer's disease.
<I>Ann Neurol</I>
39: 395-399, 1996<!-- HIGHWIRE ID="81:2:741:35" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996UC47300019&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8602762&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Gearing M,
Wilson RW,
Unger ER,
Shelton ER,
Chan HW,
Masters CL,
Beyreuther K, and Mirra SS.


Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study.
<I>J Neuropathol Exp Neurol</I>
52: 22-30, 1993<!-- HIGHWIRE ID="81:2:741:36" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7678853&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Georgakopoulos A,
Marambaud P,
Efthimiopoulos S,
Shioi J,
Cui W,
Li HC,
Schutte M,
Gordon R,
Holstein GR,
Martinelli G,
Mehta P,
Friedrich VL Jr, and Robakis NK.


Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts.
<I>Mol Cell</I>
4: 893-902, 1999<!-- HIGHWIRE ID="81:2:741:37" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000084485900002&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10635315&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Glenner GG, and Wong CW.


Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
<I>Biochem Biophys Res Commun</I>
122: 1131-1135, 1984<!-- HIGHWIRE ID="81:2:741:38" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1984TE95600038&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=6236805&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Glenner GG, and Wong CW.


Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
<I>Biochem Biophys Res Commun</I>
120: 885-890, 1984<!-- HIGHWIRE ID="81:2:741:39" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1984SS90300026&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=6375662&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Goate A,
Chartier-Harlin MC,
Mullan M,
Brown J,
Crawford F,
Fidani L,
Guiffra L,
Haynes A,
Irving N,
James L,
Mant R,
Newton P,
Rooke K,
Roques P,
Talbot C,
Pericak-Vance M,
Roses A,
Williamson R,
Rossor M,
Owen M, and Hardy J.


Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
<I>Nature</I>
349: 704-706, 1991<!-- HIGHWIRE ID="81:2:741:40" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=1671712&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Goedert M,
Trojanowski JQ, and Lee VM-Y.

The neurofibrillary pathology of Alzheimer's disease.
In:
<I>The Molecular and Genetic Basis of Neurological Disease</I> (2nd ed.), edited by 
Rosenberg RN,
Prusiner SB,
DiMauro S, and
Barchi RL.  Boston, MA: Butterworth-Heinemann, 1996, p. 613-627.
    <!-- HIGHWIRE ID="81:2:741:41" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B38">38.</a>
    <TD VALIGN=TOP>

Gorevic P,
Goni F,
Pons-Estel B,
Alvarez F,
Peress R, and Frangione B.


Isolation and partial characterization of neurofibrillary tangles and amyloid plaque cores in Alzheimer's disease: immunohistological studies.
<I>J Neuropathol Exp Neurol</I>
45: 647-664, 1986<!-- HIGHWIRE ID="81:2:741:42" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1986E508500004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=3772397&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B39">39.</a>
    <TD VALIGN=TOP>

Gouras GK,
Tasi J,
Naslund J,
Vincent B,
Edgar M,
Greenfield JP,
Haroutunian V,
Buxbaum JD,
Xu H,
Greengard P, and Relkin NR.


Intraneuronal A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>42</SUB> accumulation in human brain.
<I>Am J Pathol</I>
156: 15-20, 2000<!-- HIGHWIRE ID="81:2:741:43" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=amjpathol&amp;resid=156/1/15" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B40">40.</a>
    <TD VALIGN=TOP>

Greenberg SM,
Rebeck GW,
Vonsattel JPG,
Gomez-Isla T, and Hyman BT.


Apolipoprotein E <IMG SRC="http://physrev.physiology.org/math/12pt/normal/epsilon.gif" ALIGN=BOTTOM ALT="epsilon ">4 and cerebral hemorrhage associated with amyloid angiopathy.
<I>Ann Neurol</I>
38: 254-259, 1995<!-- HIGHWIRE ID="81:2:741:44" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995RN98500018&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7654074&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B41">41.</a>
    <TD VALIGN=TOP>

Greenwald I.


LIN-12/Notch signaling: lessons from worms and flies.
<I>Genes Dev</I>
12: 1751-1762, 1998<!-- HIGHWIRE ID="81:2:741:45" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=FULL&amp;journalCode=genesdev&amp;resid=12/12/1751" ><nobr>[<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B42">42.</a>
    <TD VALIGN=TOP>

Griffin WST,
Stanley LC,
Ling C,
White L,
MacLeod V,
Perrot LJ,
White CL III, and Araoz C.


Brain interleukin 1&nbsp;and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
<I>Proc Natl Acad Sci USA</I>
86: 7611-7615, 1989<!-- HIGHWIRE ID="81:2:741:46" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=86/19/7611" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B43">43.</a>
    <TD VALIGN=TOP>

Grundke-Iqbal I,
Iqbal K,
Tung YC,
Quinlan M,
Wisniewski HM, and Binder LI.


Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cytoskeletal pathology.
<I>Proc Natl Acad Sci USA</I>
83: 4913-4917, 1986<!-- HIGHWIRE ID="81:2:741:47" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=83/13/4913" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B44">44.</a>
    <TD VALIGN=TOP>

Haass C,
Hung AY,
Schlossmacher MG,
Teplow DB, and Selkoe DJ.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.
<I>J Biol Chem</I>
268: 3021-3024, 1993<!-- HIGHWIRE ID="81:2:741:48" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=268/5/3021" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B45">45.</a>
    <TD VALIGN=TOP>

Haass C,
Hung AY, and Selkoe DJ.


Processing of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein in microglia and astrocytes favors a localization in internal vesicles over constitutive secretion.
<I>J Neurosci</I>
11: 3783-3793, 1991<!-- HIGHWIRE ID="81:2:741:49" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=11/12/3783" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B46">46.</a>
    <TD VALIGN=TOP>

Haass C,
Hung AY,
Selkoe DJ, and Teplow DB.


Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein precursor.
<I>J Biol Chem</I>
269: 17741-17748, 1994<!-- HIGHWIRE ID="81:2:741:50" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=269/26/17741" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B47">47.</a>
    <TD VALIGN=TOP>

Haass C,
Koo EH,
Capell A,
Teplow DB, and Selkoe DJ.


Polarized sorting of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals.
<I>J Cell Biol</I>
128: 537-547, 1995<!-- HIGHWIRE ID="81:2:741:51" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=128/4/537" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B48">48.</a>
    <TD VALIGN=TOP>

Haass C,
Koo EH,
Teplow DB, and Selkoe DJ.


Polarized secretion of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein and amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide in MDCK cells.
<I>Proc Natl Acad Sci USA</I>
91: 1564-1568, 1994<!-- HIGHWIRE ID="81:2:741:52" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/4/1564" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B49">49.</a>
    <TD VALIGN=TOP>

Haass C,
Lemere CA,
Capell A,
Citron M,
Seubert P,
Schenk D,
Lannfelt L, and Selkoe DJ.


The Swedish mutation causes early-onset Alzheimer's disease by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-secretase cleavage within the secretory pathway.
<I>Nature Med</I>
1: 1291-1296, 1995<!-- HIGHWIRE ID="81:2:741:53" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995TH78600042&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7489411&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B50">50.</a>
    <TD VALIGN=TOP>

Haass C,
Schlossmacher M,
Hung AY,
Vigo-Pelfrey C,
Mellon A,
Ostaszewski B,
Lieberburg I,
Koo EH,
Schenk D,
Teplow D, and Selkoe DJ.


Amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide is produced by cultured cells during normal metabolism.
<I>Nature</I>
359: 322-325, 1992<!-- HIGHWIRE ID="81:2:741:54" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=1383826&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B51">51.</a>
    <TD VALIGN=TOP>

Hansen LA,
Masliah E,
Galasko D, and Terry RD.


Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa.
<I>J Neuropathol Exp Neurol</I>
52: 648-654, 1993<!-- HIGHWIRE ID="81:2:741:55" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1993MG71800012&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8229084&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B52">52.</a>
    <TD VALIGN=TOP>

Hardy J.


The Alzheimer family of diseases: many etiologies, one pathogenesis?
<I>Proc Natl Acad Sci USA</I>
94: 2095-2097, 1997<!-- HIGHWIRE ID="81:2:741:56" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=FULL&amp;journalCode=pnas&amp;resid=94/6/2095" ><nobr>[<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B53">53.</a>
    <TD VALIGN=TOP>

Harper JD,
Wong SS,
Lieber CM, and Lansbury PT Jr.


Observation of metastable A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> amyloid protofibrils by atomic force microscopy.
<I>Chem Biol</I>
4: 119-125, 1997<!-- HIGHWIRE ID="81:2:741:57" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WP12900005&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9190286&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B54">54.</a>
    <TD VALIGN=TOP>

Harris ME,
Hensley K,
Butterfield DA,
Leedle RA, and Carney JM.


Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1---40) in cultured hippocampal neurons.
<I>Exp Neurol</I>
131: 193-202, 1995<!-- HIGHWIRE ID="81:2:741:58" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995QP93900004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7895820&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B55">55.</a>
    <TD VALIGN=TOP>

Hartley D,
Walsh DM,
Ye CP,
Diehl T,
Vasquez S,
Vassilev PM,
Teplow DB, and Selkoe DJ.


Protofibrillar intermediates of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.
<I>J Neurosci</I>
19: 8876-8884, 1999<!-- HIGHWIRE ID="81:2:741:59" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=19/20/8876" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B56">56.</a>
    <TD VALIGN=TOP>

Hendriks L,
van Duijn CM,
Cras P,
Cruts M,
Van Hul W,
van Harskamp F,
Warren A,
McInnis MG,
Antonarakis SE,
Martin J-J,
Hofman A, and Van Broeckhoven C.


Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692&nbsp;of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein gene.
<I>Nature Genet</I>
1: 218-221, 1992<!-- HIGHWIRE ID="81:2:741:60" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1992JC98200017&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=1303239&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B57">57.</a>
    <TD VALIGN=TOP>

Holcomb L,
Gordon MN,
McGowan E,
Yu X,
Benkovic S,
Jantzen P,
Wright K,
Saad I,
Mueller R,
Morgan D,
Sanders S,
Zehr C,
O'Campo,
Hardy J,
Prada CM,
Eckman C,
Younkin S,
Hsiao K, and Duff K.


Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1&nbsp;transgenes.
<I>Nature Med</I>
4: 97-100, 1998<!-- HIGHWIRE ID="81:2:741:61" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000072249700042&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9427614&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B58">58.</a>
    <TD VALIGN=TOP>

Holtzman DM,
Bales KR,
Wu S,
Bhat P,
Parsadanian M,
Fagan AM,
Chang LK,
Sun Y, and Paul SM.


Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.
<I>J Clin Invest</I>
103: R15-R21, 1999<!-- HIGHWIRE ID="81:2:741:62" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10079115&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B59">59.</a>
    <TD VALIGN=TOP>

Hong CS,
Caromile L,
Nomata Y,
Mori H,
Bredesen DE, and Koo EH.


Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro.
<I>J Neurosci</I>
19: 637-643, 1999<!-- HIGHWIRE ID="81:2:741:63" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=19/2/637" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B60">60.</a>
    <TD VALIGN=TOP>

Hsia AY,
Masliah E,
McConlogue L,
Yu GQ,
Tatsuno G,
Hu K,
Kholodenko D,
Malenka RC,
Nicoll RA, and Mucke L.


Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
<I>Proc Natl Acad Sci USA</I>
96: 3228-3233, 1999<!-- HIGHWIRE ID="81:2:741:64" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=96/6/3228" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B61">61.</a>
    <TD VALIGN=TOP>

Hsiao K,
Chapman P,
Nilsen S,
Ekman C,
Harigaya Y,
Younkin S,
Yang F, and Cole G.


Correlative memory deficits, A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> elevation, and amyloid plaques in transgenic mice.
<I>Science</I>
274: 99-102, 1996<!-- HIGHWIRE ID="81:2:741:65" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=274/5284/99" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B62">62.</a>
    <TD VALIGN=TOP>

Hung AY, and Selkoe DJ.


Selective ectodomain phosphorylation and regulated cleavage of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>EMBO J</I>
13: 534-542, 1994<!-- HIGHWIRE ID="81:2:741:66" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994MV86400005&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8313898&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B63">63.</a>
    <TD VALIGN=TOP>

Hussain I,
Powell D,
Howlett DR,
Tew DG,
Meek TD,
Chapman C,
Gloger IS,
Murphy KE,
Southan CD,
Ryan DM,
Smith TS,
Simmons DL,
Walsh FS,
DIngwall C, and Christie G.


Identification of a novel aspartic protease (Asp 2) as beta-secretase.
<I>Mol Cell Neurosci</I>
14: 419-427, 1999<!-- HIGHWIRE ID="81:2:741:67" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000084490600001&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10656250&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B64">64.</a>
    <TD VALIGN=TOP>

Hutton M,
Lendon C,
Rizzu P,
Baker M,
Froelich S,
Houlden H,
Pickering-Brown S,
Chakraverty S,
Isaacs A,
Grover A,
Hackett J,
Adamson J,
Lincoln S,
Dickson D,
Davies P,
Peterson R,
Stevens M,
de Graaff E,
Wauters E,
van Baren J,
Hillebrand M,
Joosse M,
Kwon J,
Nowotny P,
Che L,
Norton J,
Morris J,
Ree L,
Trojanowski J,
Basun H,
Lannfelt L,
Neystat M,
Fahn S,
Dark F,
Tannenberg T,
Dodd P,
Hayward N,
Kowk J,
Schofield P,
Andreadis A,
Snowden J,
Craufurd D,
Neary D,
Owen F,
Oostra B,
Hardy J,
Goate A,
van Swieten,
Mann D,
Lynch T, and Hutink P.


Association of missense and 5'-splice-site mutations in tau with the inherited FTDP-17.
<I>Nature</I>
393: 702-705, 1998<!-- HIGHWIRE ID="81:2:741:68" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9641683&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B65">65.</a>
    <TD VALIGN=TOP>

Illenberger S,
Zheng-Fischhofer Q,
Preuss U,
Stamer K,
Baumann K,
Trinczek B,
Biernat J,
Godemann R,
Mandelkow EM, and Mandelkow E.


The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.
<I>Mol Biol Cell</I>
9: 1495-1512, 1998<!-- HIGHWIRE ID="81:2:741:69" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=molbiolcell&amp;resid=9/6/1495" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B66">66.</a>
    <TD VALIGN=TOP>

Itagaki S,
Akiyama H,
Saito H, and McGeer PL.


Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.
<I>Brain Res</I>
645: 78-84, 1994<!-- HIGHWIRE ID="81:2:741:70" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994NK54000010&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8062101&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B67">67.</a>
    <TD VALIGN=TOP>

Itagaki S,
McGeer PL,
Akiyama H,
Zhu S, and Selkoe DJ.


Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.
<I>J Neuroimmunol</I>
24: 173-182, 1989<!-- HIGHWIRE ID="81:2:741:71" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1989CA77200001&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2808689&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B68">68.</a>
    <TD VALIGN=TOP>

Iwatsubo T,
Mann DM,
Odaka A,
Suzuki N, and Ihara Y.


Amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein (A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">) deposition: A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">42(43) precedes A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">40 in Down syndrome.
<I>Ann Neurol</I>
37: 294-299, 1995<!-- HIGHWIRE ID="81:2:741:72" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995QM19500004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7695229&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B69">69.</a>
    <TD VALIGN=TOP>

Iwatsubo T,
Odaka A,
Suzuki N,
Mizusawa H,
Nukina H, and Ihara Y.


Visualization of A beta 42(43) and A beta 40&nbsp;in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).
<I>Neuron</I>
13: 45-53, 1994<!-- HIGHWIRE ID="81:2:741:73" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994NZ24700004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8043280&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B70">70.</a>
    <TD VALIGN=TOP>

Jarrett JT,
Berger EP, and Lansbury PT Jr.


The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
<I>Biochemistry</I>
32: 4693-4697, 1993<!-- HIGHWIRE ID="81:2:741:74" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8490014&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B71">71.</a>
    <TD VALIGN=TOP>

Joachim CL,
Morris JH, and Selkoe DJ.


Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
<I>Am J Pathol</I>
135: 309-319, 1989<!-- HIGHWIRE ID="81:2:741:75" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=amjpathol&amp;resid=135/2/309" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B72">72.</a>
    <TD VALIGN=TOP>

Kang J,
Lemaire HG,
Unterbeck A,
Salbaum JM,
Msters CL,
Grzeschik K-H,
Multhaup G,
Beyreuther K, and Muller-Hill B.


The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
<I>Nature</I>
325: 733-736, 1987<!-- HIGHWIRE ID="81:2:741:76" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2881207&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B73">73.</a>
    <TD VALIGN=TOP>

Kim TW,
Pettingell WH,
Hallmark OG,
Moir RD,
Wasco W, and Tanzi RE.


Endoproteolytic cleavage and proteasomal degradation of presenilin 2&nbsp;in transfected cells.
<I>J Biol Chem</I>
272: 11006-11010, 1997<!-- HIGHWIRE ID="81:2:741:77" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/17/11006" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B74">74.</a>
    <TD VALIGN=TOP>

Kimberly WT,
Xia W,
Rahmati R,
Wolfe MS, and Selkoe DJ.


The transmembrane aspartates in presenilin 1&nbsp;and 2&nbsp;are obligatory for <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase activity and amyloid &szlig;-protein generation.
<I>J Biol Chem</I>
275: 3173-3178, 2000<!-- HIGHWIRE ID="81:2:741:78" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=275/5/3173" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B75">75.</a>
    <TD VALIGN=TOP>

Kondo J,
Honda T,
Mori H,
Hamada Y,
Miura R,
Ogawara M, and Ihara Y.


The carboxyl third of tau is tightly bound to paired helical filaments.
<I>Neuron</I>
1: 827-834, 1988<!-- HIGHWIRE ID="81:2:741:79" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1988R144000007&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2483105&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B76">76.</a>
    <TD VALIGN=TOP>

Koo EH,
Sisodia SS,
Archer DA,
Martin LJ,
Weidemann A,
Beyreuther K,
Masters CL,
Fischer P, and Price DL.


Precursor of amyloid protein in Alzheimer's disease undergoes fast anterograde axonal transport.
<I>Proc Natl Acad Sci USA</I>
87: 1561-1565, 1990<!-- HIGHWIRE ID="81:2:741:80" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=87/4/1561" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B77">77.</a>
    <TD VALIGN=TOP>

Koo EH, and Squazzo S.


Evidence that production and release of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein involves the endocytic pathway.
<I>J Biol Chem</I>
269: 17386-17389, 1994<!-- HIGHWIRE ID="81:2:741:81" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=269/26/17386" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B78">78.</a>
    <TD VALIGN=TOP>

Kopan R,
Schroeter EH,
Weintraub H, and Nye JS.


Signal transduction by activated Notch: importance of proteolytic processing and its regulation by the extracellular domain.
<I>Proc Natl Acad Sci USA</I>
93: 1683-1688, 1996<!-- HIGHWIRE ID="81:2:741:82" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=93/4/1683" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B79">79.</a>
    <TD VALIGN=TOP>

Kosik KS,
Joachim CL, and Selkoe DJ.


Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer's disease.
<I>Proc Natl Acad Sci USA</I>
83: 4044-4048, 1986<!-- HIGHWIRE ID="81:2:741:83" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=83/11/4044" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B80">80.</a>
    <TD VALIGN=TOP>

Kosik KS,
Orecchio LD,
Binder L,
Trojanowski JQ,
Lee VM-Y, and Lee G.


Epitopes that span the tau molecule are shared with paired helical filaments.
<I>Neuron</I>
1: 817-825, 1988<!-- HIGHWIRE ID="81:2:741:84" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1988R144000006&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2483104&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B81">81.</a>
    <TD VALIGN=TOP>

Kovacs DM,
Fausett HJ,
Page KJ,
Kim T-W,
Mori RD,
Merriam DE,
Hollister RD,
Hallmark OG,
Mancini R,
Felsenstein KM,
Hyman BT,
Tanzi RE, and Wasco W.


Alzheimer-associated presenilins 1&nbsp;and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.
<I>Nature Med</I>
2: 224-229, 1996<!-- HIGHWIRE ID="81:2:741:85" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996TU06000044&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8574969&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B82">82.</a>
    <TD VALIGN=TOP>

Lah JJ,
Heilman CJ,
Nash NR,
Rees HD,
Yi H,
Counts SE, and Levey AI.


Light and electron microscopic localization of presenilin-1 in primate brain.
<I>J Neurosci</I>
17: 1971-1980, 1997<!-- HIGHWIRE ID="81:2:741:86" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=17/6/1971" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B83">83.</a>
    <TD VALIGN=TOP>

Lambert MP,
Barlow AK,
Chromy BA,
Edwards C,
Freed R,
Iosatos M,
Morgan TE,
Rozovsky I,
Trommer B,
Viola KL,
Wals P,
Zhang C,
Finch CE,
Krafft GA, and Klein WL.


Diffusible, nonfribrillar ligands derived from A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "><SUB>1-42</SUB> are potent central nervous system neurotoxins.
<I>Proc Natl Acad Sci USA</I>
95: 6448-6453, 1998<!-- HIGHWIRE ID="81:2:741:87" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=95/11/6448" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B83a">83a.</a>
    <TD VALIGN=TOP>

Lee M-S,
Kwon YT,
Li M,
Peng J,
Friedlander RM, and Tsai L-H.


Neurotoxicity induces cleavage of p35 to p25 by calpain.
<I></I>Nature<I></I>
405: 360-364, 2000<!-- HIGHWIRE ID="81:2:741:88" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10830966&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B84">84.</a>
    <TD VALIGN=TOP>

Lee VMY,
Balin BJ,
Otvos L, and Trojanowski JQ.


A68: a major subunit of paired helical filaments and derivatized forms of normal tau.
<I>Science</I>
251: 675-678, 1991<!-- HIGHWIRE ID="81:2:741:89" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=251/4994/675" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B85">85.</a>
    <TD VALIGN=TOP>

Lemere CA,
Blustzjan JK,
Yamaguchi H,
Wisniewski T,
Saido TC, and Selkoe DJ.


Sequence of deposition of heterogeneous amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptides and Apo E in Down syndrome: implications for initial events in amyloid plaque formation.
<I>Neurobiol Dis</I>
3: 16-32, 1996<!-- HIGHWIRE ID="81:2:741:90" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VU96000003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9173910&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B86">86.</a>
    <TD VALIGN=TOP>

Lemere CA,
Lopera F,
Kosik KS,
Lendon CL,
Ossa J,
Saido TC,
Yamaguchi H,
Ruiz A,
Martinez A,
Madrigal L,
Hincapie L,
Arango L JC,
Anthony DC,
Koo EH,
Goate AM,
Selkoe DJ, and Arango V JC.


The E280A presenilin 1&nbsp;Alzheimer mutation produces increased A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">42 deposition and severe cerebellar pathology.
<I>Nature Med</I>
2: 1146-1150, 1996<!-- HIGHWIRE ID="81:2:741:91" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VK99500039&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8837617&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B87">87.</a>
    <TD VALIGN=TOP>

Levitan D,
Doyle TG,
Brousseau D,
Lee MK,
Thinakaran G,
Slunt HH,
Sisodia SS, and Greenwald I.


Assessment of normal and mutant human presenilin function in <I>Caenorhabditis elegans.</I>
<I>Proc Natl Acad Sci USA</I>
93: 14940-14944, 1996<!-- HIGHWIRE ID="81:2:741:92" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=93/25/14940" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B88">88.</a>
    <TD VALIGN=TOP>

Levitan D, and Greenwald I.


Facilitation of <I>lin-12</I>-mediated signalling by <I>sel-12</I>, a <I>Caenorhabditis elegans S182</I> Alzheimer's disease gene.
<I>Nature</I>
377: 351-354, 1995<!-- HIGHWIRE ID="81:2:741:93" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7566091&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B89">89.</a>
    <TD VALIGN=TOP>

Levy E,
Carman MD,
Fernandez-Madrid IJ,
Power MD,
Lieberburg I,
van Duinen SG,
Bots GTAM,
Luyendijk W, and Frangione B.


Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch-type.
<I>Science</I>
248: 1124-1126, 1990<!-- HIGHWIRE ID="81:2:741:94" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=248/4959/1124" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B90">90.</a>
    <TD VALIGN=TOP>

Levy-Lahad E,
Wasco W,
Poorkaj P,
Romano DM,
Oshima J,
Pettingell H,
Yu C,
Jondro PD,
Schmidt SD,
Wang K,
Crowley AC,
Fu Y-H,
Guentette SY,
Galas D,
Nemens E,
Wijsman EM,
Bird TD,
Schellenberg GD, and Tanzi RE.


Candidate gene for the chromosome 1&nbsp;familial Alzheimer's disease locus.
<I>Science</I>
269: 973-977, 1995<!-- HIGHWIRE ID="81:2:741:95" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=269/5226/973" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B91">91.</a>
    <TD VALIGN=TOP>

Li X, and Greenwald I.


Additional evidence for an eight-transmembrane-domain topology for <I>Caenorhabditis elegans</I> and human presenilins.
<I>Proc Natl Acad Sci USA</I>
95: 7109-7114, 1998<!-- HIGHWIRE ID="81:2:741:96" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=95/12/7109" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B91a">91a.</a>
    <TD VALIGN=TOP>

Li Y-M,
Xu M, and Lai M-T.


Photoactivated <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase inhibitors directed to the active site covalently label presenilin 1.
<I>Nature</I>
405: 689-694, 2000<!-- HIGHWIRE ID="81:2:741:97" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10864326&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B92">92.</a>
    <TD VALIGN=TOP>

Lorenzo A, and Yankner B.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red.
<I>Proc Natl Acad Sci USA</I>
91: 12243-12247, 1994<!-- HIGHWIRE ID="81:2:741:98" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/25/12243" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B93">93.</a>
    <TD VALIGN=TOP>

Ma J,
Yee A,
Brewer HB Jr,
Das S, and Potter H.


The amyloid-associated proteins <IMG SRC="http://physrev.physiology.org/math/12pt/normal/alpha.gif" ALIGN=BOTTOM ALT="alpha "><SUB>1</SUB>-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein into filaments.
<I>Nature</I>
372: 92-94, 1994<!-- HIGHWIRE ID="81:2:741:99" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7969426&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B94">94.</a>
    <TD VALIGN=TOP>

Mann DM,
Iwatsubo T,
Fukumoto H,
Ihara Y,
Odaka A, and Suzuki N.


Microglial cells and amyloid beta protein (A beta) deposition: association with A beta 40-containing plaques.
<I>Acta Neuropathol</I>
90: 472-477, 1995<!-- HIGHWIRE ID="81:2:741:100" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8560980&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B95">95.</a>
    <TD VALIGN=TOP>

Mann DMA,
Iwatsubo T,
Cairns NJ,
Lantos PL,
Nochlin D,
Sumi SM,
Bird TD,
Poorkaj P,
Hardy J,
Hutton M,
Prihar G,
Crook R,
Rossor MN, and Haltia M.


Amyloid beta protein (A-beta) deposition in chromosome 14-linked Alzheimer's disease: predominance of A-beta [42(43)].
<I>Ann Neurol</I>
40: 149-156, 1996<!-- HIGHWIRE ID="81:2:741:101" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VC68900004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8773595&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B96">96.</a>
    <TD VALIGN=TOP>

Masters CL,
Simms G,
Weinman NA,
Multhaup G,
McDonald BL, and Beyreuther K.


Amyloid plaque core protein in Alzheimer disease and Down syndrome.
<I>Proc Natl Acad Sci USA</I>
82: 4245-4249, 1985<!-- HIGHWIRE ID="81:2:741:102" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=82/12/4245" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B97">97.</a>
    <TD VALIGN=TOP>

Matsuo ES,
Shin RW,
Billingsley ML,
Van DeVoorde A,
O'Connor M,
Trojanowski JQ, and Lee VM.


Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.
<I>Neuron</I>
13: 989-1002, 1994<!-- HIGHWIRE ID="81:2:741:103" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1994PP53300021&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7946342&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B98">98.</a>
    <TD VALIGN=TOP>

Mattson M,
Cheng B,
Culwell A,
Esch F,
Lieberburg I, and Rydel R.


Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>Neuron</I>
10: 243-254, 1993<!-- HIGHWIRE ID="81:2:741:104" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1993KP68500012&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8094963&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B99">99.</a>
    <TD VALIGN=TOP>

Mattson MP,
Cheng B,
Davis D,
Bryant K,
Lieberburg I, and Rydel RE.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.
<I>J Neurosci</I>
12: 379-389, 1992<!-- HIGHWIRE ID="81:2:741:105" --><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B100">100.</a>
    <TD VALIGN=TOP>

McGeer PL, and McGeer EG.


The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.
<I>Brain Res Rev</I>
21: 195-218, 1995<!-- HIGHWIRE ID="81:2:741:106" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8866675&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B101">101.</a>
    <TD VALIGN=TOP>

Motter R,
Vigo-Pelfrey C,
Kholodenko D,
Barbour R,
Johnson-Wood K,
Galasko D,
Chang L,
Miller B,
Clark C,
Green R,
Olson D,
Southwick P,
Wolfert R,
Munroe B,
Lieberburg I,
Seubert P, and Schenk D.


Reduction of beta-amyloid peptide 42&nbsp;in the cerebrospinal fluid of patients with Alzheimer's disease.
<I>Ann Neurol</I>
38: 643-648, 1995<!-- HIGHWIRE ID="81:2:741:107" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995RY63300012&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7574461&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B102">102.</a>
    <TD VALIGN=TOP>

Myllykangas L,
Polvikoski T,
Sulkava R,
Verkkoniemi A,
Crook R,
Tienari PJ,
Pusa AK,
Niinisto L,
O'Brien P,
Kontula K,
Hardy J,
Haltia M, and Perez-Tur J.


Genetic association of alpha<SUB>2</SUB>-macroglobulin with Alzheimer's disease in a Finnish elderly population.
<I>Ann Neurol</I>
46: 382-390, 1999<!-- HIGHWIRE ID="81:2:741:108" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000082360000014&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10482269&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B103">103.</a>
    <TD VALIGN=TOP>

Namba Y,
Tomonaga M,
Kawasaki H,
Otomo E, and Ikeda K.


Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease.
<I>Brain Res</I>
541: 163-166, 1991<!-- HIGHWIRE ID="81:2:741:109" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1991EX84500027&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2029618&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B104">104.</a>
    <TD VALIGN=TOP>

Naruse S,
Thinakaran G,
Luo JJ,
Kusiak W,
Tomita T,
Iwatsubo T,
Qian X,
Ginty DD,
Price DL,
Borchelt DR,
Wong PC, and Sisodia SS.


Effects of PS1 deficiency on membrane protein trafficking in neurons.
<I>Neuron</I>
21: 1213-1221, 1998<!-- HIGHWIRE ID="81:2:741:110" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000077386100030&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9856475&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B105">105.</a>
    <TD VALIGN=TOP>

Nathan BP,
Bellosta S,
Sanan DA,
Weisgraber KH,
Mahley RW, and Pitas RE.


Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro.
<I>Science</I>
264: 850-852, 1994<!-- HIGHWIRE ID="81:2:741:111" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=264/5160/850" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B106">106.</a>
    <TD VALIGN=TOP>

Niwa M,
Sidrauski C,
Kaufman RJ, and Walter P.


A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response.
<I>Cell</I>
99: 691-702, 1999<!-- HIGHWIRE ID="81:2:741:112" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000084488200003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10619423&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B107">107.</a>
    <TD VALIGN=TOP>

Nukina N, and Ihara Y.


One of the antigenic determinants of paired helical filaments is related to tau protein.
<I>J Biochem</I>
99: 1541-1544, 1986<!-- HIGHWIRE ID="81:2:741:113" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbiochem&amp;resid=99/5/1541" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B108">108.</a>
    <TD VALIGN=TOP>

Oltersdorf T,
Ward PJ,
Henriksson T,
Beattie EC,
Neve R,
Lieberburg I, and Fritz LC.


The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway.
<I>J Biol Chem</I>
265: 4492-4497, 1990<!-- HIGHWIRE ID="81:2:741:114" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=265/8/4492" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B109">109.</a>
    <TD VALIGN=TOP>Ozenberger BA, Lo CF, Kalkowski EM, Walker S,
Smith SC, Wood A, Bard J, and Jacobsen JS. The
<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid binding protein BBP1 mediates cellular vulnerability to
a<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> by a G protein and caspase-dependent mechanism <I>Soc
Neurosci Abstr </I>1561,&nbsp;1999.
    <!-- HIGHWIRE ID="81:2:741:115" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B110">110.</a>
    <TD VALIGN=TOP>

Paris D,
Town T,
Parker TA,
Tan J,
Humphrey J,
Crawford F, and Mullan M.


Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism.
<I>Exp Neurol</I>
157: 211-221, 1999<!-- HIGHWIRE ID="81:2:741:116" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000080226100020&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10222124&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B111">111.</a>
    <TD VALIGN=TOP>

Patrick GN,
Zukerberg L,
Nikolic M,
De La Monte S,
Dikkes P, and Tsai LH.


Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
<I>Nature</I>
402: 615-622, 1999<!-- HIGHWIRE ID="81:2:741:117" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10604467&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B112">112.</a>
    <TD VALIGN=TOP>

Perez RG,
Soriano S,
Hayes JD,
Ostaszewski BL,
Xia W,
Selkoe DJ,
Chen X,
Stokin GB, and Koo EH.


Mutagenesis identifies new signals for <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein endotycosis, turnover and the generation of secreted fragments, including A42.
<I>J Biol Chem</I>
274: 18851-18856, 1999<!-- HIGHWIRE ID="81:2:741:118" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=274/27/18851" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B113">113.</a>
    <TD VALIGN=TOP>

Perez RG,
Zheng H,
Van der Ploeg LH, and Koo EH.


The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity.
<I>J Neurosci</I>
17: 9407-9414, 1997<!-- HIGHWIRE ID="81:2:741:119" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=17/24/9407" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B114">114.</a>
    <TD VALIGN=TOP>

Pike CJ,
Burdick D,
Walencewicz AJ,
Glabe CG, and Cotman CW.


Neurodegeneration induced by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid peptides in vitro: the role of peptide assembly state.
<I>J Neurosci</I>
13: 1676-1687, 1993<!-- HIGHWIRE ID="81:2:741:120" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=13/4/1676" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B115">115.</a>
    <TD VALIGN=TOP>

Podlisny MB,
Citron M,
Amarante P,
Sherrington R,
Xia W,
Zhang J,
Diehl T,
Levesque G,
Fraser P,
Haass C,
Koo EHM,
Seubert P,
St George-Hyslop P,
Teplow DB, and Selkoe DJ.


Presenilin proteins undergo heterogeneous endoproteolysis between Thr<SUB>291</SUB> and Ala<SUB>299</SUB> and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.
<I>Neurobiol Dis</I>
3: 325-337, 1997<!-- HIGHWIRE ID="81:2:741:121" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WV41300007&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9173929&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B116">116.</a>
    <TD VALIGN=TOP>

Poduslo JF,
Curran GL,
Haggard JJ,
Biere AL, and Selkoe DJ.


Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.
<I>Neurobiol Dis</I>
4: 27-34, 1997<!-- HIGHWIRE ID="81:2:741:122" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9258909&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B117">117.</a>
    <TD VALIGN=TOP>

Poduslo JF,
Curran GL,
Sanyal B, and Selkoe DJ.


Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.
<I>Neurobiol Dis</I>
6: 190-199, 1999<!-- HIGHWIRE ID="81:2:741:123" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000081573700004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10408808&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B118">118.</a>
    <TD VALIGN=TOP>

Polvikoski T,
Sulkava R,
Haltia M,
Kainulainen K,
Vuorio A,
Verkkoniemi A,
Niinisto L,
Halonen P, and Kontula K.


Apolipoprotein E, dementia, and cortical deposition of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid protein.
<I>N Engl J Med</I>
333: 1242-1247, 1995<!-- HIGHWIRE ID="81:2:741:124" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=nejm&amp;resid=333/19/1242" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B119">119.</a>
    <TD VALIGN=TOP>

Prasher VP,
Farrer MJ,
Kessling AM,
Fisher EM,
West RJ,
Barber PC, and Butler AC.


Molecular mapping of Alzheimer-type dementia in Down's syndrome.
<I>Ann Neurol</I>
43: 380-383, 1998<!-- HIGHWIRE ID="81:2:741:125" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000072371500014&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9506555&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B120">120.</a>
    <TD VALIGN=TOP>

Probst A,
Anderton BH,
Brion JP, and Ulrich J.


Senile plaque neurites fail to demonstrate anti-paired helical filament and anti-microtubule-associated protein-tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex.
<I>Acta Neuropathol</I>
77: 430-436, 1989<!-- HIGHWIRE ID="81:2:741:126" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2711830&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B121">121.</a>
    <TD VALIGN=TOP>

Qian S,
Jiang P,
Guan XM,
Singh G,
Trumbauer ME,
Yu H,
Chen HY,
Van de Ploeg LH, and Zheng H.


Mutant human presenilin 1&nbsp;protects presenilin 1&nbsp;null mouse against embryonic lethality and elevates A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-42/43 expression.
<I>Neuron</I>
20: 611-617, 1998<!-- HIGHWIRE ID="81:2:741:127" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000072755600024&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9539133&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B122">122.</a>
    <TD VALIGN=TOP>

Qiu WQ,
Ferreira A,
Miller C,
Koo EH, and Selkoe DJ.


Cell-surface <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner.
<I>J Neurosci</I>
15: 2157-2167, 1995<!-- HIGHWIRE ID="81:2:741:128" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jneuro&amp;resid=15/3/2157" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B123">123.</a>
    <TD VALIGN=TOP>

Ratovitski T,
Slunt HH,
Thinakaran G,
Price DL,
Sisodia SS, and Borchelt DR.


Endoproteolytic processing and stabilization of wild-type and mutant presenilin.
<I>J Biol Chem</I>
272: 24536-24541, 1997<!-- HIGHWIRE ID="81:2:741:129" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/39/24536" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B124">124.</a>
    <TD VALIGN=TOP>

Ray WJ,
Yao M,
Mumm J,
Schroeter EH,
Saftig P,
Wolfe M,
Selkoe DJ,
Kopan R, and Goate AM.


Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of notch.
<I>J Biol Chem</I>
274: 36801-36807, 1999<!-- HIGHWIRE ID="81:2:741:130" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=274/51/36801" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B125">125.</a>
    <TD VALIGN=TOP>

Ray WJ,
Yao M,
Nowotny P,
Mumm J,
Zhang W,
Wu JY,
Kopan R, and Goate AM.


Evidence for a physical interaction between presenilin and Notch.
<I>Proc Natl Acad Sci USA</I>
96: 3263-3268, 1999<!-- HIGHWIRE ID="81:2:741:131" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=96/6/3263" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B126">126.</a>
    <TD VALIGN=TOP>

Rebeck GW,
Reiter JS,
Strickland DK, and Hyman BT.


Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.
<I>Neuron</I>
11: 575-580, 1993<!-- HIGHWIRE ID="81:2:741:132" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1993MD06800003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8398148&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B127">127.</a>
    <TD VALIGN=TOP>

Rogers J,
Cooper NR,
Webster S,
Schultz J,
McGeer PL,
Styren SD,
Civin Wh,
Brachova L,
Bradt B,
Ward P, and Lieberburg I.


Complement activation by <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid in Alzheimer disease.
<I>Proc Natl Acad Sci USA</I>
89: 10016-10020, 1992<!-- HIGHWIRE ID="81:2:741:133" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=89/21/10016" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B128">128.</a>
    <TD VALIGN=TOP>

Rogers J,
Webster S,
Lue L-F,
Brachova L,
Civin WH,
Emmerling M,
Shivers B,
Walker D, and McGeer P.


Inflammation and Alzheimer's disease pathogenesis.
<I>Neurobiol Aging</I>
17: 681-686, 1996<!-- HIGHWIRE ID="81:2:741:134" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VK44700003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8892340&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B128a">128a.</a>
    <TD VALIGN=TOP>

Roher AE,
Gowing E,
Woods AS,
Cotter RJ,
Chaney M,
Little SP, and Ball MJ.


Chemical characterization of A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> 17-42 peptide: a component of diffuse amyloid deposits of Alzheimer disease.
<I>J Biol Chem</I>
269: 10987-10990, 1994<!-- HIGHWIRE ID="81:2:741:135" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=269/15/10987" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B129">129.</a>
    <TD VALIGN=TOP>

Romas SN,
Mayeux R,
Rabinowitz D,
Tang MX,
Zadroga HR,
Lantigua R,
Medrano M,
Tycko B, and Knowles JA.


The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics.
<I>Neurosci Lett</I>
279: 133-136, 2000<!-- HIGHWIRE ID="81:2:741:136" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000085230400002&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10688047&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B130">130.</a>
    <TD VALIGN=TOP>

Rosen DR,
Martin-Morris L,
Luo L, and White K.


A <I>Drosophila</I> gene encoding a protein resembling the human <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>Proc Natl Acad Sci USA</I>
86: 2478-2482, 1989<!-- HIGHWIRE ID="81:2:741:137" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=86/7/2478" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B131">131.</a>
    <TD VALIGN=TOP>

Saftig P,
Peters C,
von Figura K,
Craessaerts K,
Van Leuven F, and De Strooper B.


Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of Cathepsin D.
<I>J Biol Chem</I>
271: 27241-27244, 1996<!-- HIGHWIRE ID="81:2:741:138" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=271/44/27241" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B132">132.</a>
    <TD VALIGN=TOP>

Saitoh T,
Sundsmo M,
Roch JM,
Kimura N,
Cole G,
Schubert D,
Oltersdorf T, and Schenk DB.


Secreted form of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein precursor is involved in the growth regulation of fibroblasts.
<I>Cell</I>
58: 615-622, 1989<!-- HIGHWIRE ID="81:2:741:139" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1989AM54700004&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2475254&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B133">133.</a>
    <TD VALIGN=TOP>

Sambamurti K,
Shioi J,
Anderson JP,
Pappolla MA, and Robakis NK.


Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells.
<I>J Neurosci Res</I>
33: 319-329, 1992<!-- HIGHWIRE ID="81:2:741:140" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1992JU51800015&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=1453494&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B134">134.</a>
    <TD VALIGN=TOP>

Saunders AM,
Strittmatter WJ,
Schmechel D,
George-Hyslop PH,
Pericak-Vance MA,
Joo SH,
Rosi BL,
Gusella JF,
Crapper-Machlachlan DR,
Alberts MJ,
Hulette C,
Crain B,
Goldgaber D, and Roses AD.


Association of apolipoprotein E allele epsilon 4&nbsp;with late-onset familial and sporadic Alzheimer's disease.
<I>Neurology</I>
43: 1467-1472, 1993<!-- HIGHWIRE ID="81:2:741:141" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=neurology&amp;resid=43/8/1467" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B135">135.</a>
    <TD VALIGN=TOP>

Schellenberg GD,
Bird TD,
Wijsman EM,
Orr HT,
Anderson L,
Nemens E,
White JA,
Bonnycastle L,
Weber JL,
Alonso ME,
Potter H,
Heston LH, and Martin GM.


Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.
<I>Science</I>
258: 668-671, 1992<!-- HIGHWIRE ID="81:2:741:142" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=258/5082/668" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B136">136.</a>
    <TD VALIGN=TOP>

Schenk D,
Barbour R,
Dunn W,
Gordon G,
Grajeda H,
Guido T,
Hu K,
Huang J,
Johnson-Wood K,
Khan K,
Kholodenko D,
Lee M,
Liao Z,
Lieberburg I,
Motter R,
Mutter L,
Soriano F,
Shopp G,
Vasquez N,
Vendevert C,
Wogulis SM,
Yednock T,
Games D, and Suebert P.


Immunization with amyloid-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
<I>Nature</I>
400: 173-177, 1999<!-- HIGHWIRE ID="81:2:741:143" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10408445&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B137">137.</a>
    <TD VALIGN=TOP>

Scheuner D,
Eckman C,
Jensen M,
Song X,
Citron M,
Suzuki N,
Bird TD,
hardy J,
Hutton M,
Kukull W,
Larson E,
Levy-Lahad E,
Viitanen M,
Peskind E,
Poorkaj P,
Schellenberg G,
Tanzi R,
Wasco W,
Lannfelt L,
Delkoe DJ, and Younkin S.


Secreted amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1&nbsp;and 2&nbsp;and APP mutations linked to familial Alzheimer's disease.
<I>Nature Med</I>
2: 864-870, 1996<!-- HIGHWIRE ID="81:2:741:144" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996UZ80400031&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8705854&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B138">138.</a>
    <TD VALIGN=TOP>

Schmechel DE,
Saunders AM,
Strittmatter WJ,
Crain BJ,
Hulette CM,
Joo SH,
Pericak-Vance M,
Goldgaber D, and Roses AD.


Increased amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
<I>Proc Natl Acad Sci USA</I>
90: 9649-9653, 1993<!-- HIGHWIRE ID="81:2:741:145" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=90/20/9649" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B139">139.</a>
    <TD VALIGN=TOP>

Schroeter EH,
Kisslinger JA, and Kopan R.


Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.
<I>Nature</I>
393: 382-386, 1998<!-- HIGHWIRE ID="81:2:741:146" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9620803&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B140">140.</a>
    <TD VALIGN=TOP>

Schubert D,
Jin LW,
Saitoh T, and Cole G.


The regulation of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein precursor secretion and its modulatory role in cell adhesion.
<I>Neuron</I>
3: 689-694, 1989<!-- HIGHWIRE ID="81:2:741:147" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1989CG00800003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2518372&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B141">141.</a>
    <TD VALIGN=TOP>

Schwarzman AL,
Singh N,
Tsiper M,
Gregori L,
Dranovsky A,
Vitek MP,
Glabe CG,
St. George-Hyslop PH, and Goldgaber D.


Endogenous presenilin 1&nbsp;redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix.
<I>Proc Natl Acad Sci USA</I>
96: 7932-7937, 1999<!-- HIGHWIRE ID="81:2:741:148" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=96/14/7932" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B142">142.</a>
    <TD VALIGN=TOP>

Selkoe DJ.


Alzheimer's disease: genotypes, phenotype, and treatments.
<I>Science</I>
275: 630-631, 1997<!-- HIGHWIRE ID="81:2:741:149" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=FULL&amp;journalCode=sci&amp;resid=275/5300/630" ><nobr>[<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B143">143.</a>
    <TD VALIGN=TOP>

Selkoe DJ.


Translating cell biology into therapeutic advances in Alzheimer's disease.
<I>Nature</I>
399: A23-A31, 1999<!-- HIGHWIRE ID="81:2:741:150" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10392577&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B144">144.</a>
    <TD VALIGN=TOP>

Selkoe DJ,
Abraham CR,
Podlisny MB, and Duffy LK.


Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.
<I>J Neurochem</I>
146: 1820-1834, 1986<!-- HIGHWIRE ID="81:2:741:151" --><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B145">145.</a>
    <TD VALIGN=TOP>

Selkoe DJ,
Ihara Y, and Salazar F.


Alzheimer's disease: insolubility of partially purified helical filaments in sodium dodecyl sulfate and urea.
<I>Science</I>
215: 1243-1245, 1982<!-- HIGHWIRE ID="81:2:741:152" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=215/4537/1243" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B146">146.</a>
    <TD VALIGN=TOP>

Selkoe DJ,
Podlisny MB,
Joachim CL,
Vickers EA,
Lee G,
Fritz LC, and Oltersdorf T.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid precursor protein of Alzheimer disease occurs as 110-135 kilodalton membrane-associated proteins in neural and nonneural tissues.
<I>Proc Natl Acad Sci USA</I>
85: 7341-7345, 1988<!-- HIGHWIRE ID="81:2:741:153" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=85/19/7341" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B147">147.</a>
    <TD VALIGN=TOP>

Seubert P,
Oltersdorf T,
Lee MG,
Barbour R,
Blomqist,
Davis DL,
Bryant K,
Fritz LC,
Galasko D,
Thai LJ,
Lieberburg I, and Schenk DB.


Secretion of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein cleaved at the amino-terminus of the <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid peptide.
<I>Nature</I>
361: 260-263, 1993<!-- HIGHWIRE ID="81:2:741:154" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7678698&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B148">148.</a>
    <TD VALIGN=TOP>

Seubert P,
Vigo-Pelfrey C,
Esch F,
Lee M,
Dovey H,
Davis D,
Sinha S,
Schlossmacher MG,
Whaley J,
Swindlehurst C,
McCormack R,
Wolfert R,
Selkoe DJ,
Lieberburg I, and Schenk D.


Isolation and quantitation of soluble Alzheimer's <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-peptide from biological fluids.
<I>Nature</I>
359: 325-327, 1992<!-- HIGHWIRE ID="81:2:741:155" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=1406936&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B149">149.</a>
    <TD VALIGN=TOP>

Shen J,
Bronson RT,
Chen DF,
Xia W,
Selkoe DJ, and Tonegawa S.


Skeletal and CNS defects in presnilin-1 deficient mice.
<I>Cell</I>
89: 629-639, 1997<!-- HIGHWIRE ID="81:2:741:156" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WZ32300016&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9160754&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B150">150.</a>
    <TD VALIGN=TOP>

Sherrington R,
Rogaev EI,
Liang Y,
Rogaeva EA,
Levesque G,
Ikeda M,
Chi H,
Lin C,
Li G,
Holman K,
Tsuda T,
Mar L,
Foncin J-F,
Bruni AC,
Montesi MP,
Sorbi S,
Rainero I,
Pinessi L,
Nee L,
chumakov I,
Pollen DA,
Roses AD,
Fraser PE,
Rommens JM, and St. George-Hyslop PH.


Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease.
<I>Nature</I>
375: 754-760, 1995<!-- HIGHWIRE ID="81:2:741:157" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7596406&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B151">151.</a>
    <TD VALIGN=TOP>

Shoji M,
Golde TE,
Ghiso J,
Cheung TT,
Estus S,
Shaffer LM,
Cai X,
McKay DM,
TIntner R,
Frangione B, and Younkin SG.


Production of the Alzheimer amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein by normal proteolytic processing.
<I>Science</I>
258: 126-129, 1992<!-- HIGHWIRE ID="81:2:741:158" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=258/5079/126" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B152">152.</a>
    <TD VALIGN=TOP>

Siman R,
Reaume A,
Savage MJ,
Scott RW, and Flood DG.


Presenilin 1&nbsp;P264L knock-in mutation: effect on cortical neuronal vulnerability to degeneration.
<I>J Neurosci Abstr</I>
25: 1046, 1999<!-- HIGHWIRE ID="81:2:741:159" --><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B153">153.</a>
    <TD VALIGN=TOP>

Sinha S,
Anderson JP,
Barbour R,
Basi GS,
Caccavello R,
Davis D,
Doan M,
DOvey HF,
Frigon N,
Hong J,
Jacobson-Croak K,
Jewett N,
Keim P,
Knops J,
Lieberburg I,
Power M,
Tan H,
Tatsuno G,
tung J,
Schenk D,
Seubert P,
Suomensaari SM,
Wang S,
Walker D, and John V.


Purification and cloning of amyloid precursor protein beta-secretase from human brain.
<I>Nature</I>
402: 537-540, 1999<!-- HIGHWIRE ID="81:2:741:160" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10591214&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B154">154.</a>
    <TD VALIGN=TOP>

Sinha S,
Dovey HF,
Seubert P,
Ward PJ,
Balcher RW,
Blaber M,
Bradshaw RA,
Arici M,
Mobley WC, and Lieberburg I.


The protease inhibitory properties of the Alzheimer's <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>J Biol Chem</I>
265: 8983-8985, 1990<!-- HIGHWIRE ID="81:2:741:161" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=265/16/8983" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B155">155.</a>
    <TD VALIGN=TOP>

Sisodia SS.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid precursor protein cleavage by a membrane-bound protease.
<I>Proc Natl Acad Sci USA</I>
89: 6075-6079, 1992<!-- HIGHWIRE ID="81:2:741:162" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=89/13/6075" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B156">156.</a>
    <TD VALIGN=TOP>

Sisodia SS,
Koo EH,
Beyreuther K,
Unterbeck A, and Price DL.


Evidence that <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid protein in Alzheimer's disease is not derived by normal processing.
<I>Science</I>
248: 492-495, 1990<!-- HIGHWIRE ID="81:2:741:163" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=248/4954/492" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B157">157.</a>
    <TD VALIGN=TOP>

Slunt HH,
Thinakaran G,
Von Koch C,
Lo ACY,
Tanzi RE, and Sisodia SS.


Expression of a ubiquitous, cross-reactive homologue of the mouse <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein (APP).
<I>J Biol Chem</I>
269: 2637-2644, 1994<!-- HIGHWIRE ID="81:2:741:164" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=269/4/2637" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B158">158.</a>
    <TD VALIGN=TOP>

Smith RP,
Higuchi DA, and Broze GJ Jr.


Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.
<I>Science</I>
248: 1126-1128, 1990<!-- HIGHWIRE ID="81:2:741:165" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=248/4959/1126" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B159">159.</a>
    <TD VALIGN=TOP>

Song W,
Nadeau P,
Yuan M,
Yang X,
Shen J, and Yankner BA.


Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations.
<I>Proc Natl Acad Sci USA</I>
96: 6959-6963, 1999<!-- HIGHWIRE ID="81:2:741:166" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=96/12/6959" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B160">160.</a>
    <TD VALIGN=TOP>

Spillantini MG,
Murrell JR,
Goedert M,
Farlow MR,
Klug A, and Ghetti B.


Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.
<I>Proc Natl Acad Sci USA</I>
95: 7737-7741, 1998<!-- HIGHWIRE ID="81:2:741:167" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=95/13/7737" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B161">161.</a>
    <TD VALIGN=TOP>

Steiner H,
Capell A,
Pesold B,
Citron M,
Kloetzek PM,
Selkoe DJ,
Romig H,
Mandla K, and Haass C.


Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation.
<I>J Biol Chem</I>
273: 32322-32331, 1998<!-- HIGHWIRE ID="81:2:741:168" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/48/32322" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B162">162.</a>
    <TD VALIGN=TOP>

Steiner H,
Romig H,
Pesold B,
Philipp U,
Baader M,
Citron M,
Loetscher H,
Jacobsen H, and Haass C.


Amyloidogenic function of the Alzheimer's disease-associated presenilin 1&nbsp;in the absence of endoproteolysis.
<I>Biochemistry</I>
38: 14600-14605, 1999<!-- HIGHWIRE ID="81:2:741:169" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10545183&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B163">163.</a>
    <TD VALIGN=TOP>

Strittmatter WJ,
Saunders AM,
Schmechel D,
Pericak-Vance M,
Enghild J,
Salvesen GS, and Roses AD.


Apolipoprotein E: high-avidity binding to <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid and increased frequency of type 4&nbsp;allele in late-onset familial Alzheimer disease.
<I>Proc Natl Acad Sci USA</I>
90: 1977-1981, 1993<!-- HIGHWIRE ID="81:2:741:170" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=90/5/1977" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B163a">163a.</a>
    <TD VALIGN=TOP>

Struhl G, and Adachi A.


Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins.
<I>Mol Cell</I>
6: 625-636, 2000<!-- HIGHWIRE ID="81:2:741:171" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000089578600012&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=11030342&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B164">164.</a>
    <TD VALIGN=TOP>

Struhl G, and Greenwald I.


Presenilin is required for activity and nuclear access of Notch in <I>Drosophila.</I>
<I>Nature</I>
398: 522-525, 1999<!-- HIGHWIRE ID="81:2:741:172" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10206646&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B165">165.</a>
    <TD VALIGN=TOP>

Suzuki N,
Iwatsubo T,
Odaka A,
Ishibashi Y,
Kitada C, and Ihara Y.


High tissue content of soluble <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-40 is linked to cerebral amyloid angiopathy.
<I>Am J Pathol</I>
145: 452-460, 1994<!-- HIGHWIRE ID="81:2:741:173" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=amjpathol&amp;resid=145/2/452" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B166">166.</a>
    <TD VALIGN=TOP>

Tagliavini F,
Giaccone G,
Frangione B, and Bugiani O.


Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.
<I>Neurosci Lett</I>
93: 191-196, 1988<!-- HIGHWIRE ID="81:2:741:174" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1988Q913400013&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=3241644&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B167">167.</a>
    <TD VALIGN=TOP>

Tanzi RE,
McClatchey AI,
Lamperti ED,
Villa-Komaroff L,
Gusella JF, and Neve RL.


Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
<I>Nature</I>
331: 528-532, 1988<!-- HIGHWIRE ID="81:2:741:175" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2893290&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B168">168.</a>
    <TD VALIGN=TOP>

Terry RD,
Hansen LA,
DeTeresa R,
Davies P,
TObias H, and Katzman R.


Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.
<I>J Neuropath Exp Neurol</I>
46: 262-268, 1987<!-- HIGHWIRE ID="81:2:741:176" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1987G985800003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2881985&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B169">169.</a>
    <TD VALIGN=TOP>

Thinakaran G,
Borchelt DR,
Lee MK,
Slunt HH,
Spitzer L,
Kim G,
Ratovitsky T,
Davenport F,
Nordstedt C,
Seeger M,
Hardy J,
Levey AI,
Gandy SE,
Jenkins NA,
Copeland NG,
Price DL, and Sisodia SS.


Endoprotreolysis of presenilin 1&nbsp;and accumulation of processed derivatives in vivo.
<I>Neuron</I>
17: 181-190, 1996<!-- HIGHWIRE ID="81:2:741:177" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996UY98100018&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8755489&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B170">170.</a>
    <TD VALIGN=TOP>

Thinakaran G,
Harris CL,
Ratovitski T,
Davenport F,
Slunt HH,
Price DL,
Borchelt DR, and Sisodia SS.


Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors.
<I>J Biol Chem</I>
272: 28415-28422, 1997<!-- HIGHWIRE ID="81:2:741:178" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/45/28415" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B171">171.</a>
    <TD VALIGN=TOP>

Thinakaran G,
Regard JB,
Bouton CML,
Harris CL,
Price DL,
Borchelt DR, and Sisodia SS.


Stable association of presenilin derivatives and absence of presenilin interactions with APP.
<I>Neurobiol Dis</I>
4: 438-453, 1998<!-- HIGHWIRE ID="81:2:741:179" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000073376100005&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9666482&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B172">172.</a>
    <TD VALIGN=TOP>

Thomas T,
Thomas G,
McLendon C,
Sutton T, and Mullan M.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid-mediated vasoactivity and vascular endothelial damage.
<I>Nature</I>
380: 168-171, 1996<!-- HIGHWIRE ID="81:2:741:180" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8600393&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B173">173.</a>
    <TD VALIGN=TOP>

Tokuda T,
Fukushima T,
Ikeda S,
Sekijima Y,
SHoji s,
Yanagisawa N, and Tamoaka A.


Plasma levels of amyloid beta proteins A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-40 and A<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">1-42(43) are elevated in Down's syndrome.
<I>Ann Neurol</I>
41: 271-273, 1997<!-- HIGHWIRE ID="81:2:741:181" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WH85200019&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9029078&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B174">174.</a>
    <TD VALIGN=TOP>

Tomita T,
Maruyama K,
Saido TC,
Kume H,
Shinozaki K,
Tokuhiro S,
Capell A,
Walter J,
Grunberg J,
Haass C,
Iwatsubo T, and Obata K.


The presenilin 2&nbsp;mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">&nbsp;protein ending at the 42nd (or 43rd) residue.
<I>Proc Natl Acad Sci USA</I>
94: 2025-2030, 1997<!-- HIGHWIRE ID="81:2:741:182" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=94/5/2025" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B175">175.</a>
    <TD VALIGN=TOP>

Tomita T,
Tokuhiro S,
Hashimoto T,
Aiba K,
Saido TC,
Maruyama K, and Iwatsubo T.


Molecular dissection of domains in mutant presenilin 2&nbsp;that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42.
<I>J Biol Chem</I>
273: 21153-21160, 1998<!-- HIGHWIRE ID="81:2:741:183" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/33/21153" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B176">176.</a>
    <TD VALIGN=TOP>

Trojanowski JQ, and Lee VM.


Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
<I>FASEB J</I>
9: 1570-1576, 1995<!-- HIGHWIRE ID="81:2:741:184" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=fasebj&amp;resid=9/15/1570" >[Abstract]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B177">177.</a>
    <TD VALIGN=TOP>

Vassar R,
Bennett BD,
Babu-Khan S,
Khan S,
Mendiaz EA,
Denis P,
Teplow DB,
Ross S,
Amarante P,
Loeloff R,
Luo Y,
Fisher S,
Fuller J,
Edenson S,
Lile J,
Jarosinski MA,
Biere AL,
Curran E,
Burgess T,
Louis JC,
Collins F,
Treanor J,
Rogers G, and Citron M.


Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
<I>Science</I>
286: 735-741, 1999<!-- HIGHWIRE ID="81:2:741:185" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=286/5440/735" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B178">178.</a>
    <TD VALIGN=TOP>

Verbeek MM,
Vinters H, and de Waal RM.


<I>Cerebrovascular Amyloidosis in Alzheimer's Disease and Related Disorders.</I> Amsterdam: Kluwer, 2000. In press.
    <!-- HIGHWIRE ID="81:2:741:186" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B179">179.</a>
    <TD VALIGN=TOP>

Walsh DM,
Lomakin A,
Benedek GB,
Maggio JE,
Condron MM, and Teplow DB.


Amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein fibrillogenesis: detection of a protofibrillar intermediate.
<I>J Biol Chem</I>
272: 22364-22374, 1997<!-- HIGHWIRE ID="81:2:741:187" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/35/22364" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B180">180.</a>
    <TD VALIGN=TOP>

Walsh DM,
Tseng BP,
Rydel RE,
Podlisny MB, and Selkoe DJ.


The oligomerization of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein begins intracellularly in cells derived from human brain.
<I>Biochemistry</I>
39: 10831-10839, 2000<!-- HIGHWIRE ID="81:2:741:188" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10978169&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B181">181.</a>
    <TD VALIGN=TOP>

Walter J,
Capell A,
Hung AY,
Langen H,
Schnolzer M,
thinkaran G,
Sisodia SS,
Selkoe DJ, and Haass C.


Ectodomain phosphorylation of <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein at two distinct cellular locations.
<I>J Biol Chem</I>
272: 1896-1903, 1997<!-- HIGHWIRE ID="81:2:741:189" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/3/1896" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B182">182.</a>
    <TD VALIGN=TOP>

Wasco W,
Bupp K,
Magendantz M,
Gusella J,
Tanzi RE, and Solomon F.


Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein precursor.
<I>Proc Natl Acad Sci USA</I>
89: 10758-10762, 1992<!-- HIGHWIRE ID="81:2:741:190" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=89/22/10758" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B183">183.</a>
    <TD VALIGN=TOP>

Weidemann A,
Konig G,
Bunke D,
Fischer P,
Salbaum JM,
Masters CL, and Beyreuther K.


Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein.
<I>Cell</I>
57: 115-126, 1989<!-- HIGHWIRE ID="81:2:741:191" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1989U095200014&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2649245&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B184">184.</a>
    <TD VALIGN=TOP>

Weidemann A,
Paliga K,
Durrwang U,
Czech C,
Evin G,
Masters CL, and Beyreuther K.


Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein.
<I>Nature Med</I>
3: 328-332, 1997<!-- HIGHWIRE ID="81:2:741:192" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997WL30500036&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9055862&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B185">185.</a>
    <TD VALIGN=TOP>

Wischik CM,
Novak M,
Thogersen HC,
Edwards PC,
Runswick MJ,
Jakes R,
Walker JE,
Milstein C,
Rother M, and Klug A.


Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer's disease.
<I>Proc Natl Acad Sci USA</I>
85: 4506-4510, 1988<!-- HIGHWIRE ID="81:2:741:193" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=85/12/4506" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B186">186.</a>
    <TD VALIGN=TOP>

Wolfe MS,
Citron M,
Diehl TS,
Xia W,
Donkor IO, and Selkoe DJ.


A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
<I>J Med Chem</I>
41: 6-9, 1998<!-- HIGHWIRE ID="81:2:741:194" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000071342900003&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9438016&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B187">187.</a>
    <TD VALIGN=TOP>

Wolfe MS,
Xia W,
Moore CL,
Leatherwood DD,
Ostaszewski BL,
Rahmati T,
Donkor IO, and Selkoe DJ.


Peptidomimetic probes and molecular modeling suggest Alzheimer's <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase is an intramembrane-cleaving aspartyl protease.
<I>Biochemistry</I>
38: 4720-4727, 1999<!-- HIGHWIRE ID="81:2:741:195" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10200159&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B188">188.</a>
    <TD VALIGN=TOP>

Wolfe MS,
Xia W,
Ostaszewski BL,
Diehl TS,
Kimberly WT, and Selkoe DJ.


Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and <IMG SRC="http://physrev.physiology.org/math/12pt/normal/gamma.gif" ALIGN=BOTTOM ALT="gamma ">-secretase activity.
<I>Nature</I>
398: 513-517, 1999<!-- HIGHWIRE ID="81:2:741:196" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10206644&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B189">189.</a>
    <TD VALIGN=TOP>

Wolozin B,
Iwasaki K,
Vito P,
Ganjei JK,
Lacana E,
Sunderland T,
Zhao B,
Kusiak JW,
Wasco W, and D'Adamio L.


Participation of presenilin 2&nbsp;in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.
<I>Science</I>
274: 1710-1713, 1996<!-- HIGHWIRE ID="81:2:741:197" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=274/5293/1710" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B190">190.</a>
    <TD VALIGN=TOP>

Wong P,
Zhen H,
Chen H,
Becher MW,
Sirinathsighji DJ,
Trumbauer ME,
Proce DL,
Van der Ploeg LHT, and Sisodia SS.


Presenilin 1&nbsp;is required for Notch 1&nbsp;and D111 expression in the paraxial mesoderm.
<I>Nature</I>
397: 288, 1997<!-- HIGHWIRE ID="81:2:741:198" --><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B191">191.</a>
    <TD VALIGN=TOP>

Wood JG,
Mirra SS,
Pollock NL, and Binder LI.


Neurofibrillary tangles of Alzheimer's disease share antigenic determinants with the axonal microtubule-associated protein tau.
<I>Proc Natl Acad Sci USA</I>
83: 4040-4043, 1986<!-- HIGHWIRE ID="81:2:741:199" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=83/11/4040" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B192">192.</a>
    <TD VALIGN=TOP>

Wu G,
Hubbard EJ,
Kitajewski JK, and Greenwald I.


Evidence for functional and physical association between <I>Caenorhabditis elegans</I> SEL-10, a Cdc4p-related protein, and SEL-12 presenilin.
<I>Proc Natl Acad Sci USA</I>
95: 15787-15791, 1998<!-- HIGHWIRE ID="81:2:741:200" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=95/26/15787" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B193">193.</a>
    <TD VALIGN=TOP>

Xia W,
Ray WJ,
Ostaszewski BL,
Rahmati T,
Kimberly WT,
Wolfe MS,
Zhang J,
Goate AM, and Selkoe DJ.


Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein generation.
<I>Proc Natl Acad Sci USA</I>
97: 9299-9304, 2000<!-- HIGHWIRE ID="81:2:741:201" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=97/16/9299" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B195">195.</a>
    <TD VALIGN=TOP>

Xia W,
Zhang J,
Kholodenko D,
Citron M,
Podlisny MB,
Teplow DB,
Haass C,
Seubert P,
Koo EH, and Selkoe DJ.


Enhanced production and oligomerization of the 42-residue amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein by Chinese hamster ovary cells stably expressing mutant presenilins.
<I>J Biol Chem</I>
272: 7977-7982, 1997<!-- HIGHWIRE ID="81:2:741:202" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=272/12/7977" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B196">196.</a>
    <TD VALIGN=TOP>

Xia W,
Zhang J,
Ostaszewski BL,
Kimberly WT,
Seubert P,
Koo EH,
Shen J, and Selkoe DJ.


Presenilin 1&nbsp;regulates the processing APP C-terminal fragments and the generation of amyloid <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-protein in ER and Golgi.
<I>Biochemistry</I>
37: 16465-16471, 1998<!-- HIGHWIRE ID="81:2:741:203" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9843412&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B197">197.</a>
    <TD VALIGN=TOP>

Xia W,
Zhang J,
Perez R,
Koo EH, and Selkoe DJ.


Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer's disease.
<I>Proc Natl Acad Sci USA</I>
94: 8208-8213, 1997<!-- HIGHWIRE ID="81:2:741:204" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=94/15/8208" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B198">198.</a>
    <TD VALIGN=TOP>

Xu X,
Shi Y,
Wu X,
Gambetti P,
Sui D, and Cui MZ.


Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1.
<I>J Biol Chem</I>
274: 32543-32546, 1999<!-- HIGHWIRE ID="81:2:741:205" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=274/46/32543" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B199">199.</a>
    <TD VALIGN=TOP>

Yamaguchi H,
Hirai S,
Morimatsu M,
Shoji, and Harigaya Y.


Diffuse type of senile plaques in the brains of Alzheimer-type dementia.
<I>Acta Neuropathol</I>
77: 113-119, 1988<!-- HIGHWIRE ID="81:2:741:206" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=2465658&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B200">200.</a>
    <TD VALIGN=TOP>

Yamazaki T,
Selkoe DJ, and Koo EH.


Trafficking of cell surface <IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons.
<I>J Cell Biol</I>
129: 431-442, 1995<!-- HIGHWIRE ID="81:2:741:207" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=129/2/431" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B201">201.</a>
    <TD VALIGN=TOP>

Yan R,
Bienkowski MJ,
Shuck ME,
Miao H,
Tory MC,
Pauley AM,
Brashier JR,
Stratman NC,
Mathews WR,
Buhl AE,
Carter DB,
Tomasselli AG,
Parodi LA,
Heinrikson RL, and Gurney ME.


Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
<I>Nature</I>
402: 533-537, 1999<!-- HIGHWIRE ID="81:2:741:208" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10591213&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B202">202.</a>
    <TD VALIGN=TOP>

Yan SD,
Chen X,
Fu J,
Chen M,
Zhu H,
Roher A,
Slattery T,
Zhao L,
Nagashima M,
Morser J,
Migheli A,
Nawroth P,
Stern D, and Schmidt AM.


RAGE and amyloid-<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta "> peptide neurotoxicity in Alzheimer's disease.
<I>Nature</I>
382: 685-691, 1996<!-- HIGHWIRE ID="81:2:741:209" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8751438&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B203">203.</a>
    <TD VALIGN=TOP>

Ye Y, and Fortini ME.


Characterization of <I>Drosophila</I> Presenilin and its colocalization with Notch during development.
<I>Mech Dev</I>
79: 199-211, 1998<!-- HIGHWIRE ID="81:2:741:210" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=000078195700018&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10349633&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B204">204.</a>
    <TD VALIGN=TOP>

Ye Y,
Lukinova N, and Fortini ME.


Neurogenic phenotypes and altered Notch processing in <I>Drosophila</I> Presenilin mutants.
<I>Nature</I>
398: 525-529, 1999<!-- HIGHWIRE ID="81:2:741:211" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=10206647&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B205">205.</a>
    <TD VALIGN=TOP>

Yu G,
Chen F,
Levesque G,
Nishimura M,
Zhang DM,
Levesque L,
Rogaeva E,
Xu D,
Liang Y,
Duthie M,
St George-Hyslop PH, and Fraser PE.


The presenilin 1&nbsp;protein is a component of a high molecular weight intracellular complex that contains beta-catenin.
<I>J Biol Chem</I>
273: 16470-16475, 1998<!-- HIGHWIRE ID="81:2:741:212" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/26/16470" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B206">206.</a>
    <TD VALIGN=TOP>

Zhang J,
Kang DE,
Xia W,
Okochi M,
Mori H,
Selkoe DJ, and Koo EH.


Subcellular distribution and turnover of presenilins in transfected cells.
<I>J Biol Chem</I>
273: 12436-12442, 1998<!-- HIGHWIRE ID="81:2:741:213" --><a href="http://physrev.physiology.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/20/12436" ><nobr>[Abstract/<font COLOR="CC0000">Free</font>&nbsp;Full&nbsp;Text]</nobr></a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B207">207.</a>
    <TD VALIGN=TOP>

Zheng H,
Jiang M,
Trumbauer ME,
Sirinathsinghji DJS,
Hopkins R,
Smith DW,
Heavesn RP,
Dawson GR,
Boyce S,
Conner MW,
Stevens KA,
Slunt HH,
Sisodia SS,
Chen HY, and Van der Ploeg LHT.


<IMG SRC="http://physrev.physiology.org/math/12pt/normal/beta.gif" ALIGN=BOTTOM ALT="beta ">-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity.
<I>Cell</I>
81: 525-531, 1995<!-- HIGHWIRE ID="81:2:741:214" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1995QZ71000009&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=7758106&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B208">208.</a>
    <TD VALIGN=TOP>

Zhou J,
Liyanage U,
Medina M,
Ho C,
Simmons AD,
Lovett M, and Kosik KS.


Presenilin 1&nbsp;interaction in the brain with a novel member of the Armadillo family.
<I>Neuroreport</I>
8: 2085-2090, 1997<!-- HIGHWIRE ID="81:2:741:215" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1997XG76600054&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=9223106&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>
<TR><TD VALIGN=TOP><a name="B209">209.</a>
    <TD VALIGN=TOP>

Zlokovic BV.


Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
<I>Life Sci</I>
59: 1483-1497, 1996<!-- HIGHWIRE ID="81:2:741:216" --><a href="http://physrev.physiology.org/cgi/external_ref?access_num=A1996VK82600001&amp;link_type=ISI" >[Web of Science]</a><a href="http://physrev.physiology.org/cgi/external_ref?access_num=8890929&amp;link_type=MED" >[Medline]</a><!-- /HIGHWIRE -->.
    </TR>

</TABLE>



<H5>
<FONT SIZE=-1>0031-9333/01
$15.00
<A HREF="http://physrev.physiology.org/misc/terms.shtml">Copyright &#169; 2001
 The American Physiological Society</A></FONT>
</H5>




<!-- /COPYRIGHT -->
<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	
	
	




 










<BR CLEAR=ALL>




  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>




	
	
	

<A NAME="otherarticles"><!-- null --></A>



<P><FONT SIZE=+2><STRONG>
This article has been cited by other articles:</STRONG></FONT> 


<P>


	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://hmg.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Hum Mol Genet" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/hmg.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Iijima, A. Gatt, and K. Iijima-Ando<BR>
	<STRONG>Tau Ser262 phosphorylation is critical for A{beta}42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease</STRONG><BR>
	
		
			Hum. Mol. Genet.,
		
	
        
        August&nbsp;1,&nbsp;2010;
	
	19(15):
	
	2947 - 2957.
<BR>
<A HREF="http://hmg.oxfordjournals.org/cgi/content/abstract/19/15/2947">[Abstract]</A>


<A HREF="http://hmg.oxfordjournals.org/cgi/content/full/19/15/2947">[Full Text]</A>

<A HREF="http://hmg.oxfordjournals.org/cgi/reprint/19/15/2947">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Peng, J. Sun, S. Hon, A. N. Nylander, W. Xia, Y. Feng, X. Wang, and C. A. Lemere<BR>
	<STRONG>L-3-n-Butylphthalide Improves Cognitive Impairment and Reduces Amyloid-{beta} in a Transgenic Model of Alzheimer's Disease</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        June&nbsp;16,&nbsp;2010;
	
	30(24):
	
	8180 - 8189.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/30/24/8180">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/30/24/8180">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/30/24/8180">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.fasebj.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.fasebj.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.fasebj.org/"><IMG ALT="FASEB J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/fasebj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. S. Hu, P. Xu, G. Pigino, S. T. Brady, J. Larson, and O. Lazarov<BR>
	<STRONG>Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1{Delta}E9 mice</STRONG><BR>
	
		
			FASEB J,
		
	
        
        June&nbsp;1,&nbsp;2010;
	
	24(6):
	
	1667 - 1681.
<BR>
<A HREF="http://www.fasebj.org/cgi/content/abstract/24/6/1667">[Abstract]</A>


<A HREF="http://www.fasebj.org/cgi/content/full/24/6/1667">[Full Text]</A>

<A HREF="http://www.fasebj.org/cgi/reprint/24/6/1667">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jnnp.bmj.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jnnp.bmj.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jnnp.bmj.com/"><IMG ALT="J. Neurol. Neurosurg. Psychiatry" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jnnp.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	T. T. Seppala, S. K. Herukka, T. Hanninen, S. Tervo, M. Hallikainen, H. Soininen, and T. Pirttila<BR>
	<STRONG>Plasma A{beta}42 and A{beta}40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study</STRONG><BR>
	
		
			J. Neurol. Neurosurg. Psychiatry,
		
	
        
        May&nbsp;16,&nbsp;2010;
	
	(2010)
	
	jnnp.2010.205757v1.
<BR>
<A HREF="http://jnnp.bmjjournals.com/cgi/content/abstract/jnnp.2010.205757v1">[Abstract]</A>


<A HREF="http://jnnp.bmjjournals.com/cgi/content/full/jnnp.2010.205757v1/TBL1">[Full Text]</A>


<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://glycob.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://glycob.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://glycob.oxfordjournals.org/"><IMG ALT="Glycobiology" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/glycob.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. Sandwall, P. O'Callaghan, X. Zhang, U. Lindahl, L. Lannfelt, and J. P. Li<BR>
	<STRONG>Heparan sulfate mediates amyloid-beta internalization and cytotoxicity</STRONG><BR>
	
		
			Glycobiology,
		
	
        
        May&nbsp;1,&nbsp;2010;
	
	20(5):
	
	533 - 541.
<BR>
<A HREF="http://glycob.oxfordjournals.org/cgi/content/abstract/20/5/533">[Abstract]</A>


<A HREF="http://glycob.oxfordjournals.org/cgi/content/full/20/5/533">[Full Text]</A>

<A HREF="http://glycob.oxfordjournals.org/cgi/reprint/20/5/533">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo<BR>
	<STRONG>Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-{beta}, and Tau: EFFECTS ON COGNITIVE IMPAIRMENTS</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;23,&nbsp;2010;
	
	285(17):
	
	13107 - 13120.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/285/17/13107">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/285/17/13107/T1">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/285/17/13107">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Venkataramani, C. Rossner, L. Iffland, S. Schweyer, I. Y. Tamboli, J. Walter, O. Wirths, and T. A. Bayer<BR>
	<STRONG>Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;2,&nbsp;2010;
	
	285(14):
	
	10678 - 10689.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/285/14/10678">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/285/14/10678">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/285/14/10678">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://dmd.aspetjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://dmd.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://dmd.aspetjournals.org/"><IMG ALT="Drug Metab. Dispos." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/dmd.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. Yi, C. Hadden, P. Kulanthaivel, N. Calvert, W. Annes, T. Brown, R. J. Barbuch, A. Chaudhary, M. A. Ayan-Oshodi, and B. J. Ring<BR>
	<STRONG>Disposition and Metabolism of Semagacestat, a {gamma}-Secretase Inhibitor, in Humans</STRONG><BR>
	
		
			Drug Metab. Dispos.,
		
	
        
        April&nbsp;1,&nbsp;2010;
	
	38(4):
	
	554 - 565.
<BR>
<A HREF="http://dmd.aspetjournals.org/cgi/content/abstract/38/4/554">[Abstract]</A>


<A HREF="http://dmd.aspetjournals.org/cgi/content/full/38/4/554">[Full Text]</A>

<A HREF="http://dmd.aspetjournals.org/cgi/reprint/38/4/554">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Vingtdeux, L. Giliberto, H. Zhao, P. Chandakkar, Q. Wu, J. E. Simon, E. M. Janle, J. Lobo, M. G. Ferruzzi, P. Davies,  <em>et al.</em><BR>
	<STRONG>AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-{beta} Peptide Metabolism</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;19,&nbsp;2010;
	
	285(12):
	
	9100 - 9113.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/285/12/9100">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/285/12/9100">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/285/12/9100">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Kaneko, H. Koike, R. Saito, Y. Kitamura, Y. Okuma, and Y. Nomura<BR>
	<STRONG>Loss of HRD1-Mediated Protein Degradation Causes Amyloid Precursor Protein Accumulation and Amyloid-{beta} Generation</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        March&nbsp;17,&nbsp;2010;
	
	30(11):
	
	3924 - 3932.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/30/11/3924">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/30/11/3924">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/30/11/3924">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://tpx.sagepub.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://tpx.sagepub.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://tpx.sagepub.com/"><IMG ALT="Toxicol Pathol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/sptpx.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. Kodama, X. Yang, Y. Saski, S. Iwashige, Y. Tanigawa, T. Yoshikawa, T. Nagaoka, Y. Kamimura, and H. Maeda<BR>
	<STRONG>Age-Related Lesions in the Cerebrum in Middle-Aged Female Cynomolgus Monkeys</STRONG><BR>
	
		
			Toxicol Pathol,
		
	
        
        February&nbsp;1,&nbsp;2010;
	
	38(2):
	
	303 - 311.
<BR>
<A HREF="http://tpx.sagepub.com/cgi/content/abstract/38/2/303">[Abstract]</A>


<A HREF="http://tpx.sagepub.com/cgi/content/full/38/2/303">[Full Text]</A>

<A HREF="http://tpx.sagepub.com/cgi/reprint/38/2/303">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://ajp.amjpathol.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajp.amjpathol.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://ajp.amjpathol.org/"><IMG ALT="Am. J. Pathol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/amjpathol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Martinez-Coria, K. N. Green, L. M. Billings, M. Kitazawa, M. Albrecht, G. Rammes, C. G. Parsons, S. Gupta, P. Banerjee, and F. M. LaFerla<BR>
	<STRONG>Memantine Improves Cognition and Reduces Alzheimer's-Like Neuropathology in Transgenic Mice</STRONG><BR>
	
		
			Am. J. Pathol.,
		
	
        
        February&nbsp;1,&nbsp;2010;
	
	176(2):
	
	870 - 880.
<BR>
<A HREF="http://ajp.amjpathol.org/cgi/content/abstract/176/2/870">[Abstract]</A>


<A HREF="http://ajp.amjpathol.org/cgi/content/full/176/2/870">[Full Text]</A>

<A HREF="http://ajp.amjpathol.org/cgi/reprint/176/2/870">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://content.nejm.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://content.nejm.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://content.nejm.org/"><IMG ALT="NEJM" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/nejm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. W. Querfurth and F. M. LaFerla<BR>
	<STRONG>Alzheimer's Disease</STRONG><BR>
	
		
			N. Engl. J. Med.,
		
	
        
        January&nbsp;28,&nbsp;2010;
	
	362(4):
	
	329 - 344.
<BR>



<A HREF="http://content.nejm.org/cgi/content/full/362/4/329">[Full Text]</A>

<A HREF="http://content.nejm.org/cgi/reprint/362/4/329">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	X.-L. Zhao, W.-A. Wang, J.-X. Tan, J.-K. Huang, X. Zhang, B.-Z. Zhang, Y.-H. Wang, H.-Y. YangCheng, H.-L. Zhu, X.-J. Sun,  <em>et al.</em><BR>
	<STRONG>Expression of {beta}-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        January&nbsp;27,&nbsp;2010;
	
	30(4):
	
	1512 - 1522.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/30/4/1512">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/30/4/1512">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/30/4/1512">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. T. Hoopes, X. Liu, X. Xu, B. Demeler, E. Folta-Stogniew, C. Li, and Y. Ha<BR>
	<STRONG>Structural Characterization of the E2 Domain of APL-1, a Caenorhabditis elegans Homolog of Human Amyloid Precursor Protein, and Its Heparin Binding Site</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;15,&nbsp;2010;
	
	285(3):
	
	2165 - 2173.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/285/3/2165">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/285/3/2165">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/285/3/2165">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.fasebj.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.fasebj.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.fasebj.org/"><IMG ALT="FASEB J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/fasebj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. S. Minami, Y. M. Sung, S. B. Dumanis, S. H. Chi, M. P. Burns, E.-J. Ann, T. Suzuki, R. S. Turner, H.-S. Park, D. T. S. Pak,  <em>et al.</em><BR>
	<STRONG>The cytoplasmic adaptor protein X11{alpha} and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement</STRONG><BR>
	
		
			FASEB J,
		
	
        
        January&nbsp;1,&nbsp;2010;
	
	24(1):
	
	58 - 69.
<BR>
<A HREF="http://www.fasebj.org/cgi/content/abstract/24/1/58">[Abstract]</A>


<A HREF="http://www.fasebj.org/cgi/content/full/24/1/58">[Full Text]</A>

<A HREF="http://www.fasebj.org/cgi/reprint/24/1/58">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Hata, S. Fujishige, Y. Araki, N. Kato, M. Araseki, M. Nishimura, D. Hartmann, P. Saftig, F. Fahrenholz, M. Taniguchi,  <em>et al.</em><BR>
	<STRONG>Alcadein Cleavages by Amyloid {beta}-Precursor Protein (APP) {alpha}- and {gamma}-Secretases Generate Small Peptides, p3-Alcs, Indicating Alzheimer Disease-related {gamma}-Secretase Dysfunction</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;25,&nbsp;2009;
	
	284(52):
	
	36024 - 36033.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/284/52/36024">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/284/52/36024">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/284/52/36024">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jama.ama-assn.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jama.ama-assn.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jama.ama-assn.org/"><IMG ALT="JAMA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jama.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. C. Green, L. S. Schneider, D. A. Amato, A. P. Beelen, G. Wilcock, E. A. Swabb, K. H. Zavitz, and   for the Tarenflurbil Phase 3 Study Group<BR>
	<STRONG>Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease: A Randomized Controlled Trial</STRONG><BR>
	
		
			JAMA,
		
	
        
        December&nbsp;16,&nbsp;2009;
	
	302(23):
	
	2557 - 2564.
<BR>
<A HREF="http://jama.ama-assn.org/cgi/content/abstract/302/23/2557">[Abstract]</A>


<A HREF="http://jama.ama-assn.org/cgi/content/full/302/23/2557">[Full Text]</A>

<A HREF="http://jama.ama-assn.org/cgi/reprint/302/23/2557">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://endo.endojournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://endo.endojournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://endo.endojournals.org/"><IMG ALT="Endocrinology" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/endo.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. Kim, C. Backus, S. Oh, J. M. Hayes, and E. L. Feldman<BR>
	<STRONG>Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 Diabetes</STRONG><BR>
	
		
			Endocrinology,
		
	
        
        December&nbsp;1,&nbsp;2009;
	
	150(12):
	
	5294 - 5301.
<BR>
<A HREF="http://endo.endojournals.org/cgi/content/abstract/150/12/5294">[Abstract]</A>


<A HREF="http://endo.endojournals.org/cgi/content/full/150/12/5294">[Full Text]</A>

<A HREF="http://endo.endojournals.org/cgi/reprint/150/12/5294">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	C. C. Shelton, L. Zhu, D. Chau, L. Yang, R. Wang, H. Djaballah, H. Zheng, and Y.-M. Li<BR>
	<STRONG>Modulation of {gamma}-secretase specificity using small molecule allosteric inhibitors</STRONG><BR>
	
		
			PNAS,
		
	
        
        December&nbsp;1,&nbsp;2009;
	
	106(48):
	
	20228 - 20233.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/106/48/20228">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/106/48/20228/T1">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/106/48/20228">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jb.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jb.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jb.oxfordjournals.org/"><IMG ALT="J Biochem" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbiochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Suga, A. Saito, T. Tomiyama, H. Mori, and K. Akagawa<BR>
	<STRONG>The Syntaxin 5 Isoforms Syx5 and Syx5L have Distinct Effects on the Processing of {beta}-amyloid Precursor Protein</STRONG><BR>
	
		
			J. Biochem.,
		
	
        
        December&nbsp;1,&nbsp;2009;
	
	146(6):
	
	905 - 915.
<BR>
<A HREF="http://jb.oxfordjournals.org/cgi/content/abstract/146/6/905">[Abstract]</A>


<A HREF="http://jb.oxfordjournals.org/cgi/content/full/146/6/905">[Full Text]</A>

<A HREF="http://jb.oxfordjournals.org/cgi/reprint/146/6/905">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://bjo.bmj.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://bjo.bmj.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://bjo.bmj.com/"><IMG ALT="Br J Ophthalmol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/bjophthalmol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P Wostyn, K Audenaert, and P P De Deyn<BR>
	<STRONG>Alzheimer's disease and glaucoma: Is there a causal relationship?</STRONG><BR>
	
		
			Br J Ophthalmol,
		
	
        
        December&nbsp;1,&nbsp;2009;
	
	93(12):
	
	1557 - 1559.
<BR>
<A HREF="http://bjo.bmj.com/cgi/content/abstract/93/12/1557">[Abstract]</A>


<A HREF="http://bjo.bmj.com/cgi/content/full/93/12/1557">[Full Text]</A>

<A HREF="http://bjo.bmj.com/cgi/reprint/93/12/1557">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. M. Canas, L. O. Porciuncula, G. M. A. Cunha, C. G. Silva, N. J. Machado, J. M. A. Oliveira, C. R. Oliveira, and R. A. Cunha<BR>
	<STRONG>Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by {beta}-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        November&nbsp;25,&nbsp;2009;
	
	29(47):
	
	14741 - 14751.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/47/14741">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/47/14741">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/47/14741">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Szodorai, Y.-H. Kuan, S. Hunzelmann, U. Engel, A. Sakane, T. Sasaki, Y. Takai, J. Kirsch, U. Muller, K. Beyreuther,  <em>et al.</em><BR>
	<STRONG>APP Anterograde Transport Requires Rab3A GTPase Activity for Assembly of the Transport Vesicle</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        November&nbsp;18,&nbsp;2009;
	
	29(46):
	
	14534 - 14544.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/46/14534">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/46/14534">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/46/14534">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://stke.sciencemag.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://stke.sciencemag.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://stke.sciencemag.org/"><IMG ALT="Sci Signal" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/sigtrans.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Thathiah and B. De Strooper<BR>
	<STRONG>G Protein-Coupled Receptors, Cholinergic Dysfunction, and A{beta} Toxicity in Alzheimer's Disease</STRONG><BR>
	
		
			Sci. Signal.,
		
	
        
        October&nbsp;20,&nbsp;2009;
	
	2(93):
	
	re8 - re8.
<BR>
<A HREF="http://stke.sciencemag.org/cgi/content/abstract/2/93/re8">[Abstract]</A>


<A HREF="http://stke.sciencemag.org/cgi/content/full/2/93/re8">[Full Text]</A>

<A HREF="http://stke.sciencemag.org/cgi/reprint/2/93/re8">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://hmg.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Hum Mol Genet" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/hmg.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Manczak, P. Mao, K. Nakamura, C. Bebbington, B. Park, and P. H. Reddy<BR>
	<STRONG>Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease</STRONG><BR>
	
		
			Hum. Mol. Genet.,
		
	
        
        October&nbsp;15,&nbsp;2009;
	
	18(20):
	
	3876 - 3893.
<BR>
<A HREF="http://hmg.oxfordjournals.org/cgi/content/abstract/18/20/3876">[Abstract]</A>


<A HREF="http://hmg.oxfordjournals.org/cgi/content/full/18/20/3876">[Full Text]</A>

<A HREF="http://hmg.oxfordjournals.org/cgi/reprint/18/20/3876">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://stroke.ahajournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://stroke.ahajournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://stroke.ahajournals.org/"><IMG ALT="Stroke" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/strokeaha.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Gomis, T. Sobrino, A. Ois, M. Millan, A. Rodriguez-Campello, N. P. de la Ossa, R. Rodriguez-Gonzalez, J. Jimenez-Conde, E. Cuadrado-Godia, J. Roquer,  <em>et al.</em><BR>
	<STRONG>Plasma {beta}-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype</STRONG><BR>
	
		
			Stroke,
		
	
        
        October&nbsp;1,&nbsp;2009;
	
	40(10):
	
	3197 - 3201.
<BR>
<A HREF="http://stroke.ahajournals.org/cgi/content/abstract/40/10/3197">[Abstract]</A>


<A HREF="http://stroke.ahajournals.org/cgi/content/full/40/10/3197">[Full Text]</A>

<A HREF="http://stroke.ahajournals.org/cgi/reprint/40/10/3197">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Kanninen, R. Heikkinen, T. Malm, T. Rolova, S. Kuhmonen, H. Leinonen, S. Yla-Herttuala, H. Tanila, A.-L. Levonen, M. Koistinaho,  <em>et al.</em><BR>
	<STRONG>Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease</STRONG><BR>
	
		
			PNAS,
		
	
        
        September&nbsp;22,&nbsp;2009;
	
	106(38):
	
	16505 - 16510.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/106/38/16505">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/106/38/16505">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/106/38/16505">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://hmg.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Hum Mol Genet" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/hmg.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. P. Burns, L. Zhang, G. W. Rebeck, H. W. Querfurth, and C. E.-H. Moussa<BR>
	<STRONG>Parkin promotes intracellular A{beta}1-42 clearance</STRONG><BR>
	
		
			Hum. Mol. Genet.,
		
	
        
        September&nbsp;1,&nbsp;2009;
	
	18(17):
	
	3206 - 3216.
<BR>
<A HREF="http://hmg.oxfordjournals.org/cgi/content/abstract/18/17/3206">[Abstract]</A>


<A HREF="http://hmg.oxfordjournals.org/cgi/content/full/18/17/3206">[Full Text]</A>

<A HREF="http://hmg.oxfordjournals.org/cgi/reprint/18/17/3206">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://glycob.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://glycob.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://glycob.oxfordjournals.org/"><IMG ALT="Glycobiology" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/glycob.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	I. Perdivara, L. J Deterding, C. Cozma, K. B Tomer, and M. Przybylski<BR>
	<STRONG>Glycosylation profiles of epitope-specific anti-{beta}-amyloid antibodies revealed by liquid chromatography-mass spectrometry</STRONG><BR>
	
		
			Glycobiology,
		
	
        
        September&nbsp;1,&nbsp;2009;
	
	19(9):
	
	958 - 970.
<BR>
<A HREF="http://glycob.oxfordjournals.org/cgi/content/abstract/19/9/958">[Abstract]</A>


<A HREF="http://glycob.oxfordjournals.org/cgi/content/full/19/9/958">[Full Text]</A>

<A HREF="http://glycob.oxfordjournals.org/cgi/reprint/19/9/958">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jimmunol.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jimmunol.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jimmunol.org/"><IMG ALT="J. Immunol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jimmunol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, D. J. Selkoe, D. M. Altmann, H. L. Weiner, and A. Monsonego<BR>
	<STRONG>HLA-DR Alleles in Amyloid {beta}-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele</STRONG><BR>
	
		
			J. Immunol.,
		
	
        
        September&nbsp;1,&nbsp;2009;
	
	183(5):
	
	3522 - 3530.
<BR>
<A HREF="http://www.jimmunol.org/cgi/content/abstract/183/5/3522">[Abstract]</A>


<A HREF="http://www.jimmunol.org/cgi/content/full/183/5/3522">[Full Text]</A>

<A HREF="http://www.jimmunol.org/cgi/reprint/183/5/3522">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. Yan, A. W. Bero, J. R. Cirrito, Q. Xiao, X. Hu, Y. Wang, E. Gonzales, D. M. Holtzman, and J.-M. Lee<BR>
	<STRONG>Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        August&nbsp;26,&nbsp;2009;
	
	29(34):
	
	10706 - 10714.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/34/10706">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/34/10706">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/34/10706">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.fasebj.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.fasebj.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.fasebj.org/"><IMG ALT="FASEB J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/fasebj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. Planel, A. Bretteville, L. Liu, L. Virag, A. L. Du, W. H. Yu, D. W. Dickson, R. A. Whittington, and K. E. Duff<BR>
	<STRONG>Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia</STRONG><BR>
	
		
			FASEB J,
		
	
        
        August&nbsp;1,&nbsp;2009;
	
	23(8):
	
	2595 - 2604.
<BR>
<A HREF="http://www.fasebj.org/cgi/content/abstract/23/8/2595">[Abstract]</A>


<A HREF="http://www.fasebj.org/cgi/content/full/23/8/2595">[Full Text]</A>

<A HREF="http://www.fasebj.org/cgi/reprint/23/8/2595">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	N. Chennamsetty, V. Voynov, V. Kayser, B. Helk, and B. L. Trout<BR>
	<STRONG>Design of therapeutic proteins with enhanced stability</STRONG><BR>
	
		
			PNAS,
		
	
        
        July&nbsp;21,&nbsp;2009;
	
	106(29):
	
	11937 - 11942.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/106/29/11937">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/106/29/11937/T2">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/106/29/11937">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://cercor.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://cercor.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://cercor.oxfordjournals.org/"><IMG ALT="Cereb Cortex" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/cercor.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	O. Reiner, A. Shmueli, and T. Sapir<BR>
	<STRONG>Neuronal Migration and Neurodegeneration: 2 Sides of the Same Coin</STRONG><BR>
	
		
			Cereb Cortex,
		
	
        
        July&nbsp;1,&nbsp;2009;
	
	19(suppl_1):
	
	i42 - i48.
<BR>
<A HREF="http://cercor.oxfordjournals.org/cgi/content/abstract/19/suppl_1/i42">[Abstract]</A>


<A HREF="http://cercor.oxfordjournals.org/cgi/content/full/19/suppl_1/i42">[Full Text]</A>

<A HREF="http://cercor.oxfordjournals.org/cgi/reprint/19/suppl_1/i42">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H.-S. Hoe, K. J. Lee, R. S. E. Carney, J. Lee, A. Markova, J.-Y. Lee, B. W. Howell, B. T. Hyman, D. T. S. Pak, G. Bu,  <em>et al.</em><BR>
	<STRONG>Interaction of Reelin with Amyloid Precursor Protein Promotes Neurite Outgrowth</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        June&nbsp;10,&nbsp;2009;
	
	29(23):
	
	7459 - 7473.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/23/7459">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/23/7459">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/23/7459">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Gralle, M. G. Botelho, and F. S. Wouters<BR>
	<STRONG>Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;29,&nbsp;2009;
	
	284(22):
	
	15016 - 15025.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/284/22/15016">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/284/22/15016">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/284/22/15016">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. Futai, S. Yagishita, and S. Ishiura<BR>
	<STRONG>Nicastrin Is Dispensable for {gamma}-Secretase Protease Activity in the Presence of Specific Presenilin Mutations</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;8,&nbsp;2009;
	
	284(19):
	
	13013 - 13022.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/284/19/13013">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/284/19/13013">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/284/19/13013">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Xiong, D. Callaghan, A. Jones, J. Bai, I. Rasquinha, C. Smith, K. Pei, D. Walker, L.-F. Lue, D. Stanimirovic,  <em>et al.</em><BR>
	<STRONG>ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood-Brain Barrier for A{beta}1-40 Peptides</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        April&nbsp;29,&nbsp;2009;
	
	29(17):
	
	5463 - 5475.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/17/5463">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/17/5463">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/17/5463">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. A. Karlnoski, A. Rosenthal, D. Kobayashi, J. Pons, J. Alamed, M. Mercer, Q. Li, M. N. Gordon, P. E. Gottschall, and D. Morgan<BR>
	<STRONG>Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 Mice</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        April&nbsp;15,&nbsp;2009;
	
	29(15):
	
	4964 - 4971.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/15/4964">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/15/4964">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/15/4964">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. E. Hoey, R. J. Williams, and M. S. Perkinton<BR>
	<STRONG>Synaptic NMDA Receptor Activation Stimulates {alpha}-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-{beta} Production</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        April&nbsp;8,&nbsp;2009;
	
	29(14):
	
	4442 - 4460.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/29/14/4442">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/29/14/4442">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/29/14/4442">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Moreno, E. Yu, G. Pigino, A. I. Hernandez, N. Kim, J. E. Moreira, M. Sugimori, and R. R. Llinas<BR>
	<STRONG>Synaptic transmission block by presynaptic injection of oligomeric amyloid beta</STRONG><BR>
	
		
			PNAS,
		
	
        
        April&nbsp;7,&nbsp;2009;
	
	106(14):
	
	5901 - 5906.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/106/14/5901">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/106/14/5901">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/106/14/5901">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://brain.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://brain.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://brain.oxfordjournals.org/"><IMG ALT="Brain" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/brain.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Boissonneault, M. Filali, M. Lessard, J. Relton, G. Wong, and S. Rivest<BR>
	<STRONG>Powerful beneficial effects of macrophage colony-stimulating factor on {beta}-amyloid deposition and cognitive impairment in Alzheimer's disease</STRONG><BR>
	
		
			Brain,
		
	
        
        April&nbsp;1,&nbsp;2009;
	
	132(4):
	
	1078 - 1092.
<BR>
<A HREF="http://brain.oxfordjournals.org/cgi/content/abstract/132/4/1078">[Abstract]</A>


<A HREF="http://brain.oxfordjournals.org/cgi/content/full/132/4/1078">[Full Text]</A>

<A HREF="http://brain.oxfordjournals.org/cgi/reprint/132/4/1078">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.sciencemag.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.sciencemag.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.sciencemag.org/"><IMG ALT="Science" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/sci.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. Di Fede, M. Catania, M. Morbin, G. Rossi, S. Suardi, G. Mazzoleni, M. Merlin, A. R. Giovagnoli, S. Prioni, A. Erbetta,  <em>et al.</em><BR>
	<STRONG>A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis</STRONG><BR>
	
		
			Science,
		
	
        
        March&nbsp;13,&nbsp;2009;
	
	323(5920):
	
	1473 - 1477.
<BR>
<A HREF="http://www.sciencemag.org/cgi/content/abstract/323/5920/1473">[Abstract]</A>


<A HREF="http://www.sciencemag.org/cgi/content/full/323/5920/1473">[Full Text]</A>

<A HREF="http://www.sciencemag.org/cgi/reprint/323/5920/1473">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. C. Diaz, O. Simakova, K. A. Jacobson, N. Arispe, and H. B. Pollard<BR>
	<STRONG>From the Cover: Small molecule blockers of the Alzheimer A{beta} calcium channel potently protect neurons from A{beta} cytotoxicity</STRONG><BR>
	
		
			PNAS,
		
	
        
        March&nbsp;3,&nbsp;2009;
	
	106(9):
	
	3348 - 3353.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/106/9/3348">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/106/9/3348">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/106/9/3348">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jgp.sagepub.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jgp.sagepub.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jgp.sagepub.com/"><IMG ALT="J Geriatr Psychiatry Neurol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/spjgp.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Fellgiebel, E. Kojro, M. J. Muller, A. Scheurich, L. G. Schmidt, and F. Fahrenholz<BR>
	<STRONG>CSF APPs{alpha} and Phosphorylated Tau Protein Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type</STRONG><BR>
	
		
			J Geriatr Psychiatry Neurol,
		
	
        
        March&nbsp;1,&nbsp;2009;
	
	22(1):
	
	3 - 9.
<BR>
<A HREF="http://jgp.sagepub.com/cgi/content/abstract/22/1/3">[Abstract]</A>




<A HREF="http://jgp.sagepub.com/cgi/reprint/22/1/3">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.iovs.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.iovs.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.iovs.org/"><IMG ALT="IOVS" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/iovs.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. E. Perez, S. Lumayag, B. Kovacs, E. J. Mufson, and S. Xu<BR>
	<STRONG>{beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease</STRONG><BR>
	
		
			Invest. Ophthalmol. Vis. Sci.,
		
	
        
        February&nbsp;1,&nbsp;2009;
	
	50(2):
	
	793 - 800.
<BR>
<A HREF="http://www.iovs.org/cgi/content/abstract/50/2/793">[Abstract]</A>


<A HREF="http://www.iovs.org/cgi/content/full/50/2/793">[Full Text]</A>

<A HREF="http://www.iovs.org/cgi/reprint/50/2/793">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jnm.snmjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jnm.snmjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jnm.snmjournals.org/"><IMG ALT="JNM" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jnumed.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. J. O'Keefe, T. H. Saunder, S. Ng, U. Ackerman, H. J. Tochon-Danguy, J. G. Chan, S. Gong, T. Dyrks, S. Lindemann, G. Holl,  <em>et al.</em><BR>
	<STRONG>Radiation Dosimetry of {beta}-Amyloid Tracers 11C-PiB and 18F-BAY94-9172</STRONG><BR>
	
		
			J. Nucl. Med.,
		
	
        
        February&nbsp;1,&nbsp;2009;
	
	50(2):
	
	309 - 315.
<BR>
<A HREF="http://jnm.snmjournals.org/cgi/content/abstract/50/2/309">[Abstract]</A>


<A HREF="http://jnm.snmjournals.org/cgi/content/full/50/2/309">[Full Text]</A>

<A HREF="http://jnm.snmjournals.org/cgi/reprint/50/2/309">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Boissonneault, I. Plante, S. Rivest, and P. Provost<BR>
	<STRONG>MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse {beta}-Amyloid Precursor Protein-converting Enzyme 1</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;23,&nbsp;2009;
	
	284(4):
	
	1971 - 1981.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/284/4/1971">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/284/4/1971">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/284/4/1971">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Cheng, K. S. Vetrivel, R. C. Drisdel, X. Meckler, P. Gong, J. Y. Leem, T. Li, M. Carter, Y. Chen, P. Nguyen,  <em>et al.</em><BR>
	<STRONG>S-Palmitoylation of {gamma}-Secretase Subunits Nicastrin and APH-1</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;16,&nbsp;2009;
	
	284(3):
	
	1373 - 1384.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/284/3/1373">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/284/3/1373">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/284/3/1373">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Ho, X. Liu, and T. C. Sudhof<BR>
	<STRONG>Deletion of Mint Proteins Decreases Amyloid Production in Transgenic Mouse Models of Alzheimer's Disease</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        December&nbsp;31,&nbsp;2008;
	
	28(53):
	
	14392 - 14400.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/53/14392">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/53/14392">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/53/14392">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. Koenigsknecht-Talboo, M. Meyer-Luehmann, M. Parsadanian, M. Garcia-Alloza, M. B. Finn, B. T. Hyman, B. J. Bacskai, and D. M. Holtzman<BR>
	<STRONG>Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-A{beta} Antibody Administration in PDAPP Mice</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        December&nbsp;24,&nbsp;2008;
	
	28(52):
	
	14156 - 14164.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/52/14156">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/52/14156">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/52/14156">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Yamada, T. Hashimoto, C. Yabuki, Y. Nagae, M. Tachikawa, D. K. Strickland, Q. Liu, G. Bu, J. M. Basak, D. M. Holtzman,  <em>et al.</em><BR>
	<STRONG>The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid {beta} Peptides in an in Vitro Model of the Blood-Brain Barrier Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;12,&nbsp;2008;
	
	283(50):
	
	34554 - 34562.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/50/34554">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/50/34554">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/50/34554">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. H. Han, M.-l. Zhou, F. Abousaleh, R. P. Brendza, H. H. Dietrich, J. Koenigsknecht-Talboo, J. R. Cirrito, E. Milner, D. M. Holtzman, and G. J. Zipfel<BR>
	<STRONG>Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-{beta} Peptide, Partial Restoration via {gamma}-Secretase Inhibition</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        December&nbsp;10,&nbsp;2008;
	
	28(50):
	
	13542 - 13550.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/50/13542">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/50/13542">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/50/13542">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://stke.sciencemag.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://stke.sciencemag.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://stke.sciencemag.org/"><IMG ALT="Sci Signal" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/sigtrans.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Zurhove, C. Nakajima, J. Herz, H. H. Bock, and P. May<BR>
	<STRONG>{gamma}-Secretase Limits the Inflammatory Response Through the Processing of LRP1</STRONG><BR>
	
		
			Sci. Signal.,
		
	
        
        November&nbsp;25,&nbsp;2008;
	
	1(47):
	
	ra15 - ra15.
<BR>
<A HREF="http://stke.sciencemag.org/cgi/content/abstract/1/47/ra15">[Abstract]</A>


<A HREF="http://stke.sciencemag.org/cgi/content/full/1/47/ra15">[Full Text]</A>

<A HREF="http://stke.sciencemag.org/cgi/reprint/1/47/ra15">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Oddo, A. Caccamo, B. Tseng, D. Cheng, V. Vasilevko, D. H. Cribbs, and F. M. LaFerla<BR>
	<STRONG>Blocking A{beta}42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between A{beta} and Tau Pathology</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        November&nbsp;19,&nbsp;2008;
	
	28(47):
	
	12163 - 12175.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/47/12163">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/47/12163">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/47/12163">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. W. Hung, G. D. Ciccotosto, E. Giannakis, D. J. Tew, K. Perez, C. L. Masters, R. Cappai, J. D. Wade, and K. J. Barnham<BR>
	<STRONG>Amyloid-{beta} Peptide (A{beta}) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: A{beta} Dimers and Trimers Correlate with Neurotoxicity</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        November&nbsp;12,&nbsp;2008;
	
	28(46):
	
	11950 - 11958.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/46/11950">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/46/11950">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/46/11950">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	I. Y. Tamboli, K. Prager, D. R. Thal, K. M. Thelen, I. Dewachter, C. U. Pietrzik, P. St. George-Hyslop, S. S. Sisodia, B. De Strooper, M. T. Heneka,  <em>et al.</em><BR>
	<STRONG>Loss of {gamma}-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        November&nbsp;12,&nbsp;2008;
	
	28(46):
	
	12097 - 12106.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/46/12097">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/46/12097">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/46/12097">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jme.endocrinology-journals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jme.endocrinology-journals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jme.endocrinology-journals.org/"><IMG ALT="J Mol Endocrinol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jme.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Peri and M. Serio<BR>
	<STRONG>Neuroprotective effects of the Alzheimer's disease-related gene seladin-1</STRONG><BR>
	
		
			J. Mol. Endocrinol.,
		
	
        
        November&nbsp;1,&nbsp;2008;
	
	41(5):
	
	251 - 261.
<BR>
<A HREF="http://jme.endocrinology-journals.org/cgi/content/abstract/41/5/251">[Abstract]</A>


<A HREF="http://jme.endocrinology-journals.org/cgi/content/full/41/5/251">[Full Text]</A>

<A HREF="http://jme.endocrinology-journals.org/cgi/reprint/41/5/251">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	T. Suzuki and T. Nakaya<BR>
	<STRONG>Regulation of Amyloid {beta}-Protein Precursor by Phosphorylation and Protein Interactions</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;31,&nbsp;2008;
	
	283(44):
	
	29633 - 29637.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/44/29633">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/44/29633">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/44/29633">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Jan, O. Gokce, R. Luthi-Carter, and H. A. Lashuel<BR>
	<STRONG>The Ratio of Monomeric to Aggregated Forms of A{beta}40 and A{beta}42 Is an Important Determinant of Amyloid-{beta} Aggregation, Fibrillogenesis, and Toxicity</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;17,&nbsp;2008;
	
	283(42):
	
	28176 - 28189.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/42/28176">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/42/28176">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/42/28176">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Li, S. Koshiba, F. Hayashi, N. Tochio, T. Tomizawa, T. Kasai, T. Yabuki, Y. Motoda, T. Harada, S. Watanabe,  <em>et al.</em><BR>
	<STRONG>Structure of the C-terminal Phosphotyrosine Interaction Domain of Fe65L1 Complexed with the Cytoplasmic Tail of Amyloid Precursor Protein Reveals a Novel Peptide Binding Mode</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;3,&nbsp;2008;
	
	283(40):
	
	27165 - 27178.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/40/27165">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/40/27165">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/40/27165">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.molbiolcell.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.molbiolcell.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.molbiolcell.org/"><IMG ALT="Mol. Biol. Cell" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/molbiolcell.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L.-H. Kuo, M.-K. Hu, W.-M. Hsu, Y.-T. Tung, B.-J. Wang, W.-W. Tsai, C.-T. Yen, and Y.-F. Liao<BR>
	<STRONG>Tumor Necrosis Factor-{alpha}-elicited Stimulation of {gamma}-Secretase Is Mediated by c-Jun N-terminal Kinase-dependent Phosphorylation of Presenilin and Nicastrin</STRONG><BR>
	
		
			Mol. Biol. Cell,
		
	
        
        October&nbsp;1,&nbsp;2008;
	
	19(10):
	
	4201 - 4212.
<BR>
<A HREF="http://www.molbiolcell.org/cgi/content/abstract/19/10/4201">[Abstract]</A>


<A HREF="http://www.molbiolcell.org/cgi/content/full/19/10/4201">[Full Text]</A>

<A HREF="http://www.molbiolcell.org/cgi/reprint/19/10/4201">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. A. Kyriazis, Z. Wei, M. Vandermey, D.-G. Jo, O. Xin, M. P. Mattson, and S. L. Chan<BR>
	<STRONG>Numb Endocytic Adapter Proteins Regulate the Transport and Processing of the Amyloid Precursor Protein in an Isoform-dependent Manner: IMPLICATIONS FOR ALZHEIMER DISEASE PATHOGENESIS</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        September&nbsp;12,&nbsp;2008;
	
	283(37):
	
	25492 - 25502.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/37/25492">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/37/25492">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/37/25492">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://cpt.sagepub.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://cpt.sagepub.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://cpt.sagepub.com/"><IMG ALT="J CARDIOVASC PHARMACOL THER" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/spcpt.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. S. Kostapanos, H. J. Milionis, and M. S. Elisaf<BR>
	<STRONG>An Overview of the Extra-Lipid Effects of Rosuvastatin</STRONG><BR>
	
		
			Journal of Cardiovascular Pharmacology and Therapeutics,
		
	
        
        September&nbsp;1,&nbsp;2008;
	
	13(3):
	
	157 - 174.
<BR>
<A HREF="http://cpt.sagepub.com/cgi/content/abstract/13/3/157">[Abstract]</A>




<A HREF="http://cpt.sagepub.com/cgi/reprint/13/3/157">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jpet.aspetjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jpet.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jpet.aspetjournals.org/"><IMG ALT="J. Pharmacol. Exp. Ther." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jpet.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki,  <em>et al.</em><BR>
	<STRONG>Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease</STRONG><BR>
	
		
			J. Pharmacol. Exp. Ther.,
		
	
        
        September&nbsp;1,&nbsp;2008;
	
	326(3):
	
	739 - 744.
<BR>
<A HREF="http://jpet.aspetjournals.org/cgi/content/abstract/326/3/739">[Abstract]</A>


<A HREF="http://jpet.aspetjournals.org/cgi/content/full/326/3/739">[Full Text]</A>

<A HREF="http://jpet.aspetjournals.org/cgi/reprint/326/3/739">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://endo.endojournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://endo.endojournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://endo.endojournals.org/"><IMG ALT="Endocrinology" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/endo.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. Luciani, C. Deledda, F. Rosati, S. Benvenuti, I. Cellai, F. Dichiara, M. Morello, G. B. Vannelli, G. Danza, M. Serio,  <em>et al.</em><BR>
	<STRONG>Seladin-1 Is a Fundamental Mediator of the Neuroprotective Effects of Estrogen in Human Neuroblast Long-Term Cell Cultures</STRONG><BR>
	
		
			Endocrinology,
		
	
        
        September&nbsp;1,&nbsp;2008;
	
	149(9):
	
	4256 - 4266.
<BR>
<A HREF="http://endo.endojournals.org/cgi/content/abstract/149/9/4256">[Abstract]</A>


<A HREF="http://endo.endojournals.org/cgi/content/full/149/9/4256">[Full Text]</A>

<A HREF="http://endo.endojournals.org/cgi/reprint/149/9/4256">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. Osenkowski, W. Ye, R. Wang, M. S. Wolfe, and D. J. Selkoe<BR>
	<STRONG>Direct and Potent Regulation of {gamma}-Secretase by Its Lipid Microenvironment</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;15,&nbsp;2008;
	
	283(33):
	
	22529 - 22540.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/33/22529">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/33/22529">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/33/22529">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jpet.aspetjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jpet.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jpet.aspetjournals.org/"><IMG ALT="J. Pharmacol. Exp. Ther." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jpet.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. E. Meredith Jr., L. A. Thompson, J. H. Toyn, L. Marcin, D. M. Barten, J. Marcinkeviciene, L. Kopcho, Y. Kim, A. Lin, V. Guss,  <em>et al.</em><BR>
	<STRONG>P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid {beta} Reduction by {beta}-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice</STRONG><BR>
	
		
			J. Pharmacol. Exp. Ther.,
		
	
        
        August&nbsp;1,&nbsp;2008;
	
	326(2):
	
	502 - 513.
<BR>
<A HREF="http://jpet.aspetjournals.org/cgi/content/abstract/326/2/502">[Abstract]</A>


<A HREF="http://jpet.aspetjournals.org/cgi/content/full/326/2/502">[Full Text]</A>

<A HREF="http://jpet.aspetjournals.org/cgi/reprint/326/2/502">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Osawa, S. Funamoto, M. Nobuhara, S. Wada-Kakuda, M. Shimojo, S. Yagishita, and Y. Ihara<BR>
	<STRONG>Phosphoinositides Suppress {gamma}-Secretase in Both the Detergent-soluble and -insoluble States</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;11,&nbsp;2008;
	
	283(28):
	
	19283 - 19292.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/28/19283">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/28/19283">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/28/19283">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jem.rupress.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jem.rupress.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jem.rupress.org/"><IMG ALT="JEM" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Bacher, R. Dodel, B. Aljabari, K. Keyvani, P. Marambaud, R. Kayed, C. Glabe, N. Goertz, A. Hoppmann, N. Sachser,  <em>et al.</em><BR>
	<STRONG>CNI-1493 inhibits A{beta} production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease</STRONG><BR>
	
		
			J. Exp. Med.,
		
	
        
        July&nbsp;7,&nbsp;2008;
	
	205(7):
	
	1593 - 1599.
<BR>
<A HREF="http://jem.rupress.org/cgi/content/abstract/205/7/1593">[Abstract]</A>


<A HREF="http://jem.rupress.org/cgi/content/full/205/7/1593">[Full Text]</A>

<A HREF="http://jem.rupress.org/cgi/reprint/205/7/1593">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Iijima-Ando, S. A. Hearn, L. Granger, C. Shenton, A. Gatt, H.-C. Chiang, I. Hakker, Y. Zhong, and K. Iijima<BR>
	<STRONG>Overexpression of Neprilysin Reduces Alzheimer Amyloid-{beta}42 (A{beta}42)-induced Neuron Loss and Intraneuronal A{beta}42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;4,&nbsp;2008;
	
	283(27):
	
	19066 - 19076.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/27/19066">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/27/19066">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/27/19066">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. R. Mowrer and M. S. Wolfe<BR>
	<STRONG>Promotion of BACE1 mRNA Alternative Splicing Reduces Amyloid {beta}-Peptide Production</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;4,&nbsp;2008;
	
	283(27):
	
	18694 - 18701.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/27/18694">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/27/18694">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/27/18694">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.pnas.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.pnas.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.pnas.org/"><IMG ALT="Proc. Natl. Acad. Sci. USA" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/pnas.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. S. Jacobsen, T. A. Comery, R. L. Martone, H. Elokdah, D. L. Crandall, A. Oganesian, S. Aschmies, Y. Kirksey, C. Gonzales, J. Xu,  <em>et al.</em><BR>
	<STRONG>Enhanced clearance of A{beta} in brain by sustaining the plasmin proteolysis cascade</STRONG><BR>
	
		
			PNAS,
		
	
        
        June&nbsp;24,&nbsp;2008;
	
	105(25):
	
	8754 - 8759.
<BR>
<A HREF="http://www.pnas.org/cgi/content/abstract/105/25/8754">[Abstract]</A>


<A HREF="http://www.pnas.org/cgi/content/full/105/25/8754">[Full Text]</A>

<A HREF="http://www.pnas.org/cgi/reprint/105/25/8754">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Shimojo, N. Sahara, T. Mizoroki, S. Funamoto, M. Morishima-Kawashima, T. Kudo, M. Takeda, Y. Ihara, H. Ichinose, and A. Takashima<BR>
	<STRONG>Enzymatic Characteristics of I213T Mutant Presenilin-1/{gamma}-Secretase in Cell Models and Knock-in Mouse Brains: FAMILIAL ALZHEIMER DISEASE-LINKED MUTATION IMPAIRS {gamma}-SITE CLEAVAGE OF AMYLOID PRECURSOR PROTEIN C-TERMINAL FRAGMENT {beta}</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        June&nbsp;13,&nbsp;2008;
	
	283(24):
	
	16488 - 16496.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/24/16488">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/24/16488">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/24/16488">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.iovs.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.iovs.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.iovs.org/"><IMG ALT="IOVS" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/iovs.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Koyama, S. Matsuzaki, F. Gomi, K. Yamada, T. Katayama, K. Sato, T. Kumada, A. Fukuda, S. Matsuda, Y. Tano,  <em>et al.</em><BR>
	<STRONG>Induction of Amyloid {beta} Accumulation by ER Calcium Disruption and Resultant Upregulation of Angiogenic Factors in ARPE19 Cells</STRONG><BR>
	
		
			Invest. Ophthalmol. Vis. Sci.,
		
	
        
        June&nbsp;1,&nbsp;2008;
	
	49(6):
	
	2376 - 2383.
<BR>
<A HREF="http://www.iovs.org/cgi/content/abstract/49/6/2376">[Abstract]</A>


<A HREF="http://www.iovs.org/cgi/content/full/49/6/2376">[Full Text]</A>

<A HREF="http://www.iovs.org/cgi/reprint/49/6/2376">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://mcb.asm.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://mcb.asm.org/"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Shimizu, A. Tosaki, K. Kaneko, T. Hisano, T. Sakurai, and N. Nukina<BR>
	<STRONG>Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid {beta} Protein Production</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        June&nbsp;1,&nbsp;2008;
	
	28(11):
	
	3663 - 3671.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/28/11/3663">[Abstract]</A>


<A HREF="http://mcb.asm.org/cgi/content/full/28/11/3663">[Full Text]</A>

<A HREF="http://mcb.asm.org/cgi/reprint/28/11/3663">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. Zhang, Y. Dong, G. Zhang, R. D. Moir, W. Xia, Y. Yue, M. Tian, D. J. Culley, G. Crosby, R. E. Tanzi,  <em>et al.</em><BR>
	<STRONG>The Inhalation Anesthetic Desflurane Induces Caspase Activation and Increases Amyloid {beta}-Protein Levels under Hypoxic Conditions</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;2,&nbsp;2008;
	
	283(18):
	
	11866 - 11875.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/18/11866">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/18/11866">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/18/11866">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://joe.endocrinology-journals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://joe.endocrinology-journals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://joe.endocrinology-journals.org/"><IMG ALT="J Endocrinol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/joe.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S Benvenuti, P Luciani, I Cellai, C Deledda, S Baglioni, R Saccardi, S Urbani, F Francini, R Squecco, C Giuliani,  <em>et al.</em><BR>
	<STRONG>Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors</STRONG><BR>
	
		
			J. Endocrinol.,
		
	
        
        May&nbsp;1,&nbsp;2008;
	
	197(2):
	
	437 - 446.
<BR>
<A HREF="http://joe.endocrinology-journals.org/cgi/content/abstract/197/2/437">[Abstract]</A>


<A HREF="http://joe.endocrinology-journals.org/cgi/content/full/197/2/437">[Full Text]</A>

<A HREF="http://joe.endocrinology-journals.org/cgi/reprint/197/2/437">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://ajp.amjpathol.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajp.amjpathol.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://ajp.amjpathol.org/"><IMG ALT="Am. J. Pathol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/amjpathol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. S. El-Amouri, H. Zhu, J. Yu, R. Marr, I. M. Verma, and M. S. Kindy<BR>
	<STRONG>Neprilysin: An Enzyme Candidate to Slow the Progression of Alzheimer's Disease</STRONG><BR>
	
		
			Am. J. Pathol.,
		
	
        
        May&nbsp;1,&nbsp;2008;
	
	172(5):
	
	1342 - 1354.
<BR>
<A HREF="http://ajp.amjpathol.org/cgi/content/abstract/172/5/1342">[Abstract]</A>


<A HREF="http://ajp.amjpathol.org/cgi/content/full/172/5/1342">[Full Text]</A>

<A HREF="http://ajp.amjpathol.org/cgi/reprint/172/5/1342">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. Lee, C. Retamal, L. Cuitino, A. Caruano-Yzermans, J.-E. Shin, P. van Kerkhof, M.-P. Marzolo, and G. Bu<BR>
	<STRONG>Adaptor Protein Sorting Nexin 17 Regulates Amyloid Precursor Protein Trafficking and Processing in the Early Endosomes</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;25,&nbsp;2008;
	
	283(17):
	
	11501 - 11508.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/17/11501">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/17/11501">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/17/11501">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jneurosci.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jneurosci.org/"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. Zhang, Y. Dong, B. Zhang, F. Ichinose, X. Wu, D. J. Culley, G. Crosby, R. E. Tanzi, and Z. Xie<BR>
	<STRONG>Isoflurane-Induced Caspase-3 Activation Is Dependent on Cytosolic Calcium and Can Be Attenuated by Memantine</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        April&nbsp;23,&nbsp;2008;
	
	28(17):
	
	4551 - 4560.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/28/17/4551">[Abstract]</A>


<A HREF="http://www.jneurosci.org/cgi/content/full/28/17/4551">[Full Text]</A>

<A HREF="http://www.jneurosci.org/cgi/reprint/28/17/4551">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Y. H. Hook, M. Kindy, and G. Hook<BR>
	<STRONG>Inhibitors of Cathepsin B Improve Memory and Reduce {beta}-Amyloid in Transgenic Alzheimer Disease Mice Expressing the Wild-type, but Not the Swedish Mutant, {beta}-Secretase Site of the Amyloid Precursor Protein</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;21,&nbsp;2008;
	
	283(12):
	
	7745 - 7753.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/12/7745">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/12/7745">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/12/7745">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://tpx.sagepub.com/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://tpx.sagepub.com/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://tpx.sagepub.com/"><IMG ALT="Toxicol Pathol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/sptpx.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Calderon-Garciduenas, A. C. Solt, C. Henriquez-Roldan, R. Torres-Jardon, B. Nuse, L. Herritt, R. Villarreal-Calderon, N. Osnaya, I. Stone, R. Garcia,  <em>et al.</em><BR>
	<STRONG>Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid {beta}-42 and {alpha}-Synuclein in Children and Young Adults</STRONG><BR>
	
		
			Toxicol Pathol,
		
	
        
        February&nbsp;1,&nbsp;2008;
	
	36(2):
	
	289 - 310.
<BR>
<A HREF="http://tpx.sagepub.com/cgi/content/abstract/36/2/289">[Abstract]</A>


<A HREF="http://tpx.sagepub.com/cgi/content/full/36/2/289">[Full Text]</A>

<A HREF="http://tpx.sagepub.com/cgi/reprint/36/2/289">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://hmg.oxfordjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://hmg.oxfordjournals.org/"><IMG ALT="Hum Mol Genet" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/hmg.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Ganguly, R.M. R. Feldman, and M. Guo<BR>
	<STRONG>ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila</STRONG><BR>
	
		
			Hum. Mol. Genet.,
		
	
        
        January&nbsp;15,&nbsp;2008;
	
	17(2):
	
	293 - 302.
<BR>
<A HREF="http://hmg.oxfordjournals.org/cgi/content/abstract/17/2/293">[Abstract]</A>


<A HREF="http://hmg.oxfordjournals.org/cgi/content/full/17/2/293">[Full Text]</A>

<A HREF="http://hmg.oxfordjournals.org/cgi/reprint/17/2/293">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Yagishita, M. Morishima-Kawashima, S. Ishiura, and Y. Ihara<BR>
	<STRONG>A 46 Is Processed to A 40 and A 43, but Not to A 42, in the Low Density Membrane Domains</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;11,&nbsp;2008;
	
	283(2):
	
	733 - 738.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/283/2/733">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/283/2/733">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/283/2/733">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://mcb.asm.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://mcb.asm.org/"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Tagami, M. Okochi, K. Yanagida, A. Ikuta, A. Fukumori, N. Matsumoto, Y. Ishizuka-Katsura, T. Nakayama, N. Itoh, J. Jiang,  <em>et al.</em><BR>
	<STRONG>Regulation of Notch Signaling by Dynamic Changes in the Precision of S3 Cleavage of Notch-1</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        January&nbsp;1,&nbsp;2008;
	
	28(1):
	
	165 - 176.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/28/1/165">[Abstract]</A>


<A HREF="http://mcb.asm.org/cgi/content/full/28/1/165">[Full Text]</A>

<A HREF="http://mcb.asm.org/cgi/reprint/28/1/165">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.mcponline.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.mcponline.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.mcponline.org/"><IMG ALT="Mol. Cell. Proteomics" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/mcprot.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Bai, K. Markham, F. Chen, R. Weerasekera, J. Watts, P. Horne, Y. Wakutani, R. Bagshaw, P. M. Mathews, P. E. Fraser,  <em>et al.</em><BR>
	<STRONG>The in Vivo Brain Interactome of the Amyloid Precursor Protein</STRONG><BR>
	
		
			Mol. Cell. Proteomics,
		
	
        
        January&nbsp;1,&nbsp;2008;
	
	7(1):
	
	15 - 34.
<BR>
<A HREF="http://www.mcponline.org/cgi/content/abstract/7/1/15">[Abstract]</A>


<A HREF="http://www.mcponline.org/cgi/content/full/7/1/15">[Full Text]</A>

<A HREF="http://www.mcponline.org/cgi/reprint/7/1/15">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. G. Iben, R. E. Olson, L. A. Balanda, S. Jayachandra, B. J. Robertson, V. Hay, J. Corradi, C. V. C. Prasad, R. Zaczek, C. F. Albright,  <em>et al.</em><BR>
	<STRONG>Signal Peptide Peptidase and {gamma}-Secretase Share Equivalent Inhibitor Binding Pharmacology</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;21,&nbsp;2007;
	
	282(51):
	
	36829 - 36836.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/282/51/36829">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/282/51/36829">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/282/51/36829">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://bjr.birjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://bjr.birjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://bjr.birjournals.org/"><IMG ALT="Br. J. Radiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/bjradio.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S L PIMLOTT and K P EBMEIER<BR>
	<STRONG>SPECT imaging in dementia</STRONG><BR>
	
		
			Br. J. Radiol.,
		
	
        
        December&nbsp;1,&nbsp;2007;
	
	80(Special_Issue_2):
	
	S153 - S159.
<BR>
<A HREF="http://bjr.birjournals.org/cgi/content/abstract/80/Special_Issue_2/S153">[Abstract]</A>


<A HREF="http://bjr.birjournals.org/cgi/content/full/80/Special_Issue_2/S153">[Full Text]</A>

<A HREF="http://bjr.birjournals.org/cgi/reprint/80/Special_Issue_2/S153">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Z. Ren, D. Schenk, G. S. Basi, and I. P. Shapiro<BR>
	<STRONG>Amyloid  -Protein Precursor Juxtamembrane Domain Regulates Specificity of {gamma}-Secretase-dependent Cleavages</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;30,&nbsp;2007;
	
	282(48):
	
	35350 - 35360.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/282/48/35350">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/282/48/35350">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/282/48/35350">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.iovs.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.iovs.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.iovs.org/"><IMG ALT="IOVS" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/iovs.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	D. Goldblum, A. Kipfer-Kauer, G.-M. Sarra, S. Wolf, and B. E. Frueh<BR>
	<STRONG>Distribution of Amyloid Precursor Protein and Amyloid-{beta} Immunoreactivity in DBA/2J Glaucomatous Mouse Retinas</STRONG><BR>
	
		
			Invest. Ophthalmol. Vis. Sci.,
		
	
        
        November&nbsp;1,&nbsp;2007;
	
	48(11):
	
	5085 - 5090.
<BR>
<A HREF="http://www.iovs.org/cgi/content/abstract/48/11/5085">[Abstract]</A>


<A HREF="http://www.iovs.org/cgi/content/full/48/11/5085">[Full Text]</A>

<A HREF="http://www.iovs.org/cgi/reprint/48/11/5085">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://jpet.aspetjournals.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jpet.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://jpet.aspetjournals.org/"><IMG ALT="J. Pharmacol. Exp. Ther." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jpet.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. E. Goldstein, Y. Cao, T. Fiedler, J. Toyn, L. Iben, D. M. Barten, M. Pierdomenico, J. Corsa, C. V. C. Prasad, R. E. Olson,  <em>et al.</em><BR>
	<STRONG>Ex Vivo Occupancy of {gamma}-Secretase Inhibitors Correlates with Brain beta-Amyloid Peptide Reduction in Tg2576 Mice</STRONG><BR>
	
		
			J. Pharmacol. Exp. Ther.,
		
	
        
        October&nbsp;1,&nbsp;2007;
	
	323(1):
	
	102 - 108.
<BR>
<A HREF="http://jpet.aspetjournals.org/cgi/content/abstract/323/1/102">[Abstract]</A>


<A HREF="http://jpet.aspetjournals.org/cgi/content/full/323/1/102">[Full Text]</A>

<A HREF="http://jpet.aspetjournals.org/cgi/reprint/323/1/102">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://ajpcell.physiology.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpcell.physiology.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://ajpcell.physiology.org/"><IMG ALT="Am. J. Physiol. Cell Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/ajpcell.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	V. Lamarca, A. Sanz-Clemente, R. Perez-Pe, M. J. Martinez-Lorenzo, N. Halaihel, P. Muniesa, and J. A. Carrodeguas<BR>
	<STRONG>Two isoforms of PSAP/MTCH1 share two proapoptotic domains and multiple internal signals for import into the mitochondrial outer membrane</STRONG><BR>
	
		
			Am J Physiol Cell Physiol,
		
	
        
        October&nbsp;1,&nbsp;2007;
	
	293(4):
	
	C1347 - C1361.
<BR>
<A HREF="http://ajpcell.physiology.org/cgi/content/abstract/293/4/C1347">[Abstract]</A>


<A HREF="http://ajpcell.physiology.org/cgi/content/full/293/4/C1347">[Full Text]</A>

<A HREF="http://ajpcell.physiology.org/cgi/reprint/293/4/C1347">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.molbiolcell.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.molbiolcell.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.molbiolcell.org/"><IMG ALT="Mol. Biol. Cell" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/molbiolcell.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Z. Muresan and V. Muresan<BR>
	<STRONG>The Amyloid-beta Precursor Protein Is Phosphorylated via Distinct Pathways during Differentiation, Mitosis, Stress, and Degeneration</STRONG><BR>
	
		
			Mol. Biol. Cell,
		
	
        
        October&nbsp;1,&nbsp;2007;
	
	18(10):
	
	3835 - 3844.
<BR>
<A HREF="http://www.molbiolcell.org/cgi/content/abstract/18/10/3835">[Abstract]</A>


<A HREF="http://www.molbiolcell.org/cgi/content/full/18/10/3835">[Full Text]</A>

<A HREF="http://www.molbiolcell.org/cgi/reprint/18/10/3835">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	
		
 
 
 <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
 
 <TR BGCOLOR="#D9D4C5">
 
 
  <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"><BR>
   
  </TD>
 
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 
 <TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
 	<A HREF="http://www.jbc.org/"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
 </TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 <TD VALIGN="TOP" WIDTH="499" NOWRAP>
 <A HREF="http://www.jbc.org/"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="http://physrev.physiology.org/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="http://physrev.physiology.org/icons/shared/search/homelink.gif"></A><BR>
 <FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. J. Huttunen, S. Y. Guenette, C. Peach, C. Greco, W. Xia, D. Y. Kim, C. Barren, R. E. Tanzi, and D. M. Kovacs<BR>
	<STRONG>HtrA2 Regulates beta-Amyloid Precursor Protein (APP) Metabolism through Endoplasmic Reticulum-associated Degradation</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        September&nbsp;21,&nbsp;2007;
	
	282(38):
	
	28285 - 28295.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/282/38/28285">[Abstract]</A>


<A HREF="http://www.jbc.org/cgi/content/full/282/38/28285">[Full Text]</A>

<A HREF="http://www.jbc.org/cgi/reprint/282/38/28285">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="http://physrev.physiology.org/icons/spacer.gif">
 </FONT></TD>
 <TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="http://physrev.physiology.org/icons/spacer.gif"></TD>
 </TR>
 <TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>

	










<BR CLEAR=ALL>


	
	 
		
		
		  
			
	
		<table class="content_box_outer_table"
		 
			
				
					
						align="right"
					
				
			
		>
		
		
			<tr>
			<td>
		
	

<!-- beginning of inner table -->
	<table class="content_box_inner_table">
<!-- citation -->
	
		




	

	

	
		
			
<tr><td class="content_box_title_highlight" colspan="2">This Article</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				
				<strong><a href="http://physrev.physiology.org/cgi/content/abstract/81/2/741">
				Abstract</a></strong>
				 					<img alt="Freely available" width="32" height="7" border="0" src="http://physrev.physiology.org/icons/shared/toc/free.gif" />
				
	
				</td></tr>
			
		
		
	

	
	
	

	
	
	


	
	
	

	
	
	

	
	
	
	
	
	
	
	
	

	
		
		
	
	
		
	

	

	
		
			
		
	

	

	
	 

	
	 

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
		<strong>
		
		
		
			<a href="http://physrev.physiology.org/cgi/reprint/81/2/741">
		<strong>Full Text</strong> (PDF)</a>

 
		
		</strong>
		</td></tr>
	
	

	
	
	
	
	

	
	
	
	
	

	
	
	

	
	





	

	
		
	

	
		
	

	
		

	
		
		

			


	

			

			
		
	

			
	  
	

			

			

			
	
	




	
		
	

	
	









	
		
	





	
	
	

	
		
	

	 

	
	
		  
    

	

	

	

	








		
	
		
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;saveAlert=no&amp;cited_by_criteria_resid=physrev;81/2/741&amp;return_type=article&amp;return_url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741">
				Alert me when this article is cited</a></strong>
			</td></tr>
	

		
		

		
		

		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;saveAlert=no&amp;correction_criteria_value=81/2/741&amp;return_type=article&amp;return_url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741">
				Alert me if a correction is posted</a></strong>
			</td></tr>
		























			
		
			
			
			
				
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
					<strong><a rel="nofollow" href="http://physrev.physiology.org/cgi/citemap?id=physrev;81/2/741">
					Citation Map</a></strong>
				</td></tr>
		
	

			
			
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Services</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/mailafriend?url=http%3A%2F%2Fphysrev.physiology.org%2Fcgi%2Fcontent%2Ffull%2F81%2F2%2F741&amp;title=Alzheimer%27s+Disease%3A+Genes%2C+Proteins%2C+and+Therapy">
				Email this article to a friend</a></strong>
			</td></tr>
			
			


	

	

	

		
		



			
			
			
		
	

		
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
		<strong>
		<a href="http://physrev.physiology.org/cgi/search?qbe=physrev;81/2/741&amp;journalcode=physrev&amp;minscore=5000">
		Similar articles in this journal</a>
		</strong>
		</td></tr>


		


		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong>
				<a href="http://physrev.physiology.org/cgi/external_ref?access_num=physrev%3B81%2F2%2F741&amp;link_type=ISI_RelatedRecords">
				Similar articles in Web of Science</a></strong>
				</strong>
			</td></tr>
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/external_ref?access_num=11274343&amp;link_type=MED_NBRS">
				Similar articles in PubMed</a></strong>
			</td></tr>
		
	


		



			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/alerts/etoc">
				Alert me to new issues of the journal</a></strong>
			</td></tr>
		

		
		
	

		
		
		

			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
			<strong><a href="http://physrev.physiology.org/cgi/citmgr?gca=physrev;81/2/741">
			Download to citation manager</a></strong>
			</td></tr>
		
		
	


	
		
	

	



  			
		


	

	




	





		

		

	
	
	
		


	

	

	


	


<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Citing Articles</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="#otherarticles">
				Citing Articles via HighWire</a></strong>
			</td></tr>
	



	


	
		
		
		


			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong>
				
					
					<a href="http://physrev.physiology.org/cgi/external_ref?access_num=physrev%3B81%2F2%2F741&amp;link_type=ISI_Citing">
					Citing Articles via Web of Science (1912)</a>
				
				</strong>
			</td></tr>
		
	 
	

		
		
			
		

					
						
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=http://physrev.physiology.org/cgi/content/abstract/81/2/741&amp;link_type=GOOGLESCHOLAR">Citing Articles via Google Scholar</a></strong>
						</td></tr>		
						
				
			
		
		

	

	
	















	
		
			
				
				
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">Google Scholar</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://scholar.google.com/scholar?q=%22author%3AD. J.+author%3ASelkoe%22">
							Articles by Selkoe, D. J.</a></strong></td></tr>
				
				
			
		
		
	
	
	
	

		
			
				
					
						
						
						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=http://physrev.physiology.org/cgi/content/abstract/81/2/741&amp;link_type=GOOGLESCHOLARRELATED">Search for Related Content</a></strong>
						</td></tr>		
						
				
			
		
	










	





	
		
<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr><tr><td class="content_box_title" colspan="2">PubMed</td></tr>

	

	<tr><td class="content_box_space_between_sections" colspan="2"><img alt=" " width="200" height="1" src="http://physrev.physiology.org/icons/spacer.gif" /></td></tr>
			
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
				<strong><a href="http://physrev.physiology.org/cgi/external_ref?access_num=11274343&amp;link_type=PUBMED">
				PubMed Citation</a></strong>
			</td></tr>
		
	

	
		
		
			
				

						
		<tr><td width="4" class="content_box_arrow" valign="top"><img alt="Right arrow" width="4" height="11" border="0" src="http://physrev.physiology.org/icons/shared/misc/arrowTtrim.gif" /></td><td class="content_box_item">
							<strong><a target="_blank" href="http://physrev.physiology.org/cgi/external_ref?access_num=Selkoe+DJ&amp;link_type=AUTHORSEARCH">
							Articles by Selkoe, D. J.</a></strong>
						</td></tr>
				
			
		

		
	

	















	
	


	












	


































	
		

	

		
			
		
	 
		











	

	






































	</td></tr></table>
</td></tr></table> 


					
					
	

<BR CLEAR=ALL>









        
                
	<P>
	<HR NOSHADE ALIGN=LEFT WIDTH=450>
	
	<TABLE CELLPADDING=2 CELLSPACING=2 WIDTH=450>
	<TR>
		<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/help/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">HELP</FONT></A></FONT></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/cgi/feedback"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/subscriptions"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/contents-by-date.0.shtml"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/search.dtl"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="http://physrev.physiology.org/content/vol81/issue2/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>
	</TR>
	</TABLE>
	
	
        <TABLE CELLPADDING=2 CELLSPACING=2 WIDTH=


500


>
        <TR>
                <TD ALIGN=CENTER VALIGN=TOP BGCOLOR=003399 NOWRAP><A STYLE="text-decoration: none" HREF="http://www.physiology.org/"><FONT SIZE=-2 COLOR=FFFFFF FACE="arial,helvetica">Visit Other APS Journals Online</A></TD>
        </TR>
        </TABLE>

	
<script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> 
</script> 
<script type="text/javascript"> 
  _uacct = "UA-2924550-1"
  _udn="physiology.org"
  urchinTracker();
</script>

	
        




</BODY>

<!-- Mirrored from physrev.physiology.org/cgi/content/full/81/2/741 by HTTrack Website Copier/3.x [XR&CO'2010], Fri, 16 Jul 2010 00:29:24 GMT -->
</HTML>
